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Abstract 
Breast cancer is the leading cause of death in women in the western countries. The 
diagnosis of breast cancer at the earlier stage may be particularly important since it 
provides early treatment, this will decreases the chance of cancer spreading and increase 
the survival rates. The hard work is the early detection of any tissues abnormal and 
confirmation of their cancerous natures. In additionally, finding abnormal on very early 
stage can also affected by poor quality of image and other problems that might show on 
a mammogram.  
Mammograms are high resolution x-rays of the breast that are widely used to screen for 
cancer in women. This report describes the stages of development of a novel 
representation of Cartesian Genetic programming as part of a computer aided diagnosis 
system. Specifically, this work is concerned with automated recognition of 
microcalcifications, one of the key structures used to identify cancer. Results are 
presented for the application of the proposed algorithm to a number of mammogram 
sections taken from the Lawrence Livermore National Laboratory Database. 
The performance of any algorithm such as evolutionary algorithm is only good as the 
data it is trained on. More specifically, the class represented in the training data must 
consist of the true examples or else reliable classifications. Considering the difficulties 
in obtaining a previously constructed database, there is a new database has been 
construct to avoiding pitfalls and lead on the novel evolutional algorithm Multi-
chromosome Cartesian genetic programming the success on classification of 
microcalcifications in mammograms. 
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1 Introduction 
Each year, breast cancer accounts for one third of cancers in women in the western 
world. In 2005, it caused the death of 10,500 women in the UK and therefore is one of 
the most common cancers in women and the second most common death cancer. [1] 
In 1988, breast cancer screening was introduced and deaths caused by breast cancer 
have declined. The survival rate for people diagnosed as having breast cancer has 
increased, since detection of breast cancer in the early stages. Screening is therefore 
essential in reducing deaths from breast cancer and it is important to make this accurate. 
It has been shown in research that [2]screening could reduce the mortality rate of the 
regularly screened women by 35% in the UK.  
There are several modalities of screening patients, such as ultrasound, magnetic 
resonance imaging and mammograms, and the main method of screening patients is the 
mammogram, which is a high resolution X-ray of the breast. Refer to [2] [3] [4]the basis 
of several clinical trials, the World Health Organization announced in [5] in 2002 that 
screening mammography for women aged between 50 and 69 years reduced the rate of 
death from breast cancer by 25%. Mammography is X- ray imaging which allows the 
radiologist to see the details of the breast.  It uses does ironing radiation to create 
images with lower energy X-ray compared to regular radiography screening used in  
bones. This is high resolution, high contrast film and the goal of mammography is to 
achieve early detection of breast cancer. For the average woman, according to [5], the 
US Food and Drug Administration (FDA) pointed out that mammography could detect 
85 to 90 percent of breast cancer for women aged 50 and over, the FDA also showed the 
evidence that mammography could discover a lump up to 2 years before it could be felt. 
18 
 
[7] shows about 15% of cancers have not been detected on a mammogram film. There 
are several reasons for this, such as the differentiations of the tissue between the 
appearance of cancerous and normal parenchyma; the morphology findings which are 
not related with the cancer and possible miss diagnosis from radiologist caused by 
visual fatigue. Generally, each mammogram image is checked by one or two 
radiologists for improving the sensitivity. Nevertheless, double reading makes the 
process inefficient from a medical point of view because the cost to train a radiologist is 
high just to ensure a small group of specialists is available at each given medical 
institution, thus reducing productivity. Therefore several researchers have tried to use 
the Computer Aided Detection/Diagnosis System (CAD) to detect or classify cancer in 
digital mammograms as a second opinion for radiologists. CAD systems help scan 
digital mammograms to support preventive medical check-ups. Consequently, CAD 
systems focus on specific aspects of the diagnostic process, such as identification of 
microcalcifications clusters or the detection of irregular tissue structures, where either of 
these suggests the specific abnormalities. It is fundamentally based on pattern 
recognition, normally many images are required to optimize the algorithm, and digital 
mammograms are copied to a CAD server. Therefore, a mature mammogram data set is 
really important for CAD to analyse in several steps. 
The process of identifying and evaluating signs of cancer from mammograms is a very 
difficult and time consuming task, usually requiring skilled and experienced radiologists. 
Two fully trained radiologists are usually required for each diagnosis. However by its 
nature, this assessment is highly subjective and susceptible to errors and can easily lead 
to cancers being missed and patients being misdiagnosed. CAD systems have the 
potential to help in two main ways: (i) the detection of suspicious areas in the 
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mammogram that require further investigation and (ii) the classification of such areas as 
cancerous (malignant) or non-cancerous (benign) [5]. 
The radiologist is looking for several things when reviewing a mammogram such as 
clusters of white specks called microcalcifications, distortions, special patterns or tissue 
density, any mass and its shape, also the differences between the images of both breasts.  
The two most powerful indicators of cancer can be seen on mammograms are spiculated 
masses and microcalcifications. It is difficult to distinguish between malignant and 
benign and malignant microcalcifications. Although most processes are benign, it is also 
found that malignant processes could be identified easier by looking at 
microcalcifications that occur as a result of the malignant process.  
Over recent years, there has been much research into the application of CAD to breast 
cancer using numerous different approaches. However the CAD systems have a few 
limitations that are most CAD systems are based on classical image processing 
operations that are limited to the general understanding of how malignancies are found, 
the limitation of practical implementation and limitation of the classical image 
processing operations. One method to overcome these problems is to use an 
evolutionary algorithm. Evolutionary Algorithms have the great advantage that they are 
based on learning how to do a task rather than just following a sequence of orders. The 
ultimate aim of our work is to assess the potential benefit of a new representation of 
evolutionary algorithm called Multiple chromosomes Cartesian genetic programming in 
the classification of mammograms as part of a CAD system and determine whether 
further development of such algorithms will lead to a more confident diagnosis.   
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To support this investigation, there are 2 sets of data (mammograms) taken from the 
Lawrence Livermore National Laboratory database (LLNL) and York District Hospital 
(YDH). The set of data in LLNL is used to train and test the evolutionary algorithms, 
and then another set of data from YDH will be used to verify the multi-chromosome 
CGP network. This gives strong evidence in developing an algorithm that could reliably 
distinguish between those microcalcifications indicating cancer or those indicating 
benign. 
1.1 Thesis Organisation 
This thesis is organised into three main segments. Chapters 1 to 4 introduce the 
concepts of background, related work in computer detected system, and genetic 
programming. Chapters 6 to 7 describe the novel contributions of this research.  
Specifically: 
Chapter 1: Overall introduction 
Chapter 2: Reviews of breast cancer screening Modalities especially focusing on 
mammography 
Chapter 3: Reviews of related work in CAD system in past years  
Chapter 4: Introduces Cartesians Genetic Programming; discussing the motivation 
behind the approach and its implementation. 
Chapter 5: Reviews image data sets especially mammography data in research  
Chapter 6: Constructs a dataset and designed Multi chromosome Cartesian Genetic 
Programming network for automatic analysis of mammograms 
21 
 
Chapter 7: Presents experimental results on Multi-chromosome Cartesians Genetic 
Programming in two stages: detection of microcalcifications and classification of 
microcalcifications  
Chapter 8: summarises, draw conclusions, and offers some speculative suggestions 
for future research. 
1.2 Hypothesis 
The work presented in this thesis addresses the following hypothesis 
―Multi-chromosome Cartesian Genetic programming is an effective evolutionary 
algorithm to facilitate automatic analysis of mammograms.‖  
In this automatic analysis system, Multi-chromosome CGP network classify 
microcalcifications by using the raw pixel values, this self-learning algorithm has great 
advantages as they are based on learning how to do a task rather than just following a 
sequence of orders. This learning algorithm relies on its training dataset, therefore, a 
highly objective and dependable dataset has been constructed with standard protocol. 
1.3 Contribution 
The current study was based on these issues:  
 To show that Multi-chromosome Cartesian Genetic Programming as a 
representation of Evolutionary Algorithm has potential benefit on automated 
analysis of mammograms.  
 To propose a specified mammographic image database, containing clearly 
identified and verified cases of benign or malignant tumours.  All cases were 
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evaluated and annotated in relation to the previously defined mammographic 
dataset properties. 
 Therefore, a general reviews of properties of medical dataset for diagnosis of 
breast cancer will be organised, with disadvantages of the existing datasets , 
at the end, a suggestion of a new dataset for diagnosis and classification of 
microcalcifications will be provide.  
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2  Breast Cancer screening mammography 
Breast cancer is one of the leading causes of death of women in western countries, it is 
also one of the leading common malignant tumours found in women around the world.  
Based on statistics from the world Health organisation(WHO), cancer is becoming one 
of the leading causes of death worldwide, accounting for 7.6 million deaths which is 
about 13% of all deaths in 2008 [8]. And there is an estimated about 12 million people 
dying from cancer by 2030 [9] . In all known cancers, breast cancer is currently the top 
cancer in women world wise and one of the leading deaths among women in high 
income countries. According to published statistics around the world, breast cancer has 
become a major health problem in women worldwide. In 2008, it was estimated that 
about 1.38 million women worldwide were diagnosed with breast cancer. In the UK, 
there were 48,034 new cases of breast cancer diagnosed and 47,693 cases appears in 
women [3]. In 2008, there were 12.116 deaths from breast cancer and 12,047 deaths 
among women [3].   
The number of deaths was in a direct ratio with age-specific mortality rates for female 
breast cancer.  The majority of breast cancers are diagnosed in women over 50 years of 
age and in younger women aged from 35 to 54. Breast cancer is the most common cause 
of all deaths from cancer [3]. However, mortality rate fell by 44% in women aged 40 to 
49 between 1989 and 2008 in Britain [3]; by 44% in women aged 50-64[3]; by 37% in 
women aged 65-69[3]; by 39% in women aged 15-39[3]; and by 19% in women over 
70[3]. There are several different causes for the reduction of breast cancer mortality rate 
including NHS screening policy, personal education of specialisation of care and the 
widespread adoption of tamoxifen treatment since 1992[4]. So far, the exact cause of 
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breast cancer is unknown so there is no effective prevention for breast cancer. However,  
efficient diagnosis of breast cancer at an early stage could lead to better chances of 
survival rate for women. Therefore, an early detection of breast cancer could reduce 
breast cancer mortality and morbidity rate and increases the chance for successful 
treatment. There are two major components for early detection of breast cancer in 
Britain: screening and online personal education and risk assessment (OPERA) [5]. 
Those at risk increases with ages, all women aged between 50 and 70 are invited for 
breast cancer screening every 3 years and also women aged over 70 and over are 
entitled to be screened [5].  
2.1 Introduction of breast cancer 
2.1.1     The Breast 
Breast cancer is a type of cancer originating from breast tissue, it occurs in humans and 
other mammals, while in the majority of cases, it overwhelmingly occurs in women, 
although breast cancer can also occur in men. The breast lies on the upper ventral region 
of the torso of the primate, in both the left and right side. In women, the budding breasts 
is one of the secondary significant characteristics.  
In human female breast anatomy, it belongs to the reproductive system. It is a porcine 
gland which can produce milk to feed babies or little children. The minor‘s breast shape 
is like a half ball, firm and persistently rich. During the latter half of gestation and 
lactation period, breasts enlarges due to hyperplasia of the mammary glands; after breast 
feeding, mammary gland starts to degenerate, while the breasts gets smaller. Older 
women have pendulous breasts due to loss of elastic fibre.   
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In women, the breast overlays the pectoralis major muscles and cover much of the chest 
area in front of the human rib cage from the level of the second rib to the sixth rib. 
Breast is also one of the significant organs of a woman. In women's breast, the breast 
has apocine glands which produce milk to feed babies. The centre of a breast is a nipple 
which is surrounded by an areola, the colour of that varies from pink to dark brown and 
it has many sebaceous glands. Women‘s breast is made up of connective tissues, fats, 
and many glands known as lobules. Lobules produces the fatty breast milk, which are 
then delivered through from the duct to nipple. From a functional aspect of breast, it is a 
gland that produces milk to feed offspring. The basic units of the breast are the terminal 
duct lobular units which could produce fatty breast milk as a mammary gland.  The 
mammary glands are situated in the breast in humans and in ruminants‘ udders 
Figure 2.1 shows the anatomic structure of a human female breast cross section scheme 
with the mammary gland. In women, the breast overlays the pectorals major muscles 
and cover much of the chest area in the front of the human rib cage from the level of the 
second rib to the sixth rib. One functional aspect of the breast is it is a gland that 
produces milk to feed offspring. The nipple of the breast is centred and surrounded by 
an areola. The basic units of the breast are the terminal duct lobular units which could 
produce fatty breast milk as a mammary gland. The basic components of a mammary 
gland are the alveoli, these alveoli join up together to form as lobules. Each lobule has a 
lactiferous duct which drains into the nipple. Nearly all breast cancer originates from the 
lobules or ducts of the mammary glands. One cause of a tumour in a mammary gland 
can be caused by an abnormal expression level of circulating hormones, or from a 
mechanical mammary stoma change. Under either of these two circumstances, 
mammary epithelial cells would grow out of control and eventually become as cancer.  
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Figure 2-1 Human female breast structure from [10] 
2.1.2 Symptoms of breast cancer 
There are several different types of cancer in the world and they all have in common a 
growth of abnormal cells, which grow out of control.  When the malignant tumour 
shows up in the breast, it forms breast cancer. Generally, patients are encouraged to do 
self-checking for lumps in the breast. Patients could also check for changes to the size 
and shape, or feel of their breasts to find whether there are any changes inside. The first 
noticeable symptom of breast cancer is a lump or mass which is painless, hard, uneven 
edge from the rest of the breast tissues. More than 80% of breast cancer cases are 
discovered when the woman feels a lump; however UK cancer research centre showed 
that although many women have breast lumps but around 90% are benign. Generally, 
benign breast lumps are: 
1. Chest wall 
2. Pectoralis muscle 
3. Lobules 
4. Nipple 
5. Areola 
6. Milk duct 
7. Fatty tissue 
8. Skin 
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 cysts : containing sacs of fluid in breast tissue;   
 Lumpiness: before a period, areas of breast cell changes causing the lumpiness to 
be more obvious, this could happen particularly in women over 35. 
 Fibro adenoma: it is a collection of fibrous glandular tissue and more common in 
young women.        
American Cancer Society [11]listed the following unusual changes with could be 
symptoms of breast cancer:  
 A lump or thickening in the underarm area. 
 A change in the size or shape of a breast. 
 Breast or nipple Pain. 
 Skin irritation or dimpling. 
 A change in the shape of nipple such as if it turns inward sinking into the breast 
or has an irregular shape 
 A redness, scaliness or thickening of the nipple or the surround area. 
 A nipple discharge other than breast milk, especially a blood.  
 Swelling of all or part of the breast. 
Like breast lumps, these symptoms do not necessarily mean cancer. Different types of 
breast cancer have different symptoms and patients are encouraged to see their GP once 
they find any of these symptoms.  
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2.1.3 Stages of cancer development 
Initially, breast cancer may not present any signs or symptoms or problems as the 
irregularities are too small to be noticed. A lump or any changes may be too small to 
cause any noticeable changes during the self-examination. Thus, mammography is 
successful if it finds out any irregularities earlier than a self examination. It is crucial for 
mammography needs to detect the tumour before it becomes palpable. 
 The source of breast cancer is as a cell which multiplies like a regular cell does, 
however the speed at which the cancer cell multiplies might be different because it 
depends on how the cell has been damaged. The process of growing a tumour could be 
divided into three stages.  Kopans [12] divides the whole process of growing a tumour 
into three stages. The first stage is called the occult stage. At this stage, cancer is not 
detectable, indicating that ―until there are well over a million cells‖ in a tumour, then 
the tumour enters  the second stage. During the second stage, the tumour starts to be 
recognised on mammograms; however it is still hard to be detected by self -examination. 
Therefore, at this time, the tumour is still in its preclinical phase and is not palpable. 
This period has been called the sojourn time. At the final stage, the tumour becomes big 
enough to be palpable and detectable in self-examination.  
Therefore, we need make sure we have  a screening programme which works well to 
detect tumours before they becomes palpable to enable the earlier treatment for patients. 
Having said the above, the time difference between finding the tumour by screening 
programme and finding the tumour by self examination is very little. And tumours do 
not have a fixed growth rate in their sojourn time, every tumour has its own growth rate 
and even change the growth rate during its development. This problem has become a 
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good discussion point for researchers who are concerned about the screening intervals. 
[12] describe a model to for better understanding of screening intervals. He mentioned 
that although the speed of at which the tumour grow varies and is never the same for 
different tumours, but it is generally possible to assume that tumours constantly start 
growing and assume that the speed of growth is same for all tumours. This means that 
mammography could only be used as an appropriate method of diagnosis when it is 
performed at regular interval. The intervals not only should be short enough that no 
tumour could grow from its occult stage to palpable stage without being detected but 
also should be long enough to avoid any unnecessary radiation [13] pointed out 
especially that there is another benefit that mammographic screening will especially 
save unnecessary cost.  
In fact the  breast cancer does not kill the patient, instead it is the metastatic spread to 
other vital organs which results in possible deaths. Metastasis means ―next placement‖, 
it means the spread of cancer from the affected part to unaffected part, most used for the 
spread of cancerous cell to other organs in the body. The spread of cancer typically 
happens through lymphatic or blood vessels [3]. There is an area of breast tissue which 
leads into the armpit. The armpit contains a lot of lymph glands known as lymph nodes. 
These lymph glands around the breast form as a network and are connected by tiny 
tubes, all of these together are known as part of the body's lymphatic system. One of the 
chains of the lymph gland goes into the centre of chest, known as the internal mammary 
chain.  Lymphatic system helps to get rid of waste products from the body. Lymph 
glands are important for breast cancer, based on the characteristic that lymph glands 
drain into the lymphatic system and goes into circulation. If any cancer cells have 
broken off from the tumour they could be carried out by the lymph fluid to the nearest 
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lymph glands. The general problem of metastatic spread is it makes the treatment even 
harder because cancerous cells  could go to anywhere over the body. The single 
metastases may only be discovered when they are already affecting the organ. In order 
to increase the likelihood of successful treatment, we need mammography to find the 
likelihood of tumours as soon as possible before metastatic spread occurs.  [14] stated 
that when the tumour has been detected, the diameter is about 1cm. However [4] 
explained that once a tumour is in its occult stage ―until there are well over a million 
cells‖ that would be a diameter about 0.5cm. Also, he mentioned  that we should be 
trying to find  the invasive cancer before it goes to 1cm and ―Invasive cancers are 
potentially lethal, and prognosis is improved if they can be treated while they are 
smaller than 1cm in size‖, that is because the metastasis begins to grow faster and 
spreads when they are bigger than 1 cm. Detection needs to be noticed  early because 
[15] states  when a tumour goes into the palpable stage, it has an average size of about 
2cm and approximately 50% of these cases have turned to metastases.  
2.1.4 Diagnosis methods for breast cancer 
There are different methods about how to  detect breast cancers, all these methods have 
their advantages and disadvantages. There is no one perfect method which is suitable for 
all the patients with all the conditions. However, all these used methods have given their  
advantages which   can result in  relatively accurate diagnosis.  
Firstly, for detection of breast cancer, this would mean that to find a cancer by self 
examination when the tumour is palpable. Self-examination is firstly recommended as 
the first breast cancer screening in 1930 [16]. The major problem about this method is 
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that the cancer may have already caused metastasis and started  to  spread to other part 
of the body.  
The second method is called lymphography. It is shown on radiography of the 
lymphatic channels after a radiopaque material has been injected. This method is rather 
old and the effect is not really successful when comparing with other methods. 
Therefore, lymphography is rarely used in recent time. 
The third method is Computer Tomography (CT), which is an x-ray technology and 
gives information about the internal organs or cross-section in 2-dimensional slice. 
Currently, it is out of the market for breast cancer detection. CT scan is not used 
routinely to evaluate the breast currently or for an early detection of breast cancer. This 
is because the CT scan could not give information about the internal structures of the 
glands. However, if the patients have large breast cancer, doctors still order CT scans to 
check whether the cancer has spread to other parts of the body such as the lymph nodes, 
lungs, liver, brain or spine.  There are other advantages of using a CT scan during the 
treatment. This allows the doctor to see whether the treatment is working or not, or to 
see  if there is the breast cancer and if it  has spread or recurred outside of the breast. 
Some researchers are investigating whether CT scan could do better or as good as 
traditional mammography as a screening tool. CT scan uses higher energy X-ray which 
gives it an ability to indicate microcalcifications for breast cancer.  [2] also indicated 
during the breast CT, if the patients lie face down on the table to let the CT scanner 
rotate around the breast, there would be less compression to the breast than 
mammography and the total dose of radiation is the  same as mammogram. However, 
research on breast CT scanning for screening is still in its an early stage. 
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2.1.4.1 Magnetic Resonance Imaging (MRI) 
Another method which has been used for detection and distinction between breast 
cancer which is Magnetic Resonance Imaging (MRI). MRI is a technology which uses 
magnets and radio waves to produce cross-sectional images in details of the body. It 
does not use X-rays, so there is no radiation exposure worries. As figure 2-2 shows, 
patients need to lie on the stomach on a padded platform with cushioned opening for the 
breasts, so the breasts hang down. This position gives a better picture and reduces the 
negative effect of breathing. Before the test, patients need to have a contrast solution 
which is called dye injected into their arm. The dye could give the contrast solution 
which help any potential cancerous breast tissue show up more clearly. The best 
advantage for MRI breast scan is that it can show scars, cysts, and even invasive 
tumours well. And MRI could perform really well on women with really dense breast 
tissue; it could get more accurate information than mammograms. Also, doctors use 
MRI scans for women with lobular breast cancer to help them decide whether 
lumpectomy is an option.  However, there are also disadvantages of this method. 
 Not only is that MRI a very expensive method and requires highly specialized 
equipment and highly trained experts  it could also could miss out some cancers that 
would be detected by mammography. The dye could affect the kidneys, so the doctor 
may perform kidney function tests before injecting dye. There are certain conditions to 
the dye being absorbed better like a tumour in the duct lead to the dye being stopped 
from going further and the dye builds up in one spot. This means that the general 
procedure of an MRI is rather a time consuming. The patients need to stay still during 
the test while takes around 30 to 45 minutes. Plus an MRI is expensive compared to the 
other methods which makes MRI less attractive than other mass screening programmes.  
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An MRI is better for distinguishing between scars and a malignant tumour and could be 
used for more detailed examination of cysts. After treatment, MRI can be used for 
checking scar tissues in women who have undergone lumpectomy and any significant 
changes could be noticed by MRI, suggesting a return of breast cancer. This means that 
MRI is suitable for additional examination. However, MRI is not recommended as a 
routine screening tool for all women due to its high cost, and limitations about 
dislodging certain metal devices. Even at its best, MRI produces many uncertain 
findings which are called unidentified bright objects (UBOs) by radiologists. Finally, 
MRI cannot detect calcifications which is one of the main indicators  for breast cancer.  
 
Figure 2-2 MRI breast screening from  
2.1.4.2 Ultrasound 
The Ultrasound method has been used for detection of breast cancer as well. Its main 
advantage is that Ultrasound is widely used for other examination and it is considered to 
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be more economical. This makes ultrasound very attractive for mass screening. [17] 
showed about 90% of small tumours which can be monitored by ultrasound have a size 
of about 8mm in diameter, therefore ultrasound works just as good as mammography 
with the tumours‘ size about 1cm. Ultrasound works very well on detection of cysts. 
When the patient has been suspected of  having a cyst during mammography, the patient 
is sent to have an ultrasound examination to confirm the diagnosis of a cyst or to exam 
the wall around the cyst to have a look whether the cyst is in a dangerous condition. 
Ultrasound is also a main method for examination of younger women. Younger women 
usually have very dense breast tissue which joins together as a big white mass on 
mammogram. Research by  [18] showed that mammograms caused high ―false positives‖ 
that require follow-up to rule out cancer for women under the age of 40 and did not 
detect any tumours among women under the age 25. There are  two strong evidences 
that breast ultrasound is very good at distinguishing between lumps and cancer in 
women aged younger than 40. It showed that ultrasound was 100% effective at 
classifying a lump as benign without a biopsy for women aged younger than 39. The 
studies suggest that ultrasound monitoring of the breast is really good at distinguishing 
between benign lumps and cancer in women younger than 40. There is another useful 
point about breast ultrasound for the radiologist to help perform a biopsy. In order to 
take a sample from a suspicious area of the breast, the radiologist needs ultrasound to 
guide the positioning of the needle, this is because ultrasound is a very safe, easy and 
quick method. The disadvantage about ultrasound is it cannot show microcalcifications 
which could be seen as a strong indicator for breast cancer.  Additionally, the 
visualization of ultrasound is relatively poorer than in mammograms, therefore it 
requires the highly skilled and really careful experts to work on in order to avoid any 
missing indicators.  
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2.1.4.3 Mammography 
The most important method of diagnosis for breast cancer is mammography. It is an 
imaging technique which uses low-doses of amplitude-X-rays (usually around 0.7 mSv) 
to examine the human breast. Mammogram is the examination of mammography and it 
is used as a diagnostic and a screening tool in the early detection of breast cancer, in 
order to reduce the death rate. It goes through the detection of characteristic masses or 
microcalcifications. The x-rays are a form of radiation; it passes through most objects 
including the body. Different parts of the body absorb the x-rays in varying degrees. 
Bone absorbs much of the radiation while soft tissue allows more of the x-rays to pass 
through. As a result, bones appear white on the x-ray, soft tissue shows up in shades of 
grey and air appears black. It is important for mammography to distinguish between the 
different structures within the tissue. Research in [19] showed that typically 28-30kV on 
does for a mammography X-ray system could increase the contrast by 5-10%.   
 
Figure 2-3 The Process of mammography from [2] 
There are reasons to choose mammography as a main screening for early detection of 
breast cancer. The main advantage is it is a very economical method that is easily and 
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quickly carried out without any injection compared to other methods. Additionally, 
mammography gives a good image of the breast and it is the only examination method 
showing both microcalcifications and mass which are two main important indicators for 
malignant cancer. However in some cases, the radiologists cannot be sure whether the 
condition is benign or malignant, therefore an extra call back mammography or other 
methods of examinations like ultrasound or MRI will be used. In the past several years, 
some women may have areas of concern which cannot be resolved with the only the 
information available from the mammogram. They would be called back for a 
diagnostic mammogram. At this stage, radiologist will monitor each of the additional 
films as they are taken from the technologist. Generally, the unusual appearance is 
found to be benign, if the cause cannot be determined certainly, a biopsy will be 
recommended, and it will be used to get the real tissue from the site of pathology to 
examine microscopically. Depending on the nature of the findings; an ultrasound may 
be applied at this stage as well. 
The mammography examination process will take approximately 30 minutes and it is 
usually performed on an outpatient basis. During examination, a qualified radiological 
technologist will position one breast in a mammography unit which looks like a 
rectangular box that contains a tube for producing x-ray. The breast will be placed on a 
special platform and compressed with a paddle. Breast compression is then operated by 
the technologist, it is necessary in order to: 
 Even out the thickness of the breast, so all the tissue can be pictured. 
 Hold the breast, so the blurring of the image caused by motion is minimized. 
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 Spread out the tissue so that small abnormalities are less likely to be obscured by 
overlying the breast tissue. 
 Allow the use of a lower does of x-ray for imaging the thinner part of breast 
tissue  
 Reduce X-ray scatter in order to increase the sharpness of the image. 
The patient will be asked to change positions between images. The routine views are 
from top to bottom and side angle. 
Views of screening mammograms are done as a regular screening to get an overview 
picture of the breasts and make sure that everything is well. Different views increase the 
likelihood of detection.  The X-ray mammograms are typically made in medio-lateral 
oblique (MLO) view and cranio-caudal (CC) views. The names of the directions are 
from Latin and are used worldwide.  The term of ' medio-lateral ' means x-ray direction 
is from the medial (inner) part of the breast to the lateral (side) part of the breast.  This 
is to give a horizontal orientation view. The term of ' cranio-caudal' means the radiation 
goes from the cranium (head) to cauda (feet). This means a vertical direction of the 
radiation coming from the top.  
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Figure 2-4 Screening orientations for mammograms 
 
Abbreviation Position Direction from X-ray 
MLO Medio-Lateral Oblique From the medial (inner) part 
to the lateral (side)  
CC Cranio-Caudal From the cranium (head) to 
cauda (feet) 
Table 2-1 views of screening mammograms 
 
MLO 
MLO 
CC 
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However, different areas have different protocols which are dependent upon the specific 
facilities. In America, there are four films which are required for breast, two for each 
breast. In Europe, most countries do one view of each breast, if a suspicious area is 
noticed, then  additional views are taken. 
A radiologist, a physician specially trained to supervise and interpret radiology 
examinations, will analyze the images and send a signed report back. Figure 2-4 and 2-5 
shows the example of the mammography images, on the left is a benign case versus a 
malignant case on the right. When evaluating an image the radiologist would first get 
old images as reference to see if there is any change in the overall structure of the breast. 
If radiologists find anything of concern in the images, then they could see whether the 
conditions have appeared during the last screening. If it has, then the radiologists are 
able to compare the images to state the change of the size and to give a report about the 
rate of growth of the tumour. When the radiologists are evaluating the new image, they 
will first step back to look through asymmetries. Then they could get a bit closer and 
look for masses. After that, the radiologists will zoom in on the image to examine the 
mammogram. This means they are looking for microcalcifications which could indicate 
a malignancy. They even need a magnifying glass if the condition is not that clear.  
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Mammography is believed to reduce the modality; there are several benefits for the 
patient: 
 Imaging the breast improves the ability of physicians to detect small tumour, 
therefore if the cancers are smaller, the women have more treatment options 
and a higher cure rate.  
 No radiation remains in the patient‘s body after an x-ray examination. 
 X-ray usually has no side effects in the diagnostic range. 
The use of screen mammography increase the ductal carcinoma in situ (DCIS), which is 
the small abnormal tissue growths confined to the milk ducts in the breast. These early 
tumours will not harm the patient if they are removed at the early stage and 
mammography is the only proven method that  reliably detects these tumours. 
Figure 2-5 mammogram with a spiculated mass 
(Ozekes S, Osman O, Camurcu AY, 2005) from 
Figure 2-6 mammogram containing microcalcifications (J. 
Suckling, J. Parker, D.R. Dance, S.M. Astley, I. Hutt, C.R.M. 
Boggis, I. Ricketts, E. Stamatakis, N. Cerneaz, S.L. Kok, P. 
Taylor, D. Betal, J. Savage,, 1994) 
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While mammography is the only breast cancer screening method that has been proved 
to save lives, however it is not perfect.  
 The radiation exposure is a potential risk of screening.  
The effective radiation dose from a mammogram is 0.7 mSv, this is the  same as the 
average person receiving from radiation  in the background for three months, and it 
appears to be greater in younger women. There are a lot of studies about radiation from 
mammogram which shows that the women aged 40 years or older have a small risk of 
radiation induced breast cancer. Therefore, special care is taken during x-ray 
examination to use the lowest radiation dose possible while producing the best images 
for evaluation. Organizations such as the national cancer research institute take such 
risk into account and update the technical standards when formatting screening 
guidelines. [20]  
 False Positives  
The screening exam is intended to have a high sensitivity to make sure it does not miss 
any cancers, the cost of this high sensitivity is that a large number of results which  
would be regarded as suspicious in patients without cancer. The patient is called back 
for further testing and are sometimes referred to as ―false positives‖, implying an error. 
Also, paper [21]shows that women who receive false positive results may be affected in 
their well-being and behaviour. Some of them may intend to return for routine screening 
more frequently, and some of them become anxious, worried about the possibilities of 
having breast cancer.  
 False negatives 
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  Mammograms also have a rate of missed tumours – ―false negative‖. This is     partly 
due to dense tissues obscuring the cancer and the fact that the appearance of cancer on 
mammograms have a large overlap with the appearance of normal tissues. [22]for this 
reason, in the UK, the screening program does not start calling women for screening 
mammograms until the age of 50. Dr Samuel S. Epstein reported in ‗the politics of 
cancer‘ that in women aged 40 to 49; a quarter of instances of cancer are missed at each 
mammography [23].  
There is always a slight chance of cancer from inordinate exposure to radiation, 
however the benefits of an accurate diagnosis far outweighs these risks. 
 
2.1.5 Mammogram Indicators 
When examining a mammogram, there is a recommendation to examine the 
mammogram in three steps which  include to look at the mammogram at a  certain 
distance.  Radiologists are typically looking for asymmetries or architectural distortion, 
mass and clusters of calcifications which are the main indicators for mammograms.  
First step the radiologists will look for is the distance to allow them to recognise any 
large structural changes.  In this step it is important to look out for asymmetries of the 
two breasts. Asymmetries are normally being seen as differences in structure between 
two equal views of the breasts. They do not contain any information about cancerous 
tissue, however they provide an indication about whether there are any structural 
changes in the breast so the radiologists could take a closer look into the changed areas 
to see if the structure has changed and is part of a benign process or if the change 
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indicates a malignant process. [24] gave some cases that symmetries are closely 
measured as they present a likelihood of cancerous changes than normal tissue.  
Two of the powerful indicators: masses and microcalcifications are commonly used in 
evaluating mammograms.  
2.1.5.1 Spiculated Masses 
Masses are the larger of the two indicators and can be either benign or malignant. 
Characteristics such as the borders and density of the mass are greater for malignant 
cases; this could be used as classifications. Comparing to asymmetry, masses don‘t just 
have structure changes in the breast tissue, but they also have dense irregular lumps. On 
mammograms, the denseness masses will exist as bright lumps and are not easy to 
identify. An example of a mass is shown in Figure 2-7.Mass is the larger of the two 
indicators and can be either benign or malignant. Characteristics such as the border and 
density of the mass, which is greater for malignant examples, can be used for 
classification. 
 
Figure 2-6 mammogram showing a mass from [137] 
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2.1.5.2 Microcalcifications 
Only mammography screening could show the microcalcifications in cluster, they look 
like a small group of white dots and look like almost noise, and to organize them will 
depend on their size, shape, distributions and texture and of course the quality of 
mammogram.   
Generally, masses are more difficult to classify than microcalcifications. 
Microcalcifications are small calcium deposits which occur as secretion from the ducal 
structures which have been thickened and dried. They can have the most benign cases 
but also can indicate a malignancy. They are common on mammograms and their 
appearance increases with age so that they could be found in 8% of mammograms of 
women in their 20s and 86% in late 70s. (D.B.KOPANS, Third Edition,2007)  
One condition that is often not recognized as a cancer but is thought to be a preliminary 
stage to invasive cancer is DCIS which will be mentioned in Section 5. The only 
indication of DCIS leaves on a mammogram are the typical clusters of 
microcalcifications. [12]introduced that DCIS is virtually only found by finding 
calcifications on a mammogram.  
Microcalcifications could be commonly to seen depending on the age group. [12] states 
that there is a likelihood of having increased microcalcifications during the life, women 
in their late 20s have 8% chance of having microcalcifications, while women in their 
late 70s, have 86% chance to have microcalcifications.  However, calcification found in 
the breast is due to a benign process, therefore, microcalcifications can be an indication 
for malignancy but mostly they are benign.  
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The literature available to help successfully classify microcalcifications gives different 
results. Other showed that about half of malignant tumours were found by 
mammography because of the presence only of suspicious calcifications. [12] gave an 
opposite result that ―17% of invasive cancers were found by mammography only 
because of the calcifications that had in the intraductal portion of these cancers‖.   
The main criteria of microcalcifications can be classified Microcalcifications which 
indicate malignancy are usually less than 0.5mm in size and often grouped into clusters 
of five or more, any microcalcifications larger than 1mm are almost always benign.  
Therefore, the smaller the microcalcifications are, the harder to see them on 
mammograms. There are several researches that talk about how large the 
microcalcifications are to make them visible in mammograms. mentioned about 0.1mm-
0.2mm microcalcifications are the smallest range that could be seen in mammograms. 
[25] mentioned that the limited detect ability is 0.2mm to 0.3mm. Since the maximum 
size for calcification can indicate a malignancy is 0.5mm, it could be said that 
microcalcifications that indicate a malignancy can be seen on a mammogram are 
between 0.2mm and 0.5mm.  
The distribution of microcalcification is important as the size. Microcalcifications only 
appear in or around the centre of the malignancy. Therefore, it will be many tumours 
that would go along with other structure changes in the breast. When 
microcalcifications have been found in clusters in mammogram, it will request a further 
investment. [12] says that if a cluster of microcalcifications is considered to be 
malignant, the number of calcifications has to be 5 or above per cm
3
. The clusters 
contain microcalcifications less than 5 will be considered as benign. This regularly 
happens on routine checking for the mammogram. 
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The morphology would include the attribution of shape, texture or density  . All those 
attributes hold some important information to be able to a correct classification. It can 
only be sais that round microcalcifications with a smooth surface are typically benign 
while rough surfaces as well as irregular shapes are typically malignant. [25]described 
malignant microcalciofications as wild, unordered or with fine linear branching, while 
benign microcalcifications are rounds solid rods or with lucent centres.  
The location can be important as calcifications due to cancer usually build up in around 
a malignancy. They keep around a certain centre and that centre can possibly tell us the 
point of origin. In addition, microcalcifications that are caused by malignant processes 
are almost always located in ducts.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
2.2 Screening Mammography 
2.2.1 Breast Cancer Screening 
The aim of breast cancer screening is to detect any cancerous tumours before they 
become palpable and clinical evidence, which means in their sojourn time. Generally, 
most statistics show a steady increase of occurrence with most cases in the group of 
women aged from 50 to 70. EU recommends breast cancer screening for women 
between 50 and 69. Breast screening was first introduced in UK in 1988 and now offers 
tests to women over the age of 50 in every 3 years. Older women could also apply the 
screening, and the National Health Service (NHS) says that if a women who has reached 
their upper age of routine invitation, they are encouraged to make their own 
appointment [26]. If the women are over 70, they do get an invitation to attend 
screening, but they may go if they want to. These ages limits are about to change. The 
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UK government has decided to extend the screening programme to women aged from 
47 to 73 by 2012. For the average women, according to , the US Food and Drug 
Administration (FDA) pointed out that mammography could find 85 to 90 percent of 
breast cancer for women aged 50 and over, FDA also showed the evidence that 
mammography could discover a lump up to 2 years before it can be felt. According to 
[27]in 2009 that the US Preventive Services Task Force recommended mammography 
every two years for women from the age of 50 to 74. In [28], the U.S. Food and Drug 
administration (FDA) has approved that mammography is the only exam to screen 
breast cancer in women who cannot be tested for  any signs or symptoms of the disease 
by physical examination. [29] Also pointed out that in 2010 the European Cancer 
Observatory suggested mammography every 2-3 years between 50 and 69. In UK, the 
early detection of breast cancer is often done by mammogram, it forms the basis of a 
NHS breast screening programme [20]. The NHS Breast Screening programme provides 
free mammography every three years for women aged between 50 and 70 and it is 
expected that in 2016 the age extension range of women for mammography is from 47 
to 73. 
As already mentioned in Section 2.1, mammography is the perfect method for screening 
as an early detection of breast cancer. It is reliable, cheap, accurate, relatively 
comprehensive, not very time consuming and the images are reproducible. All these 
could make mammography appear attractive and to be taken into account for 
governments implementing a screening programme.  
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2.2.2 Mammography Screening 
In many countries routine mammography for older women is encouraged as a screening 
method to diagnose early breast cancer, as risk of breast cancer increases with age. In 
UK, all women aged from 50 to 70 have been routinely invited to have a test to look for 
early breast cancer [30]; in US, the USPSTF (United States Preventive Services Task 
Force) recommends screening mammography, with or without clinical breast 
examination, every 2 years for women aged 50 to 74 [31].  
In 1913, Albert Salomon who is a surgeon reported his investigations; he had used 
radiography of mastectomy specimens to demonstrate the spread of tumour to the 
axillaries lymph nodes. [20] In Europe, in the 1950s and 1960s, Charles Gros pointed 
out the value of mammography in the diagnosis of breast disease and its potential for 
screening asymptomatic women. From 1963 to 1966, Philip Strax, Louis Venet and 
Sam Shapiro under the sponsor of the Health Insurance Plan of new York, they 
organized the first randomized physical examination and mammography to determine 
whether it could reduce breast cancer death rate. After 5 years, the results showed that 
compared with the control group, the mortality rate was reduced by almost one third for 
the women who took screening mammography.  The decrease remained a significant 
level which was through 18 years of follow-up. [32]They proved that combined 
mammography and physical examinations of asymptomatic women could significantly 
reduce the breast cancer mortality rate.  
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2.2.2 Film mammography and digital mammography 
Conventional film screening mammography uses low energy x-rays that pass through a 
compressed breast during a mammographic examination. The exiting x-rays are 
absorbed by film which is then developed into a mammographic image that can be held 
and looked at by the radiologist. With digital mammography, low energy x-rays pass 
through the breast exactly like conventional mammograms but are recorded by means of 
an electronic digital detector instead of the film. This electronic image can be displayed 
on a video monitor like a TV or printed onto film. Again, this is similar to digital 
cameras that produce a digital picture that can be displayed on a computer screen or 
printed on paper. The radiologist can manipulate the digital mammogram electronically 
to magnify an area, change contrast, or alter the brightness.  Mammography remains the 
best method of early breast cancer detection. However, traditional film-screen 
mammography is limited in its ability to detect some cancers, especially those occurring 
in women with radiographically "dense" breasts. For this reason, extensive research 
efforts to improve mammography have occurred. Digital mammography offers 
theoretical advantages compared to film-screen mammography for cancer detection. [33] 
The differences are in the way the image are recorded, viewed by a doctor and stored. 
Several studies [34] showed that digital mammograms have no significant differences .                  
Equipment costs for digital mammography systems is 3-5 times the cost of film screen 
mammography. Additional on-going costs of maintenance and image storage compound 
the price differential. Some insurers, such as the federal government, have recognized 
these cost differences and reimburse digital mammography at a slightly higher rate than 
film screen mammography.   Different researches [35] [36] have shown no significant 
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difference in cancer detection between film screen mammography and digital 
mammography. While some critics have considered these similar results to be a 
"negative" for digital mammography, one must remember that to achieve similar cancer 
detection performance with first generation equipment is a major accomplishment. One 
study showed the call-back rate from screening, needing to return for additional 
diagnostic mammography after a screening mammogram. It was better with full field 
digital mammography than screen-film systems.                                                                                                                                                                                                   
3  Computer Aided Diagnosis System 
Over the last decade there have been a lot of researches in computer aided diagnosis 
system (CAD), it contains numerous different ways to achieve an operation. The 
different methods are designed specifically for the task range from the classical image 
processing to biological inspired evolutionary methods such as neural network. The aim 
of this chapter is to highlight the differences between widely used techniques and 
compare them in the area of the classification of microcalcifications in medical imaging 
in particular.  
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3.1 Overview of Computer Aided Diagnosis System 
At the beginning of this century, early detection mammography increases breast cancer 
treatment options and reduced the breast cancer mortality rate by approximately 30% 
[37]. However, mammography is not perfect, on a screening mammogram leading to 
further recall are identified in approximately 5% - 10% of patients in America , even 
though breast cancer is confirmed  at only 3 to 10 cases in every 1000 women screened 
[38,39]. To identify and evaluate the signs of cancer requires a skilled and experienced 
radiologist. This assessment may also lead to the cancer being missed and the patient 
being misdiagnosed, by its high susceptible to error in nature. This could happen by 
viewing of a large number of images to detect a small number of cancers. The complex 
radiologic structure of the breast, the nature of mammographic characteristics of early 
breast cancer and even radiologists fatigue. For every thousand cases analyzed by a 
radiologist, only 3 to 4 are cancerous and thus an abnormality may be overlooked. As a 
result, radiologists fail to detect 10-30% of cancers [40,41]  in these false-negative 
results, most of them caused by missing lesions which are evident retrospectively. To 
overcome the known limitation of human observes, a second reading of screening 
mammograms by another radiologist has been implemented at many sites. Rapid and 
continuing advantages in computer technology, computer prompting technology have 
increased the interest to enable the radiologist to act as their own second reader and the 
final decision is made by the radiologist. One example of this is computer aided 
detection (CAD) system in screening mammography. Previous studies have shown that 
CAD detection systems have improved radiologists accuracy of detection in breast 
cancer. Computer aided diagnosis (CAD) system for aiding in the decision between 
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follow up and biopsy are still being developed. Mammographic image analysis is a 
challenging task for the following reasons: 
 It needs to be the nearly perfect since the efficacy of CAD systems have very 
serious implications. 
 This is an extremely challenging image analysis task because the large 
variability in the appearance of abnormal condition. 
 The abnormalities are often hidden in dense breast tissue, and this makes 
detection difficult. 
3.2 Classical Imaging Processing  
Digital imaging processing has been widely used in a variety of application areas, it is 
used for tasks such as pattern recognition or classification schemes. 
Imaging processing is a special 2D version of signal processing; therefore the methods 
and structures are established similar to those of signal processing. As this area has a 
long history, there are a number of methods that need to be described. Generally in most 
cases there are several steps which are undertaken; these steps are shown in figure 3-1. 
The imaging processing will first start with pre-processing, after that the image might 
undergo segmentation which is typically followed by analysis feature extraction. There 
is a feature selection step to select the extracted features from the last step. Finally, there 
is a recognition classification depending on what the aim the image processing is.   
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3.2.1 Pre-processing 
In this stage, data is often complex and time consuming; they are not quite fit for the 
system to process. Especially the medical imaging, it is common that they are not stored 
in a conventional image format as the data needs to be processed by programs. In the 
meanwhile, it might need to define a region of Interest (ROI), or then it may be 
necessary to perform adjustment on brightness and contrast or to rotate the image. It 
may be necessary to rescale the image size to fit with the critical certainty. 
In CAD system, how the image is obtained is an important part of imaging processing 
of mammograms. The digitization techniques vary from different departments. For 
examples, Digital Database for Screening Mammography has used three different 
digitizer (described in Section 5). Each of the digitizer uses a different mapping from 
grey level to intensity. It needs to be noticed that a good performance using one capture 
scheme may give bad results when applied to an alternative technology. As well as to 
capture the image, some pre-processing might be performed. In CAD system, the key 
Sensing / Pre-processing 
Segmentation 
Feature Extraction 
Feature Selection 
Classification 
Figure 3-1A typical flow of pattern recognition of image processing 
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aim of this step is to improve the contrast so that the microcalcifications can be seen in 
dense breast tissue and the masses can be differentiated. To achieve this, different 
approaches include histogram equalization, filtering, curve fitting and contrast 
stretching at both local and global views have been used in different pieces of research. 
Chan et al. [42] investigated the application of unsharp masking for digital 
mammography. Receiver operating characteristics (ROC) studies showed that unsharp 
masking improved the detestability of calcifications in digital mammograms. However, 
the method increased noise and caused some artefacts in the images.  
3.2.2 Segmentation 
The aim of this step is to assign one pixel into one or a certain number of regions. In 
this step, pixels are partitioned for making the further steps easier. In medical images, it 
might simplify the image representation to help locate the objects or boundary. 
Typically, it tried to divide the foreground and background. For mammograms, it tries 
to separate the target of suspicion from the imaging. To achieve this, there are different 
methods. The most common one is thresholding of region based approach. It creates a 
binary image by thresholding and using the results to represent background or 
foreground, and therefore, two areas have been achieved. The disadvantage is the 
threshold which needs to be adapted, as colour shading in images varies a lot. There is 
some statistics approach to achieve segmentation stage as well. The segmentation area 
could be chosen with certainty by selecting certain areas from the image histogram. This 
principle works similarly to spatial domain and frequency domain so the general 
procedures are the same. Additionally, other methods have been developed such as edge 
detection with subsequent operation to close the gap between the edges. Region based 
approaches such as seeding with a single pixel and growth in a region to be segmented. 
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For example, to provide a brief explanation of the technologies. Certain locations are 
selected as seed points, and without any information these seed points would be all 
pixels in the image. For example, a microcalcification might be expected to have a grey 
level over a certain threshold in order to remove some pixels from consideration. 
Starting from the seed regions growing, if the neighbouring pixels are examined for 
some similar properties to the seed, or they both followed some pattern from the seed, 
then they are included in the region. The same is also done for their neighbours. A seed 
can then be included when it has successful grown in a region around it. There is 
another method called k-nearest neighbour algorithm. It is a clustering algorithm that 
partitions an image into k clusters, which is similar to the region growing method but 
involving an extra step of using statistics to confirm the regions are well formed.  
3.2.3 Feature Extraction 
 Once segmentation is completed there might be a selection of microcalcifications 
which needs to be described in terms of features. These features are collected in the 
stage of feature extraction. Classification stages applies on these features and statistical 
properties, the right features and properties are carefully selected because a good quality 
of classification is the key to classifying any given data. Features in image processing 
means real numbers obtained by applying mathematical expression to image data. From 
the simple examples is the mean grey level amongst a set of pixels. The reason for 
extracting features in image processing is that they can provide powerful measures of 
the properties of the image beyond what can obviously be seen by looking at the pixels. 
A large number of pixels can be reduced to a smaller number of features which provides 
a concise measurement of the properties of the image. Features  can then be extracted 
from the spatial domain or from the frequency domain though here the former will be 
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the focus. Features could be divided into two catalogues: textures based features and 
morphological based features. 
 Texture based feature 
A number of texture features are described in [43]based on simple statistics. One of 
these is the nth moment of the grey level z around the mean. Variance, the second 
moment and the third moment were widely used: 
        𝝁 𝒛 =   𝐳𝐢 − 𝐦 
𝐧𝐩(𝐳𝐢)
𝑳−𝟏
𝒊=𝟎
                                                                                                  Equation 3-3-1    
 The mean is defined as normal as: 
         𝒎 =  𝐳𝐢𝐩(𝐳𝐢)
𝑳−𝟏
𝒊=𝟎
                                                                                                               Equation 3-3-2      
 Normalization by dividing by (L-1)
n
 . 
3.2.4 Morphological features 
Morphological features are often referred to as shape feature and  are useful in the 
classification of microcalcifications. [44] provide several pieces of information about 
various features of benign and malignant calcifications. Such as, benign calcification 
has a round ring like shape and has  well defined borders. Malignant ones have varying 
shapes and poorly defined borders.  
Morphological or shape features are an alternative way of describing a 
microcalcification or any object in an image that we are trying to classify. Some simple 
features based on the boundary are as follows: 
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 Length of the boundary  
 Diameter of the boundary = max[D(pi, pj)] where D is distance and pi and pj are 
2 points, given that most shapes are not perfect circles.  
 Orientation is another useful feature and taken with magnitude makes up the 
major axis of the microcalcification  
 Compactness takes the length of a shape and divides it by the number of pixels 
in the shape.  
 Statistical moments can be taken by using a segment of a boundary. A straight 
line is taken from one end of the segment to the other and statistics are taken 
based on the distances of the pixels on the boundary from this straight line.  
3.2.5 Using Pixel Values 
Instead of getting and applying the features into the network, it is also possible to apply 
raw pixels to the network and train on them. One of the strengths of an evolutionary 
algorithm is that it can discover new solutions that a conventional design would never 
uncover and it does this by its random nature. If conventional features are extracted to 
be fed into the network, then this puts a major limit on what the network can achieve in 
an absolute sense. Feeding the raw pixel values in, essentially gives the network less 
limitation to extract the information it decides to be the most important. However, in 
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order to converge on a solution, there is the possibility of a much larger network and 
many generations may be needed, which takes a longer runtime. 
 
3.3 Feature selection 
Feature selection can be regarded in the same way as image enhancements, this stage is 
not required as a complete pattern recognition system works. Many neural network 
based papers [45] did not use a feature selection stage. At the end of the feature 
extraction stage there might be a very large number of features. If a statistical classifier 
has been used, it is not helpful to have so many features. It may make a longer running 
time and the likelihood is that the features may not be relevant to the benign and 
malignant lesions. Thus, the advantage is in selecting the features that are most relevant. 
Genetic Algorithms have been used in the feature selection method successfully. In [46]  
it states that with a chromosome, which is the length of the total number of features 
available, each gene in the chromosome represents a part of which is 1 or 0 where 1 
indicates a particular chromosome is  included. There is a population of random 
chromosome and for each one classification is performed. A new population is 
generated using parent selection, crossover and mutation. When the parents are selected 
it is designed so that the ones which resulted in a more accurate classification are more 
likely to be chosen. This continued for either a certain number of population generations 
or for a  certain level of classification eventually obtained.  
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3.4 Classification of microcalcifications 
Microcalcifications in mammograms appear as relatively bright regions due to the 
higher X-ray attenuation coefficient (or density) of calcium, as compared with normal 
breast tissue. Microcalcifications present within dense masses or are superimposed by 
dense tissues. In the process of acquisition mammograms these present as low grey-
level differences or contrast with respect to their local background. On the other hand, 
Microcalcifications present against a background of fat or low-density tissue and would 
possess higher differences and contrast. Malignant Microcalcifications grow to be 
numerous, clustered, small, varying in size and shape, angular, irregularly shaped, and 
branching in orientation [47] [48].On the other hand, Microcalcifications for benign 
cases are generally larger, more rounded, smaller in number, more diffusely distributed, 
and more homogeneous in size and shape. The detection and classification of 
microcalcifications has been extensively studied, with many authors reporting on 
several successful approaches to this task. A recent survey by Cheng et al. [49]lists 
almost 200 references on computer-aided detection and classification of 
microcalcifications, including methods for the visual enhancement of 
microcalcifications, segmentation, detection, analysis of malignancy, and strategies for 
the evaluation of detection algorithms.  
El-Naqa et al. [50] used support vector machines to detect microcalcification clusters. 
The algorithm was tested using 76 mammograms, containing 1120 microcalcifications. 
A sensitivity of 94% was reported, at one false positive per image. An improvement of 
the method was published by Wei et al. [51] using a relevance vector machine. A 
database of 141 mammograms containing microcalcifications was used to test the 
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algorithm. The method achieved a sensitivity of 90% at one false positive per image. 
The statistical performance of the method was similar to that of the method of El-Naqa 
et al. [50] , but the authors reported a 35-fold improvement in computational speed. Yu 
et al. [52]used a wavelet filter for the detection of microcalcifications, and a Markov 
random field model to obtain textural features from the neighbourhood of every 
detected calcification. The Markov-random-field-based textural features, along with 
three auxiliary textural features (the mean pixel value, the gray-level variance, and a 
measure of edge density), were used to reject false positives. The method was evaluated 
using 20 mammograms containing 25 areas of clustered microcalcifications. A 
sensitivity of 92% was obtained, at 0.75 false positive per image.  
[52] developed a technique for the detection of clustered microcalcifications which is 
comprised of two parts: detection of potential microcalcification pixels, and delineation 
of individual microcalcifications by the elimination of false positives. The first part 
involves the extraction of features based on wavelet decomposition and gray-level 
statistics, followed by a neural-network classifier. The detection of individual objects 
requires a vector of 31 features related to gray-level statistics and shape factors, 
followed by a second neural-network classifier. A database of 40 mammograms 
containing 105 clusters of calcifications was used to assess the performance of the 
proposed algorithm: a sensitivity of 90% was attained with 0.5 false positive per image.  
[53]compared four groups of features according to their discriminate power in 
separating microcalcifications into the benign and malignant categories. The 
microcalcifications were segmented using an automated method, and several features 
were extracted. Each feature belonged to one of the following four categories: multi-
wavelet-based features, wavelet-based features, Haralick‗s texture features [54]and 
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shape features. Within each group, a feature-selection procedure based on genetic 
algorithms was employed to identify the most-suitable features for use with a k-nearest-
neighbour classification scheme. The classification performance of each group of 
features was then determined using ROC analysis. The area under the ROC curve 
obtained ranged from 0.84 to 0.89, and it was observed that the multi-wavelet features 
gave the best performance, followed by the shape features.  
3.5 Neural Network  
Artificial Neural Networks (ANNs) are computational models inspired in the natural 
neurons. ANNs have been used in the areas such as machine learning and pattern 
recognition.  When speaking about ANN it is necessary to distinguish between ANN 
and Biological Neural Networks (BNN). For a better understanding how ANN works, it 
is helpful to understand the basic principles of BNN, although BNN is not understood in 
its full complexity in this days.  
A human brain is a piece of grey and jelly style material. It does not working as CPU 
which is only working by using single or a few processing units. The surface of a brain 
looks like an outside layer of walnuts,  and there are approximately 10
10
 of neurons 
have been compressed in the grey matter of human cerebral cortex, even a brain of ant 
has 10
4
 neurons.  
At the first 9 months of human life, neurons at brain has been produced by 25,000 
per minutes , an individual neuron can be described as consisting of three sections : the 
cell body, the axon and the dendrites, has been showed in Figure 3-2. The cell body is 
the main part of the neuron. The dendrites are originating in the cell body and are 
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branching into the surroundings like fibres. The main task is that dendrites have to fulfil 
to act as inputs to the cell so that the cell body can receive signals from other cells. 
Unlike the other cells in other parts of human body, each neuron has an axon is 
connected to the cell body as a fibre, the length of each axon could be extended to 
several centimetres, and then branches at its end into many small outputs called axon 
terminals  in order  to transfer the neurons output signal to different directions. The 
axons and dendrites of different neurons can then make connections (synapses) and fire 
their signals through those synapses.  
 
 
 
 
 
It is not entirely clear that how neurons work, however as far as they have been 
understood the sum of input signals might trigger the synapse to fir an output signal. 
The output signal is an electrical spike of very short duration, this might trigger some 
other neurons inputs which again cause another neuron to fire a spike of its own. It has 
been noticed that not all inputs of a neuron have the same significance. During a process 
of learning, the neurons simply connect to the other neurons by using their synapses, 
however the process is completely random and complex. When comparing the ANN 
and BNN it could be said that in both cases neurons are  arranged in some sort of 
Figure 3-2 Natural neurons 
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network where individual neurons fire  signals depending on their inputs signals. ANN's 
individual neuron does not have a particular shape, it is also a great difference between 
BNN and ANN. To simulate the physical properties of BNN as well as possible, , 
neurons of ANN are usually designed to have a number of different inputs, these inputs 
are weighted to simulate different significance. These inputs are summed up and if the 
resulting value is a above pre determined threshold, then the neuron fire a signal. The 
output of this particular neuron will be used by any other neurons or even the entire 
output of the network. As the two states of a brain neuron : excitory or inhibitory, the 
practical implementation of ANN means that the signal of neuron would be binary as 
there either is a signal or there is not. Figure 3-3 shows the structure of an artificial 
neuron. It basically consists of inputs like synapses in natural neuron; the inputs are 
multiplied by weights which could be seen as the strength of the respective signals; and 
then computed by a mathematical function which determines the activation of the 
neuron. Another function computes the output of the artificial neuron. If the network 
has n inputs in total, and the input could be x1, x2, x3, ..., xn,, ad each of the input should 
have a corresponding weight w1,w2,w3,...wn , the transfer function   could be the sum of 
all weight and inputs:  =  xn × wn𝑛𝑗 =0 . 
 
 
 
 
 
Figure 3-3 An artificial neuron 
Input 
Output 
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The higher a weight of an artificial neuron is, the stronger the input which is multiplied 
by it will be. The desired output could be obtained by adjusting the weights of artificial 
neurons. If the ANN contains hundreds or thousands of neurons, algorithms could be 
found to adjust weights of the ANN in order to obtain the desired output from the 
network. This process of adjusting the weights is called learning or training. 
One major difference of ANN and BNN is : neurons of ANN are positioned in a grid of 
structures while there is no recognizable BNN structure. It means that ANN are made 
up by different layers, with each layer having a defined number of neurons. Figure 3-4 
shows the first layer is called the input layer, which is connected to the input signals that 
are to be processed. The last layer of the ANN is the output layer, which is providing 
the processed signals. These are two layers in neurons may be connected to any signals 
on the outside of network. Any inter medium columns would not be accessible for 
neither the overall inputs nor outputs for using in ANN. These middle layers are called 
hidden layers. The hidden layers are required in order to allow the NN to learn a special 
behaviour, but cannot be influenced from the outside. The number of neurons in one 
layer may differ from the number of neurons in another layer, although for simplicity 
the number of neurons are kept constant in all hidden layers. Figure 3-4shows an 
example of the construction of a neural network, it is called feedforward neural network 
which was the first and simplest type of ANN. In this network, the signal moves in only 
one direction, forward, from the input nodes, through the hidden nodes and to the output 
nodes. There are no cycles or loops in the network.      
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The most interest in NN is the possibility of learning. The learning process in ANNs is 
implemented by examples, and is achieved by adjusting the connection weights and the 
network function.. Generally, there are three types of learning processes: supervised, 
unsupervised and reinforcement. Supervised learning is based on the direct comparison 
between the actual output and the expected output. The optimization algorithm could be 
used to adjust the connection weights in order to minimise the error. Reinforcement 
learning is a special case of supervised learning; it is o only based on whether the output 
is correct. Unsupervised learning is only based on the correlation of the input data.  
NNs are capable of pattern recognition in computer aided diagnosis, particularly the 
applications of mammography. There are a number of researches which have been used 
ANN based on its advantage. 
Figure 3-4 An example of an ANN 
Output layer Input layer 
Hidden layers 
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ANN could be used as a part of CAD system and used an ANN combination with 
classifier. ANN can be used for the detection of microcalcifications. Some other 
examples have using ANN are as a full CAD system.  
Paper Procedure Results 
[55] ANN was used for a whole 
CAD system as well as only 
parts of the system.  
Reported a better approach 
where ANN was used in 
conjunction of other methods 
[56] Applied ANN with error-back 
-propagation algorithm 
Sensitivity was increased from 
90%b to 95%. 
[57] ANN was used for detection 
system. 
A 87% detection rate . 
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4 Evolutionary Algorithm  
Evolutionary Computation (EC) is based on nature observations and it involves two 
main subsets: Swarm intelligent and Evolutionary Algorithm.  
Swarm Intelligent (SI) is a technique which is based on the studies around the behaviour 
of self organised systems, the natural example is ant colonies where the groups are 
working with simple rules and there is no centralised control structures, which means 
the individuals are only interacting locally with each other within the environment. The 
interactions between the agents of individuals are often leads to an emergence of global 
behaviour. The expression of SI was introduced by Gerardo Beni and Jing Wang in 
1989 in the context of cellular robotic system [58] .  
The other area is Evolutionary Algorithm (EA). In Artificial Intelligent, EA is a generic 
population based metaheuristic optimization algorithm. The interested area about EA as 
a technique that develops an ability to solve a problem by learning, especially for the 
problems which are extremely complex or with unknown solutions. It is suitable for the 
development of solutions in areas such as image processing, Roger Alsing used genetic 
programming to create specific painting of Mona Lisa [59]. Based on the 
implementation details and the nature of particular applied problems, EA has been 
differed into four major fields Evolutionary Programming (EP), Evolutionary Strategies 
(ES), Genetic Algorithm (GA), Genetic Programming (GP). 
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4.1 Biological principles 
Evolutionary algorithm is based on the principle of Darwin's theory of survival of the 
fittest as well as a number of biological principles. Therefore, an EA is inspired by 
biological evolution such as mutation, selection and crossover. These methods are 
principally the same for the algorithms of EA however they might implement varies in 
each technique.  
4.1.1 Darwin's Theory 
British naturalist Charles Robert Darwin has first made the discovery of evolutionary 
theories. The book "The Origin of Species" in 1859 has explained Darwin's theory in 
details. He mentioned that all species on earth evolved over the time from one or few 
ancestors. There was a widely nowadays accepted idea that human descended from apes 
that descended from other mammals. With all human life this could be traced back to a 
simple form in water.  
There are five observations which he made in nature and these observations have been 
summarised by Ernst Mayr [60]. Firstly, Species have great fertility and produce more 
offspring than they can grow. Secondly, the size of the populations roughly remain the 
same, although loads of the offspring are born, with a significant amount of them not 
surviving. Thirdly, food resources are limited but are relatively constant most of the 
time. All three of these observations show an inference that in such an environment, 
individuals have struggled for survival. The other two observations are : in sexually 
reproducing species, generally no two individuals are identical, variation is spreading 
out, much of these variations is inheritable. 
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From these, there may be inferred that in a world of stable populations, each individual 
must struggle to survive, those with the best characteristics will be survived and the 
desirable traits will be passed over on to their offspring. These good characteristics are 
inherited followed by generations and become dominant around populations through the 
time. It means that all only the individuals which fulfil certain criteria have a good 
chance of survival rate. The concept is called natural selection. By the definition of 
fitness, individuals with greater fitness are more likely to contribute to offspring for the 
next generation, while individuals with lesser fitness are more likely to die early or fail 
to reproduce. It is also referred to this as survival of the fittest. When Darwin mentioned 
these observations, he did not know what the genetics were, however he made basic 
observations about genetic fundamentals. Therefore Darwin's theory of evolution are 
summarised as follows:  
Variation There is Variation in Every Population. 
Competition Organisms Compete for limited resources 
Offspring Organisms produce more Offspring than can survive 
Genetics Organisms pass Genetic traits on to their offspring 
Natural Selection Those organisms with the Most Beneficial Traits are more likely to Survive and 
Reproduce. 
Table 4-1The summarised Darwin's theory of evolution 
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Some variations are helpful. For example, any variation that increases an antelope‘s 
speed may help it elude predators; any variation that increases water retention in a 
desert plant will favour survival rate of this plant in order to reach maturity. Those 
animals and plants which survive to maturity and are able to reproduce become the 
parents of the next generation, passing on the genes for the successful variation.  
Darwin called the process by which benefit variations are passed from generation to 
generation natural selection. He made many important observations on the relationship 
of individual variation to survival. During his stay on the Galapagos Islands [61], 
Darwin noted that the populations of tortoises on each island had physical features so 
that people could often tell which island an animal came from just simply by looking it.  
Natural selection is commonly referred to as survival of the fittest. Fittest means that 
organisms must not only survive to adulthood, but they must also actually reproduce. If 
they do not reproduce, their genes are not passed on to the next generation. Evolution 
occurs only when advantageous genetic variations are passed along and become 
represented with increasing frequency in succeeding generations.  
4.1.2 Biological Background 
A particular characteristic of an organism is evolution and this occurs through changes 
in heritable traits. Inherited traits are controlled by genes and these complete set of 
genes in an organism's genome is called genotype. This complete set of observable traits 
which show up the behaviour of an organism is called phenotype. Many aspects of an 
organism's phenotype are not inherited, because these traits come from the interaction of 
its genotype with the environment.   
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Heritable traits are passed from one generation to the next through DNA which is a 
molecule and it encodes genetic information. [62] Introduced that DNA is a long 
polymer which composed of 4 bases, and the sequence of bases in a particular DNA 
molecule will specify the genetic information. Before a cell divides, the DNA is copied, 
so that both of the two cells inherit the DNA sequence. Genes are a portions of a DNA 
molecule and are used to specify a functional unit , therefore different genes have 
different sequences of bases. In cells, the long string of DNA forming the condensed 
structures is called chromosomes. In a chromosome, locus is the specific location of a 
DNA sequence. If the DNA sequence at a locus varies between individuals, the different 
forms of this sequence are called alleles. DNA sequences can change through mutation 
to produce new alleles. If a mutation occurs in a gene, the new allele may affect the trait 
and finally change the phenotype of the organism. 
 
4.1.3 Biological Methods 
The natural inspired selection, crossover and mutation are the three main methods to 
achieve evolution. They are also giving benefits to achieve minor genetic changes in 
offspring; it means it does not need to produce the exact copies from parents to enlarge 
the search spaces. The success of these methods are dependent on how and which 
technique they are used. Usually selection will be the first to apply, then combination 
and finally mutation.  
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4.1.3.1 Selection 
Selection is the process which allows the best individuals to be chosen for mating. This 
follows Darwin's idea of survival and competition. The unit of selection can be the 
individual or it can be another level within the hierarchy of biological organisation, such 
as genes, cells or even organisms.  
In nature, a certain selection of individuals is taking place, according to Darwin's theory, 
the strongest or fittest individuals survive and the weak individual disappears. One of 
the natural selection examples is choosing the king of lions. For example, the male lion 
will fight to each other to be the king of their group. Once the young male lions reach to 
a certain age, the male adult lion will attack or kill the young lions to make sure he is 
the only male lion in the group. 
Inspired by this concept, selection works similar in programming; it is also the first 
method out of three to be applied to an evolution algorithm. Basically, it takes a certain 
number of individuals from a population, by calculating the best fitness through a 
fitness function, select the individual which has the best fitness score. The fitness 
function is based on what results are expected for. In some case, selection is used to find 
individuals that survive and to get rid of the individuals that are not fit enough. 
However, the chosen individuals are usually selected for reproduction which also 
concludes the mutation and crossover.  
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4.1.3.2 Mutation 
In biology, mutation is "the process or an instant changing of a small part of an 
individual's structure" [63]. In genetics, mutation "changes the structure of a gene, 
results a variant form and may be transmitted to subsequent generations" [63]. In nature, 
mutations occur spontaneously and can be induced.  It could happen as a result of 
radiation under certain environmental factors or as an error that occurs in DNA 
replication.  
4.2 Evolutionary Algorithms (EA) 
An EA is a computational optimisation algorithm which is strongly inspired by 
Darwin's biological evolution concepts.  Each EA consists of a population of potential 
solutions to the optimisation problem which alternated at generations on an artificial 
timeline via mutation and recombination. At each generation, potential solutions are 
selected from population, according to their fitness , so that better population ones are to 
be obtained in the new population. This artificial evolution cycle continues until a 
potential solution has meet the requirements. This cycle is formed in Figure 4-1 as 
follows: 
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4.2.1 Population 
The population in EA is like a number of individuals in biological evolution. Each 
individual of population consist of a genotype. A genotype represent a potential solution 
to the problem. Each genotype consists of a number of genes, each gene consists of a 
parameter or part of the solution. Depending on the types of EA, the population size 
could be different and the number of genes in a genotype can be binary numbers, 
integers, real numbers or possible combination.  
Figure 4-1Evolutionary cycle of an EA 
Generate population 
Evaluate population 
Selection Process Produce offspring 
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4.2.2 Evaluation  
The evaluation stage in an EA is that the individuals of the population are assessed to 
see if they present good solutions to the problem. When using EAs, fitness function is 
used to determine the evaluations and give a reward to an individual, this individual 
could form a solution to the problem.  
4.2.3 Selection  
Once the population has been evaluated and each individual is assigned fitness. The 
selection process takes over. It is inspired by natural evolution, and select member of 
individuals and these individuals will be promoted to the next generation. The actual 
selections varies between EAs but all the selection tries to promote sub-standard 
individuals.  
4.2.4 Reproduction 
Once the individual has been chosen to be parents, they are used to produce a number of 
offspring's so the population is always of an equal size. In order to produce offspring the 
genotype s of the parents undergo crossover/mutation operators. 
The crossover operator exchanges genetic material from two parents to produce two 
offspring. Crossover operator is a dependent on the genotype representation which vary 
between EAs. 
The mutation operator is also very dependent on the genotype representation used by 
the EA, and therefore can vary in its effect on the genotype. In most EAs, both 
crossover and mutation operators are probabilistic and happen at a centre rate in 
genotype. .  
76 
 
4.3 Genetic Algorithm 
In the computer science field of artificial intelligence, a genetic algorithm (GA) has 
been mentioned by J.H.Holland from Michigan University, USA in 1975. It is a search 
heuristic which mimics the process of natural evolution. GA is a subset of evolutionary 
algorithm (EA) which generate solutions to optimization problems which using 
techniques inspired by biological evolution: reproduction, mutation, recombination, 
selection and crossover.  
In a typical genetic algorithm, a population of string encodes individuals or phenotype 
to an optimization problem, that‘s because GA is a search based on Darwin‘s theory of 
evolution: 
 Darwin‘s theory of evolution. The most important part of Darwin‘s theory of 
evolution is the survival of the fittest and surviving individuals reproduce, 
propagate favourable characteristics. Each species starts getting more adapted to 
the environment in their development process. The basic characteristics were 
passed over to the further generations, and the off springs mutate to be different 
from their parents. When the surviving environment changes, only those who 
can adapt to the individual characteristics of the environment in order to remains. 
 Mendelian inheritance. It is a scientific theory of the genetics information that 
are encoded in the cells which known as genes in a chromosome. The different 
position of gene is represented in different characteristics. Therefore, the 
individuals which were produced by each genes have some kind of ‗resilience‘ 
to the environment. Mutation and recombination also produced offsprings who 
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could fit the environment better. Followed by the law of survival of the fittest, 
the fitter genetic structure could stay over. 
Therefore, there are several conceptions from evolution and genetic theory.  
 String. This represents as chromosomes or the genotype of the genome in 
genetics. 
 Population. The set of individuals is population, the number of individuals in a 
set is called population size, string is the elements in population. 
 Gene. Gene is the element in the string, it represents the characteristics of 
individual. For example, if a string = 1011, therefore 1, 0, 1, 1 theses four 
elements are called Gene, and their values are Alletes.  
Flow Chart explanation of GA: 
 Create a random initial population: An initial population is created by a random 
selection of solutions. These solutions have been seen as represented by 
chromosomes as in living organisms. A chromosome is a packet of genetic 
information organized in a standard way that defines completely and individual 
solution. The genetic structure enables the solution to be manipulated. The 
genetic operands enables the solutions to reproduces and evolve. 
  Evaluate fitness: a value for fitness is assigned to each solution depending on 
how close it actually is to solve the problem. Therefore the problem is needed to 
define and model it, simulate it or have a data set as sample answers. Each 
possible solution has to be tested in the problem and the answer is evaluated on 
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how good it is. The overall mark of each solution relative to all the marks of all 
solutions produces a fitness ranking. 
 Produce next generation: Those chromosomes with a high fitness value are more 
likely to reproduce offspring; the population of next generation will be produced 
using the genetic operators. Reproduction by copy or crossover and mutation 
will be applied to the chromosomes according to the selection rule. This rule 
states that the fitter and individual is , the higher the probability it has to 
reproduce.  
 Next generation or termination: if the population in the last generation contains a 
solution that produces an output that is close enough or equal to the desired 
answer then the problem has been solved. If this is not the case, then next 
generation will go through the same process as their parents did, and the 
evolution will continue. A termination criterion that always must be included is 
time out. Since one drawback of Evolution Programming is that is very difficult 
to know if the ideal termination criterion is going to satisfied or when . 
 
4.3.1 Genetic programming 
Genetic programming (GP) is a biological evolution inspired methodologically that uses 
computer programs to perform a user defined task, it is a specification of Genetic 
Algorithm where each individual is computer programmed.  
Genetic programming (GP) is the newest group member of EA. GP started to become 
more widely known after publication of John Koza‘s book in 1992 Stanford 
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University,USA. He mentioned that programs are expressed in GP as syntax trees rather 
than code line, e.g. as LISP and used this LISP expression for solving a differential 
equation. [64]Nowadays LISP is still widely used by researchers in AI. 
In 1981, Forsyth use GP as artificial intelligence, he used the primitive functions such 
as AND, OR, NOT and the arithmetic operations +,-, times and multiple to predicting 
British soccer results. In a syntax tree, programs can be written in the form of trees data 
structure. For example, the simple expression min((a+b),(a-(c*d)) becomes: 
                          (min (+ a b)(- a ( * c d))) 
The basic tree program representation used in genetic program is shown in figure 4-2. In 
the notation , it could see the expression and their syntax trees could be seen. In this 
example the program represented by the tree is equal to 𝑥3 + 2𝑥2 + 3𝑥 + 4.  The 
terminals "x" and "1" are in square background, the nodes "+" and "×" have a square 
shaped background.  
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 Figure 4-2basic tree as program representation used in genetic programming                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
The tree includes nodes and links, the node indicates the instructions to execute such as 
+,-. The links indicate the arguments for each instruction. In more advanced forms of 
GP, programs can be composed of multiple components therefore the representation 
used in GP will be a set of trees grouped together under a node called root, all the 
individual tree will be called branch.  
Just like in any other Evolutionary Algorithm, Genetic Programming works according 
to evolutionary principles. This includes using techniques like selection, mutation and 
crossover. In term of selection it needs to be differentiated between parental selection 
and survival selection. While the survival selection is based on a generational 
replacement, the parent selection is strictly executed on the bases of their according 
fitness. The excitation of mutation in GP has been introduced as a random change 
within the tree structure, based on fitness, parents have been selected probabilistically 
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for mutation. On each node of parent, mutation operation randomly pick up a node and 
detect sub tree at the picked node, this node will be seen as mutation point and the then 
new sub tree at this point has been grow in same way as generated trees for initial 
random population. The offspring produced by mutation is a syntactically valid 
executable program. It has turned out that selection and mutation work quite well for 
GP.  Crossover has been implemented as an exchange of sub-trees, there are two 
versions of crossover operations: sexual recombination and two offspring version.  
sexual recombination operation occurred on two parents which have been selected 
probabilistically based on fitness, then randomly pick a node from each of the two 
parental programs. Then these two sub trees have been switched and rooted at the two 
picked points.  The other crossover operation happened on  two offsprings.     There is a 
downside of crossover which is it allows any branch of a tree to be exchanged with any 
other brand of another tree. Therefore the resulting children are not of the same size as 
their parents. The effect of the growing size of trees have been described as bloat and is 
the most commonly described side effect of crossover in GP. Many researchers have 
been trying to find solutions to avoid bloat while introduce crossover.                                                                                                                                                                                                
4.4 Cartesian Genetic Programming  
Cartesian Genetic programming was first developed by Julian Miller [65][3] for the 
purpose of evolving digital circuits. The name of Cartesian Genetic Programming first 
came up from [66] in 1999 by representing a program of two dimensional array as 
‗Cartesian‘ and was proposed as a general programming form of genetic programming 
in 2000 [67]. Rather than using trees representing computer program it uses n-
dimensional array (typically n is 1 or 2) or network of functions, it could be seen as 
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genetic programming generalized from trees to acyclic graphs where the nodes and 
edges connections are functions. The functions are not in the form of programming 
language, they can be the simple logic gates such as AND gate. The advantages of CGP 
are: implicit reuse of expression due to its graphical representation; reuse of functional 
redundancy. [68] 
4.4.1 General form of CGP 
CGP representation consists of a network of nodes, where each node is having the same 
number of inputs and one output. The dimensions of the network have to be specified to 
fulfil special needs if necessary. For a successful application it is, however , advisable to 
have more than just one column as the network nodes will have to use the outputs of 
previous nodes, which is not possible if all nodes are arranged in one column. However, 
if all nodes are arranged in one single row the nodes have the maximum number of 
possible inputs. Although some say this arrangement is the idea one for CGP, there are 
also arguments for using multiple rows. One advantage of having multiple rows is for 
example an easier implementation in hardware should one decide to built some 
application.  
Each node consists of a basic set of information: inputs and functions. Each network of 
nodes has a certain number of inputs and usually one output, although multiple outputs 
are possible. For each component it is possible to bind to any other component that is 
further towards to the input.  It is not possible to bind any component in the same 
column because this would lead to potential recursive loops, this is forbidden in CGP. 
An example of such a network is showed below: 
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In this example, there are 3 inputs to the overall network, which in this case is one 
dimensional. The outputs of the nodes are normally not specifically stated but were 
added in brackets in this example. The outputs are then used as inputs for later 
components. The first two numbers are the two inputs that are used in each node. The 
third number in roman number is the function which needs to be defined in a separated 
function set. It is known that the function set of this example must has at least 3 
functions. It is possible that not all nodes or inputs are used to produce the output. In 
fact. in some cases it can happen that the input is connected directly to the output. I the 
given example the node providing output 11 is not used for producing the network 
output and is therefore redundant. One major difference between GP and CGP is that 
CGP has a limited number of available nodes and has the ability to reuse data rather 
than processing the same data twice. In GP, not possible to reuse data because this 
means that smaller branches would be used by some bigger branches ones. This reuse in 
code can reduce bloat as one operation only implemented once, rather than once for 
every branch. CGP thus remains a constant size and presents a certain flexibility. 
Because of this, a simple change in CGP could have a much wider impact on the result 
than GP.  
inputs: 0 1 2 
output:  10   
1 2 III (3)  0 0 I (4)  0 1 III (5)  3 4 III (6)  4 5 II (7) 2 7 I (8)  6 7 I (9)  8 9 II (10)  6 8 II (11) 
Figure 4-3 An example of CGP genotype 
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A mutation operator used could alter both the present function within a grid cell and the 
connection between components. For example, Mutations can make active genes 
become inactive and inactive genes becomes one of the several things that can happen. 
This is beneficial in evolutionary search. [74][10]  
In CGP either the inputs to a node might be mutated or the function used to calculate the 
nodes output from these inputs. The mutation impact is therefore dependent on the 
position and the kind of the mutation. The type of mutations shows as below ;  
Type of genes: Type of mutations: 
Function gene Gene will be mutated to a new 
random chosen function from valid 
functions.  
Connection gene Gene will be mutated to a new valid 
random chosen connection gene. 
Output gene  Gene will be mutated to a new valid 
output connection. 
An example is showed below in Figure 4-5 and the equivalent tree structure of CGP in 
figure 4-6 
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inputs: 0 1 2 
output: 6  10   
1 2 III (3)  0 0 I (4)  0 1 III (5)  3 4 III (6)  4 5 II (7) 2 7 I (8)  6 7 I (9)  8 9 II (10)  6 8 II (11) 
inputs: 0 1 2 
output: 11   
1 2 III (3)  0 0 I (4)  0 1 III (5)  3 4 III (6)  4 5 II (7) 2 7 I (8)  6 7 I (9)  8 9 II (10)  6 8 II (11) 
Figure 4-4 An example of the genotype of CGP 
Figure 4-5 Equivalent tree structure of CGP 
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In this example, the only parameter that has been mutated and has changed is the 
networks output, which has been mutated from node 10 to 11. Node 11 has not been 
used previously and has changed from being redundant to being in use while node 9 and 
10 have been made redundant. It is also very obvious that one simple mutation had a 
very severe impact on the function structure. It shows that mutation can have minor as 
well as major influence on the networks structure and therefore has ability to produce 
rather diverse offspring. Therefore, mutation is a powerful operator of CGP.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
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4.4.2 Decoding a CGP genotype 
In the decoding process, inactive genes in non-coding genes are not processed. Figure 
4.6 shows how the CGP genotype is decoded to produce a phenotype.
 
Figure 4-6an example of decoding procedure for a CGP genotype for the two bit multiplier problem from [8] 
(a) Output OA connects to the output of node 4, move to node 4. 
(b) Node 4 connects to the program inputs o and 2, therefore output OA has been 
decoded, and move to output OB. 
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(c) Output OB connected to the output of node 9, move to node 9. 
(d) Node 9 connected to the output of node 5 and 7, move to node 5 and 7. 
(e) Node 5 and 7 connected to the program inputs 0, 3, 1 and 2, therefore output OB has 
been decoded, and move to output OC. 
(f) Output OC connected to the output of node 12, move to node 12. 
(g) Node 12 connect to the output of node 8 and 11, move to the node 8 and 11. 
(h) Output of node 11 connected to the output of node 5 and 7, node 5 , 7 and 8 
connected to the program inputs of 0,1,2 and 3, therefore output OC has been 
decoded and move to output OD. 
The procedures continue until output OD has been decoded (step (i) and (j) 
respectively, when all outputs are decoded, the genotype is fully decoded.  
4.4.3 Evolutionary Strategy   
In CGP, a form of μ+λ evolutionary strategy (in general μ=1, λ=4) is often used, this 
give a population size of μ+λ. The μ value indicates the number of individuals promoted 
to the next generation as parents and the λ value indicates the number of offspring 
generated from the promoted parents. [9][7] [75][11]  
This has the form: (For example of 1+4)  
 randomly generate the population size of 5 programs  
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 calculate the fitness of the population  
 select the fittest of the population as the parent  
 Mutate the parent to generate 4offspring to form the new population  
 Select a new parent, by following:  
If any offspring have the best fitness which is better than the parent, this offspring 
becomes the new parent  
Else if there are many offspring have the same fitness as the parent, one of them has 
been randomly chosen as the new parent. Due to CGP chromosome have large number 
of inactive genes, so with small numbers of mutation different, population members 
could decode to the same phenotype.  
Else the current parent remains as the parent.  
A Recombination (Crossover) doesn‘t seem to add anything [7], however if there are 
multiple chromosomes with independent fitness assessment then it helps a LOT. [9]  
Each functions are chosen to use on the CGP network and will have an important effect 
on the fitness achieve. In this project, considering that the Pattern recognition is 
normally evolving mathematical techniques; therefore a good selection of mathematical 
functions would be necessary. There is no way to be sure which function is the ideal 
without experiments but the functions available could make a lot of potentially varied 
and powerful networks to be evolved.  
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CGP has been shown to perform well within a wide range of problem domain. The 
applicants of CGP so far: Digital Circuit Design, Mathematical functions, Control 
systems, Image processing, Medical diagnosis, Bio-informatics, Developmental Neural 
Architectures, Evolutionary Art, Artificial Life, Optimization problems.[7] 
4.4.4 Example of CGP 
CGP can represent many different kinds of computational structures. The example is the 
initial aim of CGP, using CGP genotype to encode a digital circuit. Figure 5.4 shows a 
CGP genotype and the corresponding phenotype that across in the evolution of a 2-bit 
parallel multiplier. 
 
Figure 4-7A CGP genotype-phenotype for a 2 bit multiplier circuits [copy from [76][12]] 
In this graph, CGP genotype parameters are: 
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nc = 10,   nr = 10,  l = 10. 
The CGP genotype represents a digital circuits for two bits parallel multiplier, it 
multiplies two by two bits number together, therefore, this circuit contains four inputs 
and four outputs, there are four logic gates which are represented as primitive functions 
in function set. The underline function genes in the genotype encodes the function of 
each node, from the look-up function table, the functions are: AND(0), AND with one 
input invert (1), XOR(2) and OR(3). The addresses are shown in each program input 
and node in the genotype and phenotype. Node 6 and 10 are inactive areas of the 
genotype and have been shown as grey.  
4.4.5 Strengths and weaknesses of CGP 
CGP has the strength that no assumptions are made, since it is GA based, it works by 
randomly searching the full solution space allowing solutions to occur that could not 
occur with conventional techniques. One of the most powerful techniques at the 
moment in image processing is the use of wavelet. Effectively a transformation similar 
to Fourier Transform but in this offer, both scale and frequencies information instead of 
just spatial domain information or just frequency, proven by M.Sifuzzamanln‘s article 
called ‗Application of Wavelet Transform and its Advantages Compared to Fourier 
Transform‘. However whilst being sophisticated it is still quite conventional with 
implementation involving blocks of filter banks. For the basis or mother wavelet only 
one of 3 or 4 families (such as Haar wavelet) tend to be used because a lot is known 
about them, not just because it is the best for the problem. CGP is far less conventional 
and solutions could involve what appears to be random arrangements of adders, 
multipliers, filters, comparators, functions to calculate means or else. 
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CGP has been shown to perform well within a wide range of problem domain. In 
Miller‘s lecture notes about CGP, it shows that the applicants of CGP so far: Digital 
Circuit Design, Mathematical functions, Control systems, Image processing, Medical 
diagnosis, Bio-informatics, Developmental Neural Architectures, Evolutionary Art, 
Artificial Life, Optimization problems.  
CGP has proven useful in image processing [71]already, for example, it has been found 
useful effectively in removing noise from an image, and it is quite likely that it can be 
used in processing mammogram. 
4.5 Multi-Chromosome CGP Network 
Multi chromosomes have been used in a number of ways within GP. One of the first 
was by Hillis [77] . He co-evolved genotypes comprising 15 pairs of chromosomes to 
produce minimal sorting networks that were capable of outperforming human designs. 
Cavill [78] discovered that the use of multi-chromosomes and also having multiple 
copies of chromosomes within the representation is advantageous to evolution on 
symbolic regression problems. Using a 2-stage crossover operator , similar 
chromosomes from 2 parents are paired using chromosome shuffling and then a n-point 
crossover is used to exchange material between the pairs of chromosomes. 
4.5.1 Multi-Chromosomes Representation  
The difference between CGP and a multi-chromosome CGP network is that the multi-
chromosome CGP genotype is divided into a number of equal length chromosomes, 
each chromosome could see as an individual single chromosome CGP network. The 
Number of chromosomes present in the genotype of an individual is depended upon by 
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the number of program outputs required by the problem, as each chromosome is 
connected to a single program output. This allows that a large difficult problem with 
multiple outputs to be broken down into many smaller problem with an individual 
output. The idea of it is making the problem easier to solve. By allowing each small 
problem to be encoded in a chromosome, the whole problem is encoded in a single 
genotype. Each chromosome contains an equal number of nodes, and been treated as a 
genotype of an individual with single program output. As an example of multi-
chromosome CGP genotype showed in Figure 4-6: 
 
4.5.2 Multi-Chromosome Evolutionary Strategy 
Rather than assigning a single fitness value to a number of program outputs, as in single 
chromosome CGP, a fitness value is assigned to the output of each chromosome in 
multi-chromosome CGP, as each chromosome's output is also a program output.  
C3 
C1 C0 
0 0 2 2 5 6 ... 0 1 3 3 3 1 ... 
3 6 9 2 5 6 ... 
95 21 14 
Figure 4-8 an example of a Multi-chromosome CGP network encoding 
a 2 bit multiplier with four outputs (Oc0 - Oc3 ) containing four 
chromosomes (C0 - C3), each consisting of 20 nodes. 
Oc1 Oc2 Oc0 
200 
Oc3 
1 20 21 40 
41 60 
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In [77], it shows that the (1+4) multi-chromosome evolutionary strategy selecting the 
best chromosome at each position from all of the individuals in the population and 
generates a new best generation of individuals, containing the fittest chromosome at 
each position. The new best of generation individuals may not exist in the population, as 
it is a combination of the best chromosomes from all the individuals. This is so it could 
be thought of as a super individual. The multi-chromosome (1+4) evolutionary strategy 
behaves as it selects the best parts from all the individuals. The overall fitness of the 
new individual also is better or equal to the fitness of any individual in the population 
from which it was generated.  
 
4.6 Advantage of EA in mammography 
Classical image process are capable of dealing with the tasks like detection and 
classification. The major difference between EA and image processing is their structures. 
Classical image processing is based on the sequential use of existing filters and 
functions, providing solution to problems have already been solved by means of 
mathematical manipulation. Programmer needs a full understanding of the problem as 
well as the processes in which the functions and filters are used. So programmer can use 
the functions or filters in a correct order with effective parameters and all these are 
needed to solve the given problem. 
EA learns to perform the tasks and build their own internal structures with no 
consequences to the programmer. The programmer may have no understanding of how 
the algorithm processes from the given data, giving the algorithm some variability. EA 
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could deal with complete different problem. It has the ability to learn to deal with new 
situation. It may be able to change the application from one to another.  
EA is suitable for complex structure problems since it learn to evolve from a solution to 
a problem.  
The particular area of mammography is extremely complex and is therefore ideal for 
evolutionary methods. There is a main restriction for those evolutionary methods is 
presented by the available database. As they have major influence on an algorithms 
performance great care needs to be taken when making a decision for a database to be 
worked with .  
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5 Mammography Datasets 
The performance of any algorithm is only as good as the data it is trained on. More 
specifically the classes represented in the training set must consist of true examples or 
else a reliable classification will be difficult, if not impossible to achieve. This presents 
a challenge for medical applications especially where the condition under investigation 
is difficult to diagnose. Therefore, an understanding of mammograms dataset has been 
considered in this research. This chapter introduces the properties, limitations of 
medical dataset, especially for mammograms. Then the dataset which is used for 
training and testing the algorithm has been introduced. 
5.1 Medical Dataset 
Medical dataset is an organised collection of data, typically in digital form for machine 
learning. The data is typically organised to model relevant aspects of reality, they are 
applied to support processes requiring the information.  
It is essential to have data sets to support the research on the detection of breast cancer. 
There are four main reasons that datasets are not only needed but also required to be 
used in this particular thesis, shown in the following. 
 Training of learning algorithms 
Machine learning algorithm is a branch of artificial intelligent, it focuses on 
prediction based on known properties learned from training data. For example, 
as evolutionary algorithm, the performance of any EA is only as good as the data 
97 
 
it trained on, therefore a completely clear, fully detailed image data set could 
lead a better training performance of evolution algorithm. 
 Evaluation of new classifiers: 
Datasets are commonly used to evaluate new classifiers. Also to investigate 
specific properties including existing conditions and clinical features of the 
mammographic datasets which are used to evaluate a new classifier - Cartesian 
Genetic Program (CGP) in CAD systems.  
 Characterisation of different medical conditions 
Different diseases have different medical conditions with the specific symptoms 
and signs. Therefore, different datasets are more like a container to model 
different specific medical conditions. A lot of scientific research is based on the 
gathering and analysis of measurement data, especially for medical image 
research. Datasets including models and parameters are important and 
sometimes can be seen as the primary intelligent input of the research because 
they cannot be reproduced and will be necessary for longitudinal research or to 
test or check for further insights in the future.   
Medical imaging widely accepted as a special case due to its reliability. Medical 
decisions are based on the clinical tests which provide huge amount of data on patients 
and their medical conditions. For example, a pathologist analyzing biopsies to decide 
whether they are malignant or not, the radiologists planning a sequence of radiation 
doses is searching for the harms. The sizes of medical datasets varies and depends on 
several conditions such as spatial distributions, collection strategies, time consuming 
issues, etc.  
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Medical dataset drives from reality and it is not easy to simply build up. The medical 
dataset usually involve subjective clinical assessment, and often there is  no definitive 
clinical test for every  condition under investigation.  
This section provides an overview of medical image datasets for early detection of 
breast cancer. Four publically available datasets of mammograms have been introduced 
in section 5.2. Finally, a suitable new dataset for developing a novel evolutionary 
algorithm for classification of microcalcifications in mammogram is constructed in 
section 5.3.  
5.2 Medical Datasets for Detection of Breast Cancer 
There are a varieties of datasets for clinical breast cancer diagnosis and research. 
These includes  information of stages, ages, pathologic record, results of physical 
exams and recent images are included.  Research shows that early detection of 
breast cancer could improve survivals. Breast cancer screening is one kind of cancer 
screening which has been provided for an early diagnosis of breast cancer. A 
number of screening tests have been employed including: clinical and self-breast 
examinations, mammography, ultrasound, and magnetic resonance imaging. 
Following the procedure of breast screening, there is a  wide range of dataset 
modalities commonly used in clinical practice including, classic x-ray based 
mammographic image, magnetic resonance imaging which is a three-dimensional 
imaging modality more sensitive to soft tissue, ultrasound which is using high 
frequency sound wave to produce images; the parameters which have been used to 
classify breast cancer and to indicate cancer stages; the biopsies for getting tissue 
sample with information about fine-needle aspiration, nipple aspirate and ductal 
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lavage; The  traditional modalities as case notes from radiologists, oncologists  and 
pathology report are also included.  
 
5.2.1  Characteristics of Breast Cancer 
Once the cancer has been confirmed, the information includes the stage of the 
breast cancer in pathology report and it is important for doctors to make a plan of 
treatment. The stages cover the range of whether breast cancer is limited in one area 
of breast  or if  it has already spread into healthy tissues inside the breast or other 
parts of the body. There are several characteristics that can be assigned as local, 
regional and distant to determine the stages of breast cancer: invasive and non-
invasive cancer, the size of the cancer, cancer is in or not in the lymph nodes, 
whether the cancer has spread to other parts of the body. 
 The size of the cancer: size indicates how large the tumour is at its widest point. 
Doctor measures the tumour in millimetres or centimetres. The size is used to 
help the radiologist to determine the stages of the breast cancer. However it 
should be noted that the size of the tumour is not everything, because a small 
size tumour could be aggressive while the large one not.  
 Cells in Lymph nodes: as mentioned in section 2, they are easily affected by 
breast cancer cells, therefore, before the surgery to remove an invasive breast 
cancer, an examination of the lymph nodes will be involved. The more lymph 
nodes that contain cancer cells, the more serious the cancer might be. 
 Spreading: Whether the cancer has grown to other parts of the body beyond the 
breast. 
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 Invasive or non-invasive breast cancer: Breast cancer normally starts to grow 
from two parts, either in the lobules cells which are the milk producing glands, 
or the ducts which are the passages which drains milk from the lobules to the 
nipple. Non-invasive cancer sometimes is called carcinoma in situ, it stays in the 
milk ducts or lobules in the breast and do not grow into normal tissues or cross 
the edge of the breast. Invasive cancer does grow into healthy tissues. Most of 
the breast cancers belong to the invasive cancer type, however it really depends 
on the patients' treatments and how the patients respond to the treatments. Figure 
5-1 and 5-2 shows the differences of the normal cells, non-invasive cells and 
invasive cells of breast cancer.       
 
 
                                                                                                                                                                                                                                                                                                             
 
 
 
 
 
Figure 5-2Invasive cell from [127] 
 
Figure 5-2Non-invasive cell from [127] 
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Cancers do not always remain as single invasive or non-invasive. That means part of the 
cancer has been grow in normal breast tissues, part of the cancer and part of tissue has 
been spread in other parts of the body. In most cases, breast cancer can be classified as 
follows:                                                                                                                                                          
DCIS (Ductal Carcinoma In situ): DCIS is the most common non-invasive breast 
cancer which stays inside the milk duct. Ductal carcinoma in situ (DCIS) is a sign that 
cells in some ducts of the breast have started to transform as cancer cells. It is a 
preliminary stage to invasive cancer. ‗In situ‘ means that cancer is ‗remaining confined 
to the duct‘. DCIS develops from a normal duct that would typically have one layer of 
cells as an outer boundary. If the cell developed more than should and form an 
additional regular layer around the boundary the condition would be called Hyperplasia. 
If additional cells of a hyperplasia takes an irregular form, the condition is called an 
atypical hyperplasia. If the condition keeps growing uncontrolled, it is called DCIS. It is 
important because it is close to the stage on early detection of breast cancer. Even it is 
not developed into cancer yet, most cancer grows in ducts, if untreated, DCIS leads I 
about 30%-50% of all cases turns into invasive cancer [12].   
LCIS (Lobular Carcinoma In Situ): LCIS is an overgrowth of cells that stay inside 
the lobule. It is not a true cancer; more like a warning sign of an increased risk for 
developing an invasive cancer in the future. 
IDC (Invasive Dutal Carcinoma): The most common type of breast cancer, invasive 
ductal carcinoma begins in the milk duct, has grown into the surrounding normal tissue 
inside the breast. 
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ILC (Invasive Lobular Carcinoma): ILC starts inside the lobule but grows into the 
surrounding normal tissue inside the breast. 
Inflammatory Breast Cancer: Inflammatory breast cancer is a fast-growing form of 
breast cancer that usually starts with the reddening and swelling of the breast, instead of 
a distinct lump. 
[78] estimates that 90% of all breast cancers are ductal cancer and only 10% are lobular 
cancer.                                                  
The stages of cancer represent how big the cancer tumour is and whether the cancer has 
spread. The stages are important because they help the professionals to make the best 
treatment plan for the patients. The main types of staging system are the number of 
systems and the  TNM (Tumour, Node, and Metastasis)  system which is the system for 
providing more details about how the cancer looks and behaves. These two types of 
staging systems are shown on table 5-1 and 5-2. 
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Table 5-1TNM staging system 
Letters:  
Category: Description 
T : Size 
TX Tumour cannot be measured or found. 
 
T0 There is no evidence to show the primary 
tumour. 
 
Tis Cancer is ‗in situ‘,  means that the tumour has 
not started  to grow into other parts of the body. 
 
T1-4 1 to 4 represent the size of the tumours and the 
chance that tumour could extend to chest wall or 
skin.   
N:  
Lymph node 
involvement 
NX Tumour cannot be measured or found. 
 
N0 There is no evidence to show the primary 
tumour. 
 
N1-3 1 to 4 represent the size of the tumours and the 
chance that tumour could extend to neighbouring 
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breast tissue.  
M: Metastasis 
MX Metastasis cannot be found. 
 
M0 There is no distant metastasis. 
 
M1 Distant metastasis is present. 
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Table 5-2Number staging system 
N umbers:  
Category: Description 
Stage 0  Non-invasive breast cancer 
Stage 1  The tumour is smaller than 2cm; 
No  cancer cells in lymph node; 
The cancer has not spread from breast. 
Stage 2 2A Tumour is smaller than 2cm and has spread to 
lymph node; or tumour is bigger than 2cm but 
smaller than 5cm and has not spread to lymph 
node. 
 2B Tumour is smaller than 5cm and has spread to 
lymph node;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
or tumour is bigger than 5cm but has not spread 
to lymph node. 
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Stage 3 3A there is no tumour in breast, and cancer in lump 
node is smaller than 5cm ad has spread to lymph 
nodes;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 3B There are cancer cells in lymph nodes and the 
cancer has spread to the tissue nearby the breast 
and may attach the skin or muscle which is 
surrounded. 
 3C The cancer has spread to lymph nodes and below 
the breastbone, near the neck or under the 
collarbone. 
Stage 4  Metastatic invasive breast cancer which has 
spread over breast and lymph nodes to other 
organs of the body. 
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5.2.2 Mammogram Datasets Properties 
A number of range of screening methods commonly used in clinical practice include 
mammography, MRI, Ultrasound which to achieve an earlier diagnosis. The dataset of it 
is an important dataset in the whole breast datasets. These varieties of breast screen give 
different properties of breast screening dataset in which the mammogram dataset plays a 
very important role. Therefore mammogram dataset plays a very important role in 
breast screening datasets. Most of the public mammogram datasets are digitized, 
because digital mammography overcomes several technologies limitation associated 
with screen film mammography. This section identifies several aspects of the image 
characteristics of mammogram data, including intensity properties such as contrast, 
spatial properties such as texture and structure properties such as breast density.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
5.2.2.1 Full Frame Digitized Mammogram 
 Overview 
The images in mammogram dataset are in digital form, it could be achieved by either 
digitizing the screen film mammograms or using the digital mammogram machine. 
Digital mammogram is and will rapidly be forming the basic of modern radiology 
process to replace the traditional filmed radiography in many health institutions. Digital 
mammogram data is a capture in digital form, it means that the digital mammogram 
data are sampled spatially and in signal level.  
The most significant property for digital mammogram is it separates the process of 
image acquisition from the image storage, image display. This helps to optimize of each 
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of the separated functions and give flexibilities in the adjustment of image display 
characteristics. A well optimized digital mammogram data provide these advantages: 
These dataset has more efficient acquisition.  
 Digital mammogram data is captured in numerical form. 
 The amount or characteristics of X-ray exposure does not affect the control of 
display brightness and contrast. 
 Digital mammogram could use image processing to adapt data for matching 
visual performance such as eyes, and also could overcome limitation of the 
display devices. 
 The digital mammogram data could be used to evaluate and compare the 
performance of a number of technologies such as quantitative imaging 
techniques, Computer aided diagnosis system, contrast imaging, 
telemammography. 
 Digital mammography or full frame digitized mammography has the abilities to 
remove other structural pattern such as fixed noise.  
To record digitized mammogram, the equipment need special x-ray detectors to perform 
digitized mammogram.  [79] stated that digital detectors have properties on increasing 
efficiency on absorbing the incident x-ray photons, a linear response over a wide range 
of radiation has enhancement on visibility of subtle contrast differences between the 
normal background tissue and tumour. 
In several public datasets, they use different digitizer to digitize the screen film 
mammograms. For example, The Digital Database for Screening Mammography 
109 
 
(DDSM) database used four different digitized scanners with different sampling rates to 
digitize the screen filmed mammograms. They have different grey levels:  
Table 5-3 The sampling rate, number of gray levels (M. Heath, 2000) 
Digitizer Sampling Rate (microns) Gray Levels (bits) 
DBA M2100 ImageClear 42 16 
Howtek 960 43.5 12 
Lumisys 200 Laser 50 12 
Howtek MultiRad850 43.5 12 
 
 Spatial Sampling Properties  
Both the spatial and intensity distribution of the X-ray transmission pattern are sampled 
to form the digital mammogram. For digitized mammography, in spatial domain, the 
interval between pitch samples and the response profile of the detector element (del) 
will determine the spatial resolution of the imaging system [80]. The basic difference 
between the detectors used for both screen film mammography and digitized 
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mammography is that the signal varies more or less continuously in spatial and intensity 
domains for screen film mammograms, however the analogue signal is sampled from 
the detector of a digital mammography system. In mammogram dataset, the data spatial 
sampling has been achieved by different detectors using different approaches; however 
there are some important common concepts to all systems. For example, a detector has 
been divided into detector elements which are also called del. In image acquisition, 
every signal detector element provides one or a set of discrete X-ray measurements. 
These measurements are used to contribute to the image data. Figure 5-3 has showed a 
simplest example, the signal from one del will provide the information displayed in one 
pixel of the final image. The del will array at centre to centre distance or pitch p. A 
detector element contains an active region whose dimension is d. Dels are spaced at one 
pitch p, non-sensitive edge area on del, the fraction of the area which is sensitive to X-
rays (𝑑2/𝑝2), can be less than 1.   
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 
Figure 5-3 The concept form of detector element and spatial sampling from [80] 
d 
d 
Detector element pitch p 
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[81]  mentioned that digitization improved abilities of detection larger, low contrast 
subject, but did not change on small objects. His experiment also approved that to a 
relatively low spatial resolution of 0.1 mm /pixel does not achieve high quality 
diagnosis performance in digital mammography.  
5.2.2.2 Image Properties of Mammogram Data 
 Image properties 
Spatial resolution is measured commonly in line-pairs per millimetre (p/mm) or cycles 
per mm, and is used for indicating the size of the smallest visible object structure by 
using a low kilo voltage and high mAs value. In the meanwhile, it increases the contrast 
while reducing noise which are the conditions that are very different from the exposure 
parameters used in diagnostic setting. Spatial resolutions improve the sharpness of the 
images and allow better detection performance on a really small detailed image. Spatial 
resolution is measured by a X-ray phantom through the alternating bars and spaces. A 
high spatial resolution improves the morphological analysis of microcalcifications [82].  
5.2.2.3 Ages                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
In the case of breast cancer, most statistics show that there is a steady increase of 
incident cases in the group of women from 50 to 70 years old. Therefore, EU 
recommends that breast cancer screening for women between the age of 50 to 69 
[83] .In the member states of EU, the target age for breast cancer screening varied from 
47 to 74 years old. In the UK, the National Health Service (NHS) invite all women 
between 50 and 70 years old for breast screening on every three years [31].Also, the 
women aged over 70 are not explicitly invited to screen, however they still can arrange 
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screening if they want. It needs to noticed that, in UK, NHS has started to extend their 
breast screening programme to invite women in their late 40s and up to 73 years old, 
and this is expected to be completed by 2016.  
                
 
Figure 5-4 Average number of cases per year and Age specified incident rate per 100,000  in UK 2011-2013 
copy from [85]  
According to Figure 5-4, age groups from 50 to 70 years old still remains at the main 
peak values. Other age groups around the NHS screening age group also have a high 
risk in breast cancer development, therefore it is reasonably understandable for NHS to 
rearrange the age group from 50-70 years old to 47-73 years old, since the age group 
between 45 to 49 years old also has a high average number of breast cancer cases and 
incident rate. In addition, the age group of female above 70 years old are still welcome 
to  attend the screening programme and there is no age limitation for older women on 
their breast screening.  That is because it is easier to catch the disease in older women, 
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therefore, there is also a disagreement about the usefulness and benefit of screening for 
women older than 70. There is a discussion about whether women around 40s should 
join the screening routine all over the world. There is no significant evidence to show 
that women in their 40s should be screened, however [84] used two different databases 
and reported that mammography screening reduces breast cancer mortality by 15% for 
women aged 39 to 49.   
The world health organisation (WHO) compared the 10 most common causes of  death 
by country and income group for women between 20 to 59 years old [85] .  There were 
223,000 deaths of women who were aged 20 to 59 caused by breast cancer worldwide. 
It was the sixth most common cause of death worldwide for women aged 20 to 59. The 
further statistics followed up by comparing the 10 most common causes of death in a 
country by income catalogue. In women aged 20 to 59, breast cancer was the fourth 
cause of death for women in mid-income countries; and the first common cause of death 
in high-income countries in other words western countries. [29] show that breast cancer 
mortality in the geographical distribution of the EU, where breast cancer occurrences 
appears mainly in Western, Middle and Eastern parts of  the EU. UK has the highest 
mortality rates of cancer occurrences while Netherlands, North-Western France, 
Western Germany, the Czech Republic, Hungary, and parts of Romania and Bulgaria 
also present high rates; whereas, north and south of that band has lower mortality rate.  
5.2.2.4   Reliability 
Mammogram is a high contrast, high resolution film and designed specifically for 
creating a detailed image of the breast. There are eight typical kinds of abnormalities 
revealed with a mammogram which have been mentioned in Chapter 2. Usually, a 
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mammographic abnormality is followed up first by additional imaging studies such as 
Ultrasound, and if the area is suspicious a sample of tissue may be sent for biopsy. The 
leading risk factor for the development of breast cancer is being a female.  The second 
important risk factor is age.  
 Sensitivity 
Sensitivity of mammogram is in the proportion of breast cancer that can be detected 
when the breast cancer exist. Sensitivity relies on a number of factors, such as lesion 
size, breast tissue density, and age, the hormone state of the tumour, image quality and 
skill of the radiologists. According to the Cancer stats report about breast screening in 
UK in 2003 [86], the sensitivity of mammograms for women aged between 50 and 69 
have been estimate to be from 69% to 90%, for women aged 40 to 49, the sensitivity is 
lower at about 62% to 71%.  
However, mammography is less effective in finding cancers in women younger than 50 
because the breast tissue is still denser compared to the fatty breast tissue for women 
over 50. Therefore, the early stage breast cancers in young women are harder to find by 
using screened mammograms. [87] shows that young women have more false positive 
mammograms and additional imaging but fewer biopsies than older women. [88] did 
one study about the  examination of 576 women who had invasive breast cancer 
following a mammogram to determine whether it was denser tissue, or that faster 
growing tumours for young women could cause lower sensitivity. They found that 
―greater breast density explained most (68%) of the decreased mammographic 
sensitivity in younger women at 12 months. Whereas at 24 months, rapid tumour 
growth and breast density explained approximately equal proportions of the interval 
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cancers.‖Research shows that the use of computer aided diagnosis systems may help to 
diagnose more breast cancer using mammography. 
 Positive Predictive Value 
Although the use of the mammogram has shown its reliability in the early stages of 
breast cancer detection, a positive predictive value has been recognized as the number 
of cancers diagnosed per recommended number of biopsies.  In the UK, 6% to 8% of 
women are recalled for further tests after their first screening indicates cancer [86]. 
 Investigator Bias 
Different trials have been introduced to document the capacity of mammography to the 
diagnosis of breast cancer, or the early detection of breast cancer. These trials also show 
that the survival rate of cancer is higher in screened women than in non-screened 
women [32] [86]. However, these comparisons are susceptible to a number of important 
biases.  
Lead time bias: 
Survival time from the diagnosis of cancer in mammography includes the time between 
detection and the time in which breast cancer would have been detected by clinical 
symptoms. However, this time does not include the survival time of finding breast 
cancer as a result of symptoms.  
Length bias 
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Mammography detects a cancer when the cancer is preclinical and this duration is not 
fixed. If breast cancer has a long preclinical time, this cancer probably could be detected 
by screening, and this kind of cancer is more likely to grow slowly and has a good 
prognoses. 
Over-diagnosis bias: 
Screening may find a cancer which grows really slow and maybe never needs to be 
clinical. This is an extreme form of length bias [89].  
Healthy volunteer bias: 
The screening population may be healthier than the general population.  
 Impartiality 
BI-RADS stands for Breast Imaging-Reporting and Data System and it is established by 
American College of Radiology. BI-RADS are a quality assurance tool designed to 
standardize mammography reporting where it reduces the confusion in breast imaging.  
BI-RADS system is now adapted for use with Ultrasound and MRI.  It is a quality 
assurance tool originally designed for mammography. Terms have been developed to 
describe breast density, lesion features, impression, and recommendations [90]. This 
system forces the radiologist to assign each case into a different catalogue, and then 
accurate statistics will be counted to evaluate the radiologists‘ work. BI-RADS 
classifications have also helped in monitoring breast cancer diagnosis, treatment and the 
supporting of breast cancer research, are also easy to calculate statistically. 
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In UK, the Royal College of Radiologists Breast Group standard scoring system is for 
improving the communications between the referrals and the radiologists. It helps avoid 
ambiguity which may cause mismanagement of patients [91].  It is recommended that 
this standard be used in the reporting of all breast imaging examinations in the U.K. In 
the national institution in the UK, the patients‘ management is based on the principle of 
the ‗triple test‘ which are clinical examination, imaging and needle sampling. If the 
clinical results are suspicious or the overall imaging results are 3, 4 or 5, the needle 
sampling will be paramount.  
Table 5-4 shows the standard U.K.RCRBG scores system and BI-RADS catalogues 
with associated meanings and there is third similar five points system developed by the 
Australian National Breast Cancer Centre. BI-RADS are widely used through North 
America and some parts of Europe, RCRBG scoring system is applicable in UK 
practices, NBCC is in collaboration with the Royal Australian and New Zealand 
College Radiologists.  
 
Table 5-4 Comparison of imaging classification systems from (A.J. Maxwella, 2009) 
Category BI-RADS NBCC RCRBG 
0 Incomplete 
assessment: 
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Need to view prior 
studies and complete 
additional imaging 
1 Negative, continue 
routine screening.  
No significant 
abnormality.  
No significant 
abnormality. 
2 Benign, continue 
routine screening. 
Benign finding. 
No further image 
is request.  
Benign finding. 
3 Probably Benign, 
malignancy chance 
<2% 
Indeterminate 
findings. 
Requires further 
investigation 
usually FNA core 
biopsy.  
Indeterminate/probably 
benign findings. 
There is a small risk of 
malignancy, further 
investigation is 
indicated.  
4 Suspicious 
abnormality, coming 
with biopsy or needle 
biopsy. 
Suspicious 
findings of 
malignancy. 
Requires further 
Findings suspicious of 
malignancy. 
There is a moderate 
119 
 
investigation. 
May require 
excision biopsy 
risk of 
malignancy. Further 
investigation 
is indicated. 
5 High suspicious 
malignant: 
Biopsy and treatment 
are necessary. 
 
Malignant 
findings, requires 
further 
investigation, 
even if non-
excision 
sampling is 
benign. 
Findings highly 
suspicious of 
malignancy. 
There is a high risk of 
malignancy. 
Further investigation is 
indicated. 
6 Biopsy proven 
malignancy, treatment 
and pending 
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5.2.3 Existing Mammogram Datasets 
Within mammographic research, there are difficulties with  the datasets which cannot be 
simply generated;  therefore the new dataset has to be taken from an existing dataset. 
Between different datasets, there are a great many differences which have to be taken 
into account. There are several different publically available datasets and many 
privately constructed datasets of mammograms for breast cancer research. There are 
currently four public datasets which have been widely used for different researches. 
They are Nijmegen database, Mammographic Image Analysis Society (MIAS) database, 
University of South Florida Digital Mammography Database for Screening (DDSM) 
and Lawrence Livermore/University of California (LLNL/UCSF) Database. The 
advance could provide broad range information for CAD system. It remains to be 
difficult to compare the performance of different algorithms without meaningful 
datasets. It is not meaningful to compare different systems if the systems are not tested 
in the same dataset.  
5.2.3.1 Nijmegen Dataset 
Nijmegen dataset is known as the first public database for screening mammography. It 
consists of 40 images, since it is no longer available, therefore it cannot be invested any 
further.  
5.2.3.2 The Mammography Imaging Analysis Society Dataset (MIAS) 
The MIAS database has been build up by the University of Manchester and was 
completed in 1994. It has 322 images of different sizes and has a later adapted to form 
the Mini-Mias dataset. The Mini-MIAS has a number of selected images scaled in 
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1024×1024 pixels and have been centred in the matrix. It needs to be noticed that the 
Mini-MIAS have a lower quality than original ones.  
The MIAS database is no longer available, and the Mini-MIAS database has been 
consistently cited for many years but it has failed to represent all the cases of 
mammograms. 
5.2.3.3 Digital Database for Screening Mammography Dataset (DDSM) 
DDSM first completed on 1999. The examinations of the present cases have been taken 
between 1988 and 1999. There are 2620 cases in total; four standard views from each 
case were digitized on one of four different mammography screen exams. The DDSM 
contains mammograms obtained from Massachusetts General Hospital, Wake Forest 
University School of Medicine, Sacred Heart Hospital and Washington University of St. 
Louis School of Medicine. 
 
 
(a) right in CC (b) Left in MLO (c) Left in MLO (d) Left in CC 
Figure 5-5 A  DDSM example case containing mammograms show left and  right standard views :cranio-caudal (CC) 
and mediolateral-oblique (MLO) [7] 
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Each case in DDSM contains the patient age, the screening exam date, the date on 
which the mammograms were digitized and ACR breast density which was marked by 
an expert radiologist. Each marking contains a subtlety value and a radiologist‘ 
description using the BI-RADS™ lexicon. 
 
Table 5-5 Contents of DDSM dataset [92] 
 
Institution 
 
Digitizer 
Number of cases by most sere finding  
Total 
Normal Benign 
without 
Call-
back 
Benign Malignant 
MGH DBA M2100 
Image Clear 
430 0 0 97 527 
Howtek 960 78 0 446 323 847 
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WFU Lumisys 200 
Laser 
82 93 126 159 490 
SH 0 48 202 234 484 
WU Howtek 
MultiRad850 
105 0 96 101 302 
Total 695 141 870 914 2620 
 
Several software tools are available for the user to download from the database website, 
these tools simplify the most common tasks, such as case selection, data extraction and 
performance evaluation.  
DDSM database is an infinitely larger database and is stored in a format which is not 
conductive to use quickly.  
5.2.3.4 The Lawrence Livermore National Laboratory Database (LLNL) 
The LLNL has been built in cooperation with the University of California in San 
Francisco. It has been completed in 1996 and contained 50 cases. Furthermore, the 
LLNL dataset has been specialised in microcalcifications. In these 50 cases, 20 cases 
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show benign microcalcifications and 12 are suspicious calcifications and 8 are 
malignant calcifications.  
However, the LLNL dataset is no longer publically available. 
5.2.3.5 Other Datasets 
In additional to those existing datasets, other datasets exist which have not been made 
public or are part of partly published project.  
 eDiaMonD project 
eDiaMonD project project is a grid computing project for the distribution 
information on breast cancer treatment promising a vast dataset of digital 
mammogram images. However, this project has been terminated in 2004 due to 
a lack of success. 
The IRMA project [93] 
This database is the dataset containing the texture pattern extracted from 
digitized mammograms of different BI-RADS classes. It collects mammograms 
image data from DDSM, MIAS, LLNL and RWTH databases and extracted 
patches and resized the image data to 128×128 pixel. The dataset could be 
catalogued into two different slots: 
12er_patches contains 2796 patches of 12 classes, each with 233 images; 
20er_patches contains 880 patches of 20 classes, each with 44 images. 
They are used for image retrieval and computer-aided diagnosis.  
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5.2.3.6 Limitation of Mammograms datasets 
There are available summarized essentials of mammography datasets when subjective 
evaluation is involved as multiple assessors. Medical datasets are more sensible than 
other datasets based on their natures and effects. A good mammography dataset requires 
multiple assessors to provide greater confidence. Since the diagnosis of screening 
mammogram has a high false positive rate and the high risk of false positive, in some 
areas, there are two radiologists who  are required to diagnose one mammogram to try 
to  avoid any misdiagnosis and later may even use a biopsy to provide more diagnostic 
confidence.  
However, a huge amount of raw information has disadvantages as these may confuse 
the system and decrease decision accuracy. These datasets have uniformity, but actual 
performance evaluation methodologies related to data selection is lacking consistency in 
for example: 
 Classification confidence. 
 Classification confidence represents the level of suspicion about malignancy on 
imaging. These levels are numerically categorised, however there are significant 
variations in the definitions of each numerical category between different areas. 
 demographic spread 
There are significant variations between countries in breast cancer [7], this is 
also true of diagnosis and survival rates. Figure 1 shows the rate in age-
standardised per 100000 women between high-income and low-middle income 
countries in 2004.   
 Diagnosis 
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The radiologists in different areas have been trained differently to classify 
mammograms; this may lead to confusion and potential error when staff moves 
between areas. 
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6 Design the Multi-Chromosomes Cartesian Genetic 
Programming (MCGP)  network for automated analysis 
mammograms 
The aim of project is to investigate the suitability of the new algorithm called multi-
chromosomes Genetic Programming network (MCGP) as described previously to 
ensure a reliable diagnosis of mammograms as part of a CAD system. For automated 
analysis of mammograms, it is possible to apply raw pixels to the network and train on 
them. One of the strengths of an evolutional algorithm is that can discover new 
solutions a conventional design would never uncover and it does this by its random 
nature. If conventional features are extracted to be fed into the network, then this puts a 
major limit on what the network can achieve in an absolute sense. Putting the raw pixel 
values in essentially free the network to extract whatever information it decides is most 
important. The downside is that in order to cover on a solution there is the possibility a 
much larger network may be needed. This increases the runtime which could already be 
a problem which MCGP has the potential to overcome.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
This chapter describes the experimental methods in detail that will be used in automated 
analysis of microcalcifications. Methods include dataset used for experiment, details of 
the new representation of Evolutionary Algorithm, which is also used for the application 
and details of performance measurement. 
6.1 Experimental dataset 
 In the entire research, an algorithm of MCGP (as described in Chapter 4) has been used 
as a solution to automated assessment of microcalcifications in mammograms. 
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Therefore the microcalcifications mammogram images have been obtained. The data for 
both the training and testing the algorithm was obtained from the LLNL database. As 
described in Section 5 compared to other databases, specialising in microcalcifications 
of the LLNL database is outbalance by the disadvantages of this database. No 
information has been found as to exactly how many malignancy calcification cases were 
found in the other three public databases. The other three public databases also contains 
masses and asymmetries.  
In total 31 images were created, of which 13 contained malignant microcalcifications 
images and 18 benign microcalcifications images from 5 separate patients. 
6.1.1  Region of Interests (ROIs) 
As a result of image restriction of the available data, there is a reduction of image size 
as a region of interest (ROI) has been marked from original mammograms and supplied 
by Dr. Eddy Munday. Each ROI has a size of 128 ×128 pixels . If the ROI has to be 
chosen to be 256 ×256 pixels, that is because the ROI of 256 ×256 pixels would have 
contain too many relatively large areas of surrounding tissue and extremely smaller 
areas of malignant microcalcifications. As a description in [94], one critical feature of 
the development of malignant microcalcifications is that when the surrounding tissue 
under these conditions grows to an approximate radius of 180 µm, then necrosis or cell 
death might be reached. This is because the tumour has grown beyond this size and any 
tissue outside this radius could be diagnosed as benign, a making the situation not 
suitable for a classification stage. Therefore a smaller ROI with 180×180 pixels haves 
relatively the best conditions which still contain a significant amount of healthy tissues, 
as microcalcifications takes about 5% of the ROI. One ROI is featuring at least one 
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microcalcification, this selection provides 31 ROIs from the dataset of 18 containing 
benign microcalcifications and 13 containing malignant microcalcifications.  
Using raw pixels values to classify the mammograms approach, it can therefore be 
appreciated that any processing using MCGP network on full field mammograms will 
take an unacceptably long time. Subsequently, the mammograms will have to be 
partitioned in to smaller part images to make feasible processing.  
6.1.2 Grid Structure for Segmentation Representation 
The segmentation is developed as a sequential representation providing a different 
approach for filtering an image. The segmentation representation theoretically allows 
for parallel processing, the aim is to break down the overall problem into a number of 
sub-problems which offers potential to be processed in parallel.  
Images containing different information are split into different parts. Based on this 
representation of segmentation, some areas contain microcalcifications which may 
differ greatly. There are also some areas which regularly holds fairly similar 
information since they contain only a breast tissue background. 
Therefore, the whole image has been divided into smaller parts, using a MCGP network, 
it was decided that one image is divided up into equally sized parts of non-overlapping 
rectangular shapes. The basic principle is shown in Figure 6-1.  
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Since the image size is fixed and the number of image parts depends on the size of the 
sub-image. For the particular experiment image of 128×128 pixels, the size of the sub-
image needs to be rectangular or squared so the whole image could be divided exactly 
into an integer number of parts. A greater number of image segmentation means that the 
size of individual image segments becomes smaller. Having too many sub-images will 
result in a large network; therefore [95] did experiments to find out the best size for a 
sub-image by using the CGP network. The results show that a sub-image sized 8×8 
pixels gives the best performance between fitness and best average fitness. As a result, 
128×128 pixels ROI have been divided into 256 non-overlapping 8×8 pixels areas or 
parts.  Figure 5-8 shows the process from choosing a ROI and then logically divided 
into 256 parts and the status of each part labelled as either being benign or malignant 
according to the radiologist.   
 
 
 
 
Segmentation 
grid Image 
Image has been divided into 
equal, non-overlap parts 
Figure 6-1Process for grid structure of segmentation  representation 
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6.1.3 Additional information for dataset 
As each ROI has been divided into 256 parts, each part could be seen as a small image 
with 8×8 pixels with 8 bit grey scale. For each pixel, it has a range between '0' to '255' 
Figure 6-2 A ROI has been point out by the expert and then be devided into 256 equal non-overlapping 
parts 
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in order to process pixel values of 8 bit depth. The detection by radiologists of 
microcalcification will use the grey shading and the white oral in the figure 
representation and mammogram ROI, as respectively have been provided by the 
radiologist experts. Two additional data files are one to one mappings of the original 
ROIs which are provided by radiologists.  The values of these additions are in a smaller 
range than the pixel values in ROIs. These additions will be used as reference materials 
in order to achieve a better training system; it is also used on evaluating the 
performance of the algorithm in the following chapter.  
6.1.3.1 White Pixel Value (WPV) 
For ROIs only with benign microcalcifications, one of the corresponding additional files 
is on the pixel level by using ‗0‘ to indicate breast tissue pixel and '1' for whether this 
pixel contains information of microcalcifications.  Therefore, there is a respective parts 
file which has then been generated for each region of interest, which simply provides 
the respective number of white (or to be precise, non-zero intensity) pixels for each 
section of the image. Since each part only has 64 pixels, therefore the range of white 
scale values is from 0 to 64. These white pixels count numbers will be called white 
pixel value (WPV) in work. The other one also uses ‗0‘ and ‗1‘ but in a level of ‗part‘. 
For each part, there is an indication of ‗0‘ to indicate benign tissue located on that part 
and the number '1' to indicate that that particular part contains microcalcifications. 
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a) Original ROI with 256 equal non-overlapping parts 
b)  Corresponding to ROI, '0' indicate breast 
tissue,'1' indicate existing microcalcifications 
c) File representation of white pixels count from 
respective parts of mammogram ROI 
Figure 6-3 An example of additional data for ROIs only with benign microcalcifications 
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Figure 6-3 shows one example of a ROI (Figure a) has been divided into 256 parts and 
each part has a relatively ‗0‘ or ‗1‘ to indicate microcalcifications in part level (Figure b) 
and 'white' pixel value in pixel level (Figure c).   
6.1.3.2 ROIs only with malignant microcalcifications  
Similarly as the ROIs with benign microcalcifications, after each image, is logically 
divided into 256 parts, the status of each part labelled as either being benign or 
malignant according to the radiologist.  The number of pixels containing information of 
malignant microcalcifications in one part have been provided by radiologists as well. ‗0‘ 
is used to indicate not only benign microcalcifications but also breast tissue and ‗1‘ is 
used to indicate malignant microcalcifications. Therefore, the corresponding data for 
benign ROIs are fully ‗0‘s since there is no malignant microcalcifications.  
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Figure 6-4 An example of additional data for ROIs only with malignant microcalcifications 
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6.1.4 K-Fold Cross Validation 
The performance of any algorithm is only as good as the data it trained on. Presenting 
the algorithm with a variety of images leads to the algorithms ability to deal with 
different problems and provide strong results. In other words, it could also be 
understood with the greater the number and diversity of the problems an algorithm is 
trained, the more stable and strong the results will be obtained. Therefore in order to 
obtain statistically meaningful measures of performance, computer learning algorithms 
should be trained and tested on large datasets. There are 31 images from 8 patients 
included in the training and testing together in dataset. The relatively small number of 
images available to train and test the CGP network has required that k-fold cross 
validation be used [12] . In this method, the original sample is randomly partitioned into 
k subsamples, each subsample is used as the validation data and the remaining k-1 
subsamples are the test data, then the process repeats k times with the folds, each time it 
makes a different k subsample as the validation data. The advantage of k-fold cross 
validation is that repeated random sub-sampling leads to all samples being used for both 
training and validation, and each sample is used for validation exactly once. [96] The 
main advantage of cross validation is that all cases in the data set are used for testing.  
The main disadvantage is that for each different data set, different classifiers may be 
learned. 
For detection of microcalcifications stage:  
Only 18 benign microcalcifications mammogram images will be used to train and test 
algorithm. As described in chapter 2, benign and malignant microcalcifications have 
different characters, since the detection of microcalcifications stage is a pre stage to 
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determine whether MCGP has strength to classify microcalcifications on mammograms, 
therefore only using benign microcalcifications mammograms images will reduce the 
complexity of this algorithm and could lead to more stable and clearer results. Therefore, 
there are two experiments which are used to assign the images into the fold in different 
ways. There are 5 patients for 18 images, so in total there are 5 sub folds for each 
experiment, and each fold could be treated as a sub-experiment of one experiment. In 
the first experiment, the images of each patient are used as the testing data in 5 different 
folds, as shown in table 6-1. In the second experiment, a random selection of images are 
used from the patients as the training data, the images for the same patient could be 
partitioned across several folds, as shown in table 6-2. In both table 6-1 and 6-2, the 5 
letters are used to represent the different patients' names, followed by a series of 
numbers to separate the different images which have come from the same patient. For 
the purpose of this investigation two experiments are conducted, each with the data 
assigned to the folds in a different way. In the first experiment, all images associated 
with each patient are used to form a separate fold; in the second experiment, images 
from each patient are distributed across several folds.  This assignment is summarized 
in Tables 6-1 and 6-2 and is intended to investigate the power of the algorithm to detect 
microcalcifications from a particular patient. For each fold in tables 6-1 and 6-2, the 
remaining images are used to train the network.   
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Table 6-1Patient-centered assignment of images for k-fold cross validation  
Fold 1 Fold 2 Fold 3 Fold 4 Fold 5 
Patient A: 
Image 1 
Patient B: Image 
1 
Patient C: Image 
1 
Patient D: 
Image 1 
Patient E: Image 
1 
Patient A: 
Image 2 
Patient B: Image 
2 
Patient C: Image 
2 
Patient D: 
Image 2 
Patient E: Image 
2 
Patient A: 
Image 3 
Patient B: Image 
3 
Patient C: Image 
3 
 
Patient E: Image 
3 
 
Patient B: Image 
4 
Patient C: Image 
4 
  
  
Patient C: Image 
5 
  
  
Patient C: Image 
6 
  
 
Table 6-2 Distributed assignment of images for k-fold cross validation  
Fold 1 Fold 2 Fold 3 Fold 4 Fold 5 
Patient D: 
Image 1 
Patient B: Image 
1 
Patient E: Image 
1 
Patient D: 
Image 2 
Patient E: Image 
2 
Patient C: Image 
2 
Patient E: Image 
3 
Patient C: Image 
6 
Patient C: Image 
3 
Patient C: Image 
4 
Patient B: Image 
2 
Patient C: Image 
1 
Patient B: Image 
4 
Patient A: 
Image 3 
Patient C: Image 
5 
Patient A: 
Image 2 
Patient A: 
Image 1 
  
Patient B: Image 
3 
 
For classification of microcalcifications stage:  
There are 31 images from 8 patients which will be used in this stage to train or test the 
algorithm. All these images contain one or two microcalcifications that are either benign 
or malignant. Similar to experiment on detection of microcalcifications, there are two 
experiments are conducted on classification of microcalcifications, each with the data 
assigned to the folds in a different way. In the first experiment, which is summarized in 
table 6-3, patients are used to form a separate fold; in the second experiment which is 
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summarized in table 6-4, images from the same patient are distributed across several 
folds. In both tables, the letter ‗M‘ represents a malignant image and letter ‗B‘ refers to 
a benign image. For each fold in tables 6-3 and 6-4, the remaining images are used to 
train the network.   
Table 6-3 Patient -centred assignment of images for k-fold cross validation 
Fold 1 Fold 2 Fold 3 Fold 4 Fold 5 
Patient A M 1 Patient C M 1 Patient D M 1 Patient F M 1 Patient bwrcc M 1 
Patient A M 2 Patient C M 2 Patient D M 2 Patient F M 2 Patient bwrcc M 2 
Patient B B 1 Patient C M 3 Patient E B 1 Patient F M 3 Patient H M3 
Patient B B 2 Patient C B1 Patient E B 2 Patient G B 2 Patient I B1 
Patient B B 3 Patient C B2 Patient E B 3 Patient G B 2 Patient I B2 
Patient B B 4 Patient C B3 Patient E B 4  Patient I B3 
  Patient E B 5   
  Patient E B 6   
Table 6-4 Distributed assignment of images for k-fold cross validation 
Fold 1 Fold 2 Fold 3 Fold 4 Fold 5 
Patient A M 1 Patient A M 2 Patient C M 3 Patient C M 2 Patient F M 2 
Patient C M 1 Patient F M 1 Patient D M 3 Patient D M 2 Patient H M 2 
Patient D M 1 Patient H M 1 Patient H B 3 Patient E B 3 Patient B B 4 
Patient C B1 Patient E B2 Patient C B3 Patient C B 2 Patient E B 4 
Patient B B 1 Patient A B1 Patient B B 3 Patient B B 2 Patient E B 5 
Patient E B 4 Patient IB1 Patient E B 6 Patient G B 2 Patient I B2 
  Patient IB 3   
 
6.2 MCGP Network Design 
The premise for this Multi-chromosomes CGP (described in Chapter 4) approach is for 
a physically large size of mammograms. Traditionally, the current technology provides 
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a pixel size of 50µm
2
 which is equal as a full field mammogram of 4800×6000 pixels 
[97]. Each chromosome in multi-chromosomes could be seen as an independent CGP 
chromosome network, the whole collection of multiple CGP chromosomes are used to 
evolve a single mammogram. This would be like a whole team of experts working 
together to solve a particular task, and this will improve the reliability and  be  highly  
effective.  
Crossover or combination has not been involved within this network since it has not 
been found to be beneficial in CGP especially [98]. Therefore, it has been perceived that 
better evolutionary processes are obtained using mutation only. 
As a result of segmentation of the parts in Section 6.1.1, each ROI image has 256 equal, 
non-overlapping sub-images. Having segments of equal size and shape ensures that 
chromosomes evaluating those parts could be identical. This provides a way of 
introducing multiple chromosomes. Therefore, each sub-image gets assigned its own 
chromosome; this means that the whole problem of evolving one large image is broken 
down into a range of small sub-problems. Each genotype contains 256 independent 
CGP chromosomes and each chromosome is encoding one sub-problem. In addition, 
each chromosome is a working individual at the same time; therefore, high levels of 
efficiency have been achieved to make the system work faster.  
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As each ROI part get its own CGP network assigned, the respective network is only 
responsble for generating the output value for one particular image part it is assigned to. 
Since the input values are pixel values, the output value from one CGP network is also 
in a range of [0,255] which can be re-arranged to compare with WPV to that part.  
Networks assigned with sub-images 
+ 
Sub-images from one ROI MCGP networks 
Figure 6-5Multi-chromosome CGP network has been assigned to individual sub-image 
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8×8 
inputs 
A ROI with equal non 
overlapped 256 parts 
MCGP output with 256 CGP 
outputs 
one part with 
8×8 piexls 
1 
output 
Output has a 
range from 0 to 
255 
one CGP 
network  
(output +1)/4 
Output has a re 
arrangment from 0 to 64 
MCGP network with 256 single 
CGP networks 
Figure 6-6 The working procedure for MCGP network 
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6.2.1 Parameters 
There are several parameters needed in order to choose and to let the algorithm give the 
best performance. Since the numbers of chromosomes have been decided, there was a 
need to decide on a size of each chromosome CGP network. 
 These are two aspects as the following has had to be considered:  
Firstly, the network needs to be considered big enough to allow free evolution. 
Generally, the larger the single chromosome networks will often lead the higher fitness 
score; this also means there will be a large variety of possible binding abilities. 
Secondly, there is a desire to design a small single chromosome network to reduce the 
limit of the computational demand needed for evolving this network [99].  
In [95], it has been shown that the ideal combination of fitness and minimum size was 
found to be a network size of 32 rows and 128 columns. This affords redundancy 
proven to be advantaged in evolution of CGP networks by [100]. However, in this work, 
the rows will be chosen as 1, the number of columns will be chosen as 500 as minor. 
That is because; firstly, the number of rows will not affect the performance of the 
algorithm; secondly, since a multiple chromosome network has been chosen, the 
individual single chromosome network needs to be as simple as possible. This will 
make sure there is a better vision of the inside the CGP network. In this work, MCGP 
are used to evolve a single mammogram. A generalized form of the 1+ 4 evolutionary 
strategy has been used in which each chromosome is selected.  This has the form:  
(1+4) Multi-chromosome Evolutionary Strategy 
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1) Generate initial population of  1+4 programs randomly  
2) Evaluate fitness of the population  
3) Select the fittest of the population as the parent  
4) Mutate the parent to generate 4 offspring to form the new population  
5) Select a new parent  using the following rules:  
            for all i chromosomes in [0, 256): 
              5.1) If an offspring chromosome i has a better or equal fitness that the parent           
chromosome i then the offspring chromosome i is as the new parent chromosome i. 
              5.2) Else if there are offspring chromosome i with the same fitness as the 
parent chromosome i, one of them is randomly selected to be the new parent 
chromosome i. 
              5.3)  Else the current parent chromosome i remains as the parent chromosome i.  
        6)  Go to step 4 unless the maximum number of generations has been reached.  
The higher the number of generations, the better the fitness results will achieve. 
However efficiency of the network needs a binding for the number of generations.  In 
order to lead the network to have enough room to approve the performance, with a 
reasonable evolution time, the number of generations will be set as fixed at as 10000. A 
mutation operator can alter both the function present within a grid cell and the 
connections between components.  A good mutation rate is important because mutation 
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plays a crucial part in the evolution of CGP networks. There are two different areas that 
need to be mutated, the connections of individual nodes made with other nodes and the 
functions used for calculating the output of the respective node. In order to investigate 
the effect of the mutation rate value to resulting fitness value, it was decided to execute 
the algorithm using different mutation rate values. To make the results comparable all 
settings other than the mutation rates were kept same. The average fitness values are 
shown in table 6-1 with different mutation rates. 
Table 6-5 Mutation rates 
 
 
 
The results show that there are two peak values for mutation rates at 0.1% and 1%, 
therefore it can be said that the mutation rate should be about 1% or less to achieve a 
good fitness. However there are the same peak values so that it is hard to tell which 
value should be used. Mutation rate 1% and 0.5% have the same results.  It was decided 
to use 1% for the algorithm in the experiment, the reason is 1% has a peak value and is 
the binding of the mutation rate, besides it is easy to calculate. It means that 5 genes 
were mutated from the parent to make each offspring (0.25% of 500*4+1 genes). 
Table 6-6 The summary of the parameter values used for the evolution of the MCGP network 
Mutation rate % Average fitness 
 0.1 0.9324 
0.25 0.9301 
0.5 0.9310 
1.0 0.9310 
3 0.9204 
5 0.9100 
Parameter Value 
Number of generations 10000 
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For each experiment, the network programming has been set to run 20 times in order to 
give 20 individual results for the same experiment, this is to make sure that all the 
experiment results are constant and stable, based on the performance of the network. 
One of the measures, which are used to direct address the algorithm‘s, is to involve the 
image pixel value was function set. The function set has a great effect on the speed of 
evolution and also on the performance of an algorithm; therefore a suitable function set 
is really important. A bad function set, if used, might lead more time to find a good 
result. The complex multiplexer was used for the function node, due to the fact it 
contains, not only  logical AND/OR gate, but the whole algorithm works on a binary 
classification. The multiplexer functions represent binary IF statements and have been 
shown to be effective when CGP chromosomes operate on the binary data [101]. 
Assuming the 8 bit binary inputs from the image are defined as x,y and z, the function 
defines as follows:  
f0 = x.z´ + y.z ,   f1` = x.z´ + y´.z                                                              Equation 6-1                        
Population_size 5 
Percent of mutation rate 0.25 
Number of runs in total 20 
Number of rows in each CGP network 1 
Number of rows in each CGP network 500 
Levels_back 500 
No parts per image  256 (16×16) 
Part size 8×8 
Function sets f0 = x.z´ + y.z ,   f1` = x.z´ + y´.z                                                               
147 
 
The symbols ‗.‘‘+‘ and ‗,‘ indicated 8 bit bitwise logical AND/OR operations and even 
more complement operations. 
6.3 Performance Measurement 
6.3.1 Confusion Matrix 
Confusion Matrix is a visualisation tool that can be used for evaluation of the 
performance of a classifier, in this paper, MCGP. Based on this theory, it could 
determine certain quality measurements for the performance, such as a receiver 
operating characteristic (ROC) curve.  
The confusion matrix consists of two rows and two columns. The two rows represent 
the outcome of the prediction value or the fact or the condition determined by a gold 
standard. The two columns represent the outcome of the test that is to be evaluated. 
Both fact and test are divided into two options: a positive or a negative classification. 
As a result there are four different categories a test can fall into: a true positive (TP) 
classification , a true negative (TN) classification, a false negative (FN) classification, 
where a condition has not been found by the test and a false positive (FP) classification 
where the test has wrongly indicated a find.  The full confusion matrix shown in Figure 
6-6.  
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Figure 6-7 Confusion Matrix 
Depending on the four values of TP, TN, FP, FN, it could determine other measures. 
The most common measures are sensibility, specificity and precision.  
 The precision is also called positive predictive value (PPV) which is the chance 
of having cancer given a positive test result.  
PPV = TP / (TP+FP) 
 Sensitivity is also called the true positive rate (TPR), or called hit rate and recall, 
it is the proportion of patients that tested cancer (positive) and prediction is  
cancer (TP) of all the patients that actually have cancer (TP+FN).  
TPR = TP / (TP+FN) 
Sensitivity can be seen as the probability the test result is cancer given that the 
patients have the cancer. With higher sensitivity, fewer actual cases of the 
disease go undetected. 
 Specificity is also called true negative rate (TNR) which is the proportion of 
patients that tested benign and the prediction is benign (TN) of all the patients 
that actually have no cancer (TN+FP).  
TNR = TN / (TN+FP) 
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Specificity can be looked at as the probability that the test result is benign 
(negative) given that the patient is not sick. With higher specificity, fewer 
healthy people are labelled as sick. 
 The false positive rate (FPR) also called false alarm rate = False positive/Total 
Negatives.  
FPR = FP / (TN+FP) 
As  there are cases in which it might be possible to achieve a high TPR but a low NPR 
and vice-versa, it in general advisable to have at least two measures or a measure that 
combines different of the previously mentioned measures.  
The sensitivity and specificity, as well as the performance of the classifier, can be 
visualized and studied using the Receiver operating characteristic (ROC)  curve, also 
called sensitivity curve. To draw an ROC curve, only the true positive rate (TPR) and 
false positive rate (FPR) are needed . The TPR defines how many correct positive 
results occur among all positive samples available during the test. FPR, on the other 
hand, defines how many incorrect positive results occur among all negative samples 
available during the test. 
A ROC space is defined by FPR and TPR as x and y axes respectively, which depicts 
relative trade-offs between true positive (benefits) and false positive (costs). Since TPR 
is equivalent to sensitivity and FPR is equal to 1- specificity, the ROC graph is 
sometimes called the sensitivity vs. 1-specificity plot. Each prediction result or instance 
of a confusion matrix represents one point in the ROC space. 
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 Figure 6-8 shows an example of a typical ROC curve. ROC analysis is used in clinical 
epidemiology to quantify how accurately medical diagnostic tests can discriminate 
between two patient states, typically referred to as benign and cancer [100] . ROC 
analysis is used in clinical epidemiology to quantify how accurately medical diagnostic 
systems) can discriminate between two patient states, typically referred to as "cancer" 
and "benign" [101].  
 
Figure 6-8 An example of  ROC curve copy from [104] 
In figure 6-8, Test A and B are examples of ROC curve, test B has a greater 
discriminate capacity than test A. Maximizing sensitivity corresponding to some large y 
value on the ROC curve. Maximizing specificity corresponds to a small x value on the 
ROC curve. Therefore a good first choice for a test cut off value is that value which 
corresponds to a point on the ROC curve nearest to the upper left corner of the ROC 
graph. This is not always true,  in some screening applications it is important not to miss 
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detecting an abnormal therefore it is more important to maximize sensitivity minimize 
FN than to maximize specificity. In this case the optimal cut-off  point on the ROC 
curve will move from the vicinity of the upper left corner over toward the upper right 
corner.    An ROC curve lying on the diagonal line reflects the performance of a 
diagnostic test that is no better than chance level. The diagonal line y = x represents the 
strategy of randomly guessing a class. For example, if a classiﬁer randomly guesses the 
positive class half the time, it can be expected to get half the positives and half the 
negatives correct; this yield s the point (0.5, 0.5) in ROC space. 
The area under the curve (AUC) summarizes the entire location of the ROC curve rather 
than depending on a specific operating point [103]. The AUC is an effective and 
combined measure of sensitivity and specificity that describes the inherent validity of 
diagnostic tests . [104] If the AUC area is equal to 1.0 then the ROC curve consists of 
two straight lines, one vertical from 0,0 to 0,1 and the next horizontal from 0,1 to 1,1. 
This means that the test is 100% accurate because both the sensitivity and specificity are 
1.0 s there are no false positive and no false negatives. On the other side a test that 
cannot discriminate between normal and abnormal corresponding to an ROC curve that 
is the diagonal line from 0,0 to 1,1. The ROC are for this line is 0.5. ROC curve areas 
are typically between 0.5 and 1.0 like shown in Figure 6-8. 
 
In this paper, the measure of the performance is called Matthews Correlation 
Coefficient (MCC).  MCC could be calculated from a confusion matrix straight away, 
and used well on a binary classification. It can be used as a single value for the 
evaluation of test. The MCC is calculated in Equation 6-2 and in a range of [-1, 1].  
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MCC =1 represents a perfect prediction; MCC=0 means random prediction and -1 
indicates the faulty prediction. 
𝑴𝑪𝑪 =
𝐓𝐏×𝐓𝐍−𝐅𝐏×𝐅𝐍
  𝐓𝐏+𝐅𝐏  𝐓𝐏+𝐅𝐍  𝐓𝐍+𝐅𝐏 (𝐓𝐍+𝐅𝐍)
                                                                       Equation 6-2  
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7 The Multi-Chromosome CGP on Mammograms Experiment 
Results 
There are two stages of experiments processed in this chapter and they are the detection 
of microcalcifications and classification of microcalcifications. Detection of 
microcalcifications is the pre-stage to investigate the suitability of MCGP into 
mammogram applications before it is used to diagnosis mammograms. Therefore, a 
MCGP network is constructed to detect microcalcifications and will be used to classify 
microcalcifications. The Centre of Gravity has been applied to evaluate the detection 
system and Matthews Correlation Coefficient is used to evaluate the performance of 
classification of microcalcifications. There are some further experiments with 
interesting results which are described in this chapter.  
7.1 Detection of Microcalcifications on Mammograms 
The detection of microcalcifications is the development of MCGP, and specifically, the 
potential to train the algorithm to successfully locate microcalcifications within the 
mammogram. It is important to state that the motivation is not merely to detect 
microcalcifications.  
7.1.1 Design Stage 
As described above, each chromosome in MCGP is used to work on one part of a whole 
ROI image as using the raw pixel values. Therefore a well organised network inputs 
will lead a better efficiency for the MCGP performance. The network was designed to 
deal with a range of values from 0 to 255 in order to process pixel values of 8 bit depth. 
The output of the program encoded in each chromosome is automatically an integer 
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between 0 and 255. This means the ratio between inputs and outputs is different when 
the detection is supposed to be performed. White pixel values (WPV) are used to be the 
ideal value to represent the intensity of white pixels for microcalcifications. The WPV 
has a value between ‗0‘ and ‗64‘, and it represents how many ‗microcalcification‘ pixels 
counted in one part (8×8) image. The range of values that were allowed from one 
chromosome CGP network is not changeable, this means the CGP network only returns 
a value between ‗0‘ and ‗255‘ because the value of inputs is from '0' to '255', this value 
needs to be assigned the meaning of how many microcalcification pixels could CGP 
detect in part of the image. The fitness function is giving the meaning about the 
potential of differences by comparing the ideal WPV to the output of CGP, and gives a 
value for the difference of these two for this performance. If fitness is equal to 0, then 
CGP could detect microcalcifications in that part successfully. Therefore, the output of 
one CGP chromosome needs to be rescaled by adding 1 first and then be divided by 4 to 
arrive at a number between 0 and 64. To calculate the fitness of a particular 
chromosome i (i is the serial number fir 256 parts in one ROI image), the 64 grey scale 
pixel values is applied from a unique section of the image as the input to the encoded 
program and compare the output of the program, Di with the known number of 
microcalcifications pixels in the image section ( WPV) (a number between 0 and 64). 
Then '1' is used to minus the difference of rearranged output and WPV to convert the 
best fitness from '0' to '1'.  
The equation for calculating fitness is shown in equation7-2.  The principle of the 
fitness function is shown in algorithm 1. The number of white pixel values of each part 
is Mi; the output of chrosome i is Di. There have been two used fitness functions in the 
work reported. The linear fitness of a single chromosome, i, fitness is defined as follows: 
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𝒇𝒊𝒕𝒏𝒆𝒔𝒔 =
𝟏
𝒊
  𝟏 −  
𝑫𝐢+𝟏
𝟒
− 𝑴𝒊  
𝟐𝟓𝟔
𝒊=𝟏
                                                                   Equation 7-1  
𝒇𝒊𝒕𝒏𝒆𝒔𝒔 =
𝟏
𝒊
  𝟏/  
𝑫𝐢+𝟏
𝟒
+ 𝑴𝒊  
𝟐𝟓𝟔
𝒊=𝟏
                                                                                                                 Equation 7-2 
 
The fitness of the genotype is by summing all the chromosome fitness up and dividing 
by the number of chromosomes (256). The non-linear function penalizes the difference 
between the CGP output and the true microcalcification counts to a large extent than the 
linear fitness. 
Table 7-1Assignment of patient images for k-fold cross validation and use of fitness function in experimental 
investigations 
Experiment k-folds assignment Fitness function 
1 Patient-centered Liner 
2 Patient-centered Non-linear 
3 Distributed Liner 
4 Distributed Non-liner 
 
7.1.2 Training Stage 
Both linear and non-linear fitness functions have also been employed.  A summary of 
these experiments, provided for the purpose of reference when considering results, is 
detailed in Table 6-5. A summary of the parameter values used for the evolution of the 
CGP networks for each experiment is given in Table 6-4. Fitness results for the training 
of the respective CGP networks are shown in Figure 6-2. 
Algorithm 1 simple fitness calculation 
fitness_value = 1-|number of whitepixel values of each part – (network_output+1)/4| 
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Figure 7-1 Average Fitness for Training Images 
The average and best fitness values are shown in Figure 7-2. From the figure 7-2, it 
shows the experiments 1 and 3 with the linear function giving a little better average 
performance with the experiments 2 and 4 with the nonlinear function. However, the 
best fitness of the 4 experiments is nearly one. Also, there is a no difference in the 
fitness between patient-centred (Experiment 1, 2) and randomly k folds assignment 
(Experiment 3, 4) for the cross validation. This indicates that the CGP networks 
detecting microcalcification is not dependent on a patient‗s examples.  
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Figure 7-2Average fitness values training the algorithm on the detection of microcalcifications 
Table 7-2 Training algorithm on detection of microcalcifications 
 
Figure 7-2 shows the development of the average fitness values over the training stage 
of 10000 generations. The average fitness increases when generations increase and 
reach to peak generation at 6101 and then increases smoothly on the following 
generation. The maximum average fitness is 0.9817, however there is still a small 
difference between the best fitness and the perfect '1' fitness. One explanation for this 
would be the fact that each chromosome has detected that there are some 
microcalcifications pixels on that part.  However, it cannot generate the exact numbers 
of microcalcification pixels as WPV in that part and therefore, an error that affects the 
fitness value has been caused. Although the fitness in train stage is not 'perfect', the high 
fitness value still indicates that the MCGP gives a good performance.  
0.92
0.93
0.94
0.95
0.96
0.97
0.98
0.99
0 2000 4000 6000 8000 10000 12000
Fi
tn
e
ss
Number of generatuion
Best fitness Average fitness Worst fitness 
0.98 0.9751 0.94 
158 
 
7.1.3 Testing Stage  
The resulting MCGP algorithm from training stage is then tested using the images from 
the partitioned testing image sets shown in Table 7-1 and 7-2.   
 
Figure 7-3 Average Fitness for Testing Images 
The test result for the respective experiments is shown in Figure 7-3. It confirms the 
analysis in the training experiments. To give a fair comparison with the networks, the 
linear fitness function is applied to evaluate the data from the CGP networks which 
were trained using nonlinear fitness function in experiment 2 and 4 from Table 7-1. 
Therefore there is little tiny difference in the test performance between linear fitness and 
nonlinear trained network and suggests that the alternative schemes offer little benefit 
over each other. It should be noted that although CGP networks where trained using 
non-linear fitness functions in experiments 2 and 4, the linear fitness function was used 
to evaluate their performance on the test set of data, to enable a fair comparison with 
those networks evolved in experiments 1 and 3. 
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An example of the microcalcifications detected by an evolved network is given in 
Figure 7-5, which resulted from presenting the test image illustrated in Figure 7-4. 
 
 Figure 7-4 shows that there is one microcalcification in a grey shadow in ROI, it is 
WPV with density of microcalcification pixels supplied by radiologists. Figure 6-5 
Figure 7-5 Corresponding MCGP outputs on detection of microcalcifications 
Figure 7-4 An example of ROI with WPV for each parts 
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shows the outputs from the MCGP network. The grey parts are the MCGP algorithms 
detecting the parts which contain microcalcifications. There are generally two areas of 
the microcalcifications in the result, one is with a small value and one is with a large 
value. The area contains a large output value on a similar area of microcalcification 
stays on the original ROI. It could tell visually that MCGP delivered a relatively good 
result to detect microcalcifications, however it is still processed some small non 
expected value. The major reason might be that, there are too many breast tissues and 
less microcalcification pixels, since each chromosome CGP network only deals with 
one part of the image.  
7.1.4 Evaluation 
In order to get better performance, a threshold is used to alter a higher scale to assigning 
the meaning of WPV to be upper level and the meaning of breast tissue to the lower 
level. After each chromosome CGP network produced output, it will be rescaled firstly 
to a WPV range from 0 to 64, then this output value will be added by a threshold. The 
threshold is interpreted as an indication of microcalcifications. For the outputs of 
MCGP, if the outputs' values are equal to or above the threshold, the outputs' values will 
remain same, else 0.  
A set of threshold with valid values [0, 2, 4, 6, 8] are applied to the output of the multi-
chromosomes CGP network for an image. Threshold=0 represents that no threshold is 
applied to the output of CGP. The maximum threshold value is 8 that is because the 
original WPV for benign microcalcifications is in part a relatively small number and the 
outputs from MCGP network; this ensures that for every image in 4 experiments there is 
at least one part in the CGP output that has a non-zero value.  
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An example of the outputs of MCGP network applied to the thresholds is shown in 
Figure 7-6.The input ROI of this example is shown on Figure 7-4. The grey parts are 
those with their outputs after threshold and in this particular case. 
 
(a) MCGP outputs after threshold '2'  
(b) MCGP outputs after threshold '4'  
(c) MCGP outputs after threshold '6'  and '8' 
Figure 7-6 MCGP outputs after threshold applied for the corresponding ROI from Figure 6-5 
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The most common method to evaluate the detection is ROC curve, however it is not 
used   in  this   experiment   since    there    are    a    lot    of    0s    indicating    the  
non- microcalcifications in the image, and this gives a large number of negative cases 
which leads to the false positive rate being too small to form a curve. For the stage of 
detection of microcalcifications, the locations of microcalcifications are important and 
it is the factor to determine the performance of the network, therefore the centre of 
gravity (COG) is applied. COG is a geometric property of any objects; it is the average 
location of the weight of an object. COG is an important indicator for the centre point 
of an irregular shape with a different density; it is commonly used in statistics to 
design the static structures. In this case, a COG is calculated to locate the centre of a 
microcalcifications area, if I compare the location of COG of one microcalcifications 
area of the image, we would say around this COG, there is an area of 
microcalcifications.  
In this experiment, there are 18 benign images used for detecting of microcalcifications, 
16 images have only one unique area of microcalcifications individually, 2 images have 
2 areas of microcalcifications. Therefore, for the images that have 2 areas of 
microcalcifications, the image needs to be divided into 2 equally sized non-overlapped 
parts and each part has one unique area of microcalcifications, then calculate the COG 
for each microcalcifications area in one image part. For example, Figure 6-6 above 
shows an image with 2 areas of microcalcifications, and this image could be divided 
into an area with the rows between rows [1, 8] and an area with rows between [9, 16], 
the general form of CGP network of this image is shown on Figure 6-7. 
163 
 
 
Figure 7-7 an image with 2 areas of microcalcifications 
 
The COG is used here to determine the location of a single microcalcifications 
distribution centre. It treats the distribution of a single microcalcification as the function 
only of the weight and the location the microcalcifications. The weight of each part 
could be seen as the white pixel number on this part.  For a 2 dimensional image which 
has 256 equally sized non-overlapping parts which could be seen as a grid of 16 by 16, 
the centre of gravity COG (COGx, COGy) of an area of microcalcifications is defined as 
the average of the sum of the co-ordinates values (rxi , ryi). For each part i who has 
microcalcifications, weighted by its rescaled output for part i, since the output for each 
Figure 7-8 general form of CGP network of an original image with 2 areas of microcalcifications has been 
divided into 2 parts 
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part of ROI is in a range of [0,255],  to make it into WPV range of [0,64], for COG of 
the microcalcifications of input image,  mi is the WPV : 
𝒎𝒊 =   
𝒐𝒖𝒕𝒑𝒖𝒕
𝒊
+𝟏
𝟒
                                                                                                                                         Equation 7-3 
𝑪𝑶𝑮𝒙 =  
 𝒓𝒙𝒊𝒎𝒊
𝟐𝟓𝟔
𝟏
 𝒎𝒊
𝟐𝟓𝟔
𝟏
       𝑪𝑶𝑮𝒚 =  
 𝒓𝒚𝒊𝒎𝒊
𝟐𝟓𝟔
𝟏
 𝒎𝒊
𝟐𝟓𝟔
𝟏
                                                                          Equation 7-4 
After the COG of the input image (COGx, COGy) and the COG of the output of the 
CGP network (COG'x, COG'y) have been generated, COG differences shows as: 
𝐶𝑂𝐺 𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑠 =   𝐶𝑂𝐺𝑥 − 𝐶𝑂𝐺 ′𝑥 2 +  𝐶𝑂𝐺𝑦 − 𝐶𝑂𝐺 ′𝑦 2 
Equation 7-5  
However, COG calculation has the limitations of calculating Location: (i) it could only 
locate the centre of the microcalcifications area in the image without giving the exact 
size of the area. To calculate the area of determining one uniform area of 
microcalcifications in one image.  To overcome these, binary number '0' and '1' are used 
as weight. For the input image and CGP the microcalcifications further investigation is 
needed. (ii) One COG is only output, '0' is indicating non-microcalcifications and '1' is 
indicating microcalcifications, this could be used to replace the white pixel values on 
each part. For the input image, if the white pixel value of each part is not zero, and then 
replace the white pixel number to '1' to indicate the microcalcifications, others are '0'. 
For the output of MCGP, if the output value is not zero, then mi for COG become '1', 
otherwise mi stays at zero. For calculating the COG for the input ROI, if WPV is not 
zero, mi is '1', others is '0'.  For the images have 2 areas of microcalcifications as Figure 
6-8, the total image has been divided into two equal areas and calculate COG for 
individual area then add them together to get the average.  
Then the difference of COG between the MCGP network's input and output is 
calculated by Equation 7-5, it is used to evaluate the ideal result for the COG difference 
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which is equal to 0.  Since COG is measured under the scale of parts if the COG 
difference is smaller than 1, it shows the centre of gravity for both input and output are 
located at the same part in the image.  If the COG difference is in a range of 1 to 4, it 
shows that the MCGP detected microcalcifications on the surrounding area of the 
original microcalcifications; if COG difference is larger than 4, it shows a random 
detection.  COG difference will be used to evaluate the performance of algorithm to 
detect microcalcifications.  
 
The average differences of COG results of the 4 experiments (discussed in Table 6-1) 
are in Figure 7-9. It shows a generally small difference of the centre of gravity between 
the input and the output of MCGP network, but a better performance using the nonlinear 
fitness function than the linear function. It is apparent, however, that there is little 
difference in COG between patient-centered and distributed k-folds assignment for the 
cross-validation exercise. This shows that the MCGP networks have evolved a generic 
Figure 7-9 Average and best difference values for centre of gravity 
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microcalcifications detector that is not dependent on a particular set of patients. From 
the results, it could be said that the multi chromosomes of CGP network could detect 
the microcalcifications in mammograms successfully. 
 
The average of the COG differences results for the different thresholds in Figure 6-10, 
shows a general low difference of COG for the thresholds [0, 2, 4, 6, 8]. The dark grey 
bar is the average COG differences after threshold have been applied; the light grey bar 
is for the best COG  differences for applying threshold, therefore the weight for COG 
calculation is scaled to 1. Threshold 0 gives the results when calculating the COG 
differences which does not involve a threshold, and for any thresholds over 8. Some of 
the test images or the outputs of the network could not find COG differences, that is due 
to the output values are too small to apply to any large threshold. It is apparent; there is 
a little difference for the results of threshold 0 to 6 and then a better performance 8. This 
Figure 7-10 The average result of 4 experiments for different values of threshold 
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can be interpreted positively; it indicates that the MCGP network outputs have small 
differences of COG white pixel values on each part to the relative image input. 
This stage has described a novel multi-chromosomes CGP network applied to the 
detection of microcalcifications in mammograms, as an important stage towards using 
the same multiple chromosomes CGP network evolutionary algorithm for the 
classification of mammograms. The results presented here have demonstrated that the 
method is very encouraging. 
7.2 Classification of microcalcifications  
The MCGP network is applied by classification of microcalcifications in this stage 
Detection of microcalcifications could be seen as a binary classification as '0' for breast 
tissue and '1' for malignant microcalcifications. Besides, the aim of detection of 
microcalcifications, it is an important stage towards to the aim of the entire work. 
Therefore, the developed MCGP algorithm for detection of microcalcifications is 
applied to classify microcalcifications. This MCGP network will be trained to classify 
microcalcifications on mammograms to automatic diagnosis microcalcifications on 
mammograms.  
A number of changes are considered, with the ranging starting from input images. The 
total of 31 images from the dataset are applied in the MCGP network. The training and 
testing images have been introduced in Chapter 5 after k fold cross validations. There 
are still 4 different experiments based on catalogues by patients and randomly chosen 
for test images, even if it has shown that there were no differences between patient-
centres. (Experiment 1, 2) and randomly k folds assignment (Experiment 3, 4) for the 
168 
 
cross validation in stage of detection of microcalcifications. In these dataset, both 
malignant and benign images are used to train the system, and the training and testing 
are followed by Table 6-3 and 6-4.  
From Chapter 2, the features of malignant microcalcifications are small and hard to 
locate. Only lets MCGP learning the features on malignancy microcalcifications, in 
order to avoiding any misdiagnosis. As mentioned in Chapter 6, after the 31 ROI 
images are logically segmented into 256 parts, the status of each part labelled as either 
being benign or malignant according to the radiologists. Both benign and malignant 
ROI‘s have WPVs for microcalcifications have different meanings as mentioned in last 
chapter. In the malignant image, all the microcalcifications which have been indicated 
by the radiologist on the images are malignant, therefore the white pixel values which 
are the non-zero intensity pixels for each part of the malignant. However for benign 
images in classification stage, the WPV values are no longer staying the same, they 
have been rescaled. Instead of having WPV values for benign microcalcifications, they 
all have '0's as the representation that there are no malignancy microcalcifications in 
benign images. Therefore, an example of representation of the intensity of 
microcalcifications of ROI will look as follows: 
169 
 
In figure 6-11, the benign case is on the left, it contains all zero WPV parts since there 
are no cancerous microcalcifications pixels. The malignancy ROI contains WPV in 
parts is on the right, there are two areas of malignant microcalcifications. The WPV 
values are relatively large numbers and means a high intensity of pixels containing 
malignancy microcalcification information. 
The output for each single chromosome will remind as previous experiment stage, 
which is in a range of 0 to 255. Therefore the outputs of an entire MCGP network will 
be a mapping of 256 parts, in each part , the output has a range of 0 to 255. Since the 
input ROIs contain both benign and malignant pixels, and the standard WPV for fitness 
function has altered to suit on both benign and malignant images, therefore the 256 
MCGP outputs in a good performance could be predicted : 
 The results of 256 outputs of individual chromosomes expected  for Benign 
mammograms: 
1). All zeros outputs from the 256 chromosomes; 
2) Few low values of outputs from the 256 chromosomes.  
Figure 7-11 an example of representation of non zero intensity pixel counts for benign(Left) and 
malignant(Right) ROIs 
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 The results of 256 outputs of individual chromosomes expected for malignancy 
mammograms: 
1). A number of large value of outputs from the 256 chromosomes; 
2). A large number of non-zero outputs from the 256 chromosomes stay on or 
surrounding on the corresponding parts which are supposed to contain malignant 
microcalcifications the relative 256 parts.  
 
This ends that there will be 3 possible results expected from the MCGP classification 
algorithm: the malignant image, the benign image, and the image with the likelihood 
of malignancy. The larger number one chromosome output is, the more numbers of 
malignancy microcalcifications pixels in one part of ROI has classified.  If the output 
of each chromosome has a big value, it could be represented as a malignancy part, if it 
has a small or zero value, it could be represented as a benign part. Therefore, a 
threshold (T1) is applied to assign the meaning of benignity to the lower level and the 
meaning of malignancy to the higher level.  
During the process of training the algorithm to perform detection of 
microcalcifications, the number of outputs of MCGP network is equal to the number 
of inputs.  Since this stage is for classification of microcalcifications, a binary 
classification with a value either '0' or '1' indicating a malignancy or a benignity is the 
For the training stage, threshold is applied on each chromosome CGP 
network  in order to filter the small value before fitness calculated: 
 
if ( CGP output > threshold(T1)) 
         CGP output =  CGP output; 
Else  
         CGP output = 0; 
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result expected. As the whole MCGP network was designed to deal with a range of 
values from '0' to '255' in order to process pixel values of a 8 bit depth, an additional 
mechanism was needed to convert this output range to a single classification integer. 
In order to achieve this, a fixed threshold was introduced. The MCGP network output 
value was then compared to the threshold (T2) to determine the classification. 
 
Fitness is calculated by comparing the binary output and the diagnosed information 
which is supplied by a radiologist. 
 
If  Output of MCGP network =1 && the input image is a 
malignant image, 
        Then fitness of chromosome +1;  
If  Output of MCGP network =0 && the input image is a 
benign image, 
         Then fitness of chromosome +1; 
Else  
         Fitness +0;  
 
After each chromosome CGP output has been rescaled, number of 
malignant parts is by counting the number of the parts which 
contain outputs of one chromosome bigger than '0' to generate an 
integer, threshold T2 is applied here to give a binary classification, 
which '0' indicate benign and '1' indicate malignant : 
If number of Malignant parts≥ Threshold T2 
        then  the input image is malignant 
        Output of MCGP = 1; 
else 
        then  the input image is Benign 
        Output of MCGP network = 0; 
 
172 
 
The fitness of MCGP network =
1
256
 fitness of chromosome i0𝑖=255         Equation 7-6 
The perfect fitness of MCGP network is 1, it means all single chromosome CGP 
networks have classified microcalcifications successfully in 256 parts. 
7.2.1 Training stage of the Algorithm 
The experiment uses parameters values based on Chapter 6 as described in table 6-6. All 
four experiments described by table 6-5 were carried out with the same parameters.  
The experiment is based on four experiments of k fold validation. Since it is a large 
scale of results represented for the same experiment, the fitness results will be 
calculated in average and the best or the worse fitness results also showed. The training 
results for the algorithm on the classification of microcalcifications shows in table 7-3: 
 
 
 
 
Best fitness Average fitness Worst fitness 
0.99 0.98 0.7 
Table 7-3 Fitness results on the classification of microcalcifications 
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As Figure 7-10 and Table 7-3 show, the MCGP network produce results showing good 
performance in training stage. It shows that the best fitness scores are almost 1, with the 
worst fitness scores being 0.7. The dark grey bar is the average fitness of all training 
results in experiment1, with a ±1 standard deviation. The light grey bar represents the 
best training fitness result with a standard deviation ±1.  These mean that the MCGP 
network has been fully trained to achieve the best fitness score as 1. For the average 
fitness for all four experiments being nearly the same, there is a no difference in the 
fitness between patient-centred (Experiment 1, 2) and randomly k folds assignment 
(Experiment 3, 4) for the cross validation. This indicates that the MCGP networks 
classifying microcalcifications is not dependent on a patient‗s examples. From Table 7-
3, the worst fitness is 0.7 and best fitness is 0.99. It shows the range of improvement is 
about 3% and it could be said that the algorithm is mainly improving the worst fitness. 
One explanation for this would be the fact that there are most parts of the ROIs showing 
benign tissues so the most algorithms in training are mainly trained with the benign 
7-12 the average fitness for each experiment 
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image parts. The chromosome CGP trained with these benign parts is therefore a good 
classifier for benign tissue. The development of average fitness against generations for 
all 4 experiments have been shown on Figure 7-13 and shows the ability of MCGP 
algorithm in learning to classify the microcalcifications.  
 
7.2.2 Testing Stage 
The resulting Algorithm was then tested using images from Table 6-3 and 6-4 from the 
LLNL database that were not used for training the algorithm. The fitness testing results 
shows from Table 7-4 and the average fitness for 4 experiments (described in Charpter 
7) has been shown in Figure 7-10.  
7-13 The average fitness values training the algorithm on the classification of microcalcifications 
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Figure 7-14Average and best fitness for 4 experiments of testing results 
The testing phase shows slightly lower fitness values than the training phase, however it 
is still in good value, with the average fitness for these 4 experiments as above 0.935 
and the best fitness value has reached 0.9683 which is really near to 1.  
Table 7-4 Average results of 4 experiments of testing MCGP network 
 Confusion Matrix (Average value) Statistics  
Experiments Bb Bm Mb Mm TP TN  FP FN MCC 
Experiment1 5 13 13 0 0 0.28 0.72 1 -0.75 
Experiment2 5 13 13 0 0 0.28 0.72 1 -0.75 
Experiment3 5 13 13 0 0 0.28 0.72 1 -0.75 
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Experiment14 5 13 13 0 0 0.28 0.72 1 -0.75 
Table 7-4 shows the average results of a further breakdown for the best chromosomes 
from each MCGP network and contains both the confusion matrices as well as 
additional statistics measures. In confusion matrix, the first character B and M is 
indicating the actual classification and the second character b and m is indicating the 
predicted classification. These numbers link the value of TP, TN, FP, FN and values of 
MCC (Chapter 6) which is used to measure of performance of system are given.  
Comparing the values of Table 7-4, FN rates are 1s; this means that all of the images 
were classified incorrectly. The values of MCCs stay as negative values indicated the 
faulty prediction have occurred.  
In order to get the better performance of the system, a closer look of the outputs of 256 
chromosome of a MCGP network for an 256 parts of testing image have been formed. 
This is due to the property of MCGP network which contains individual non-overlapped 
sub-networks. An example is shown in Figure 7-15 with one actual malignant testing 
image and Figure 7-16 for an actual benign images.  Both of the figures contain the 
WPVs in 256 parts indicated by radiologist on the top of the figure, then the output of 
MCGP network with 256 individual chromosome outputs, the bottom is the differences 
between the WPVs and outputs in the corresponding part.  
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Figure 7-15Testing output results  of MCGP for a Malignant ROI 
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Even the fitness for the testing phase is high; however it could be seen that the outputs 
of each chromosome CGP network produced small values of outputs for malignant 
image and relatively big number for benign images.  These results are completely 
Figure 7-16Test output results of MCGP for a benign ROI 
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opposite to the expected MCGP output results. To improve the performance of the 
system in testing stage,  a threshold  in a range of [0, 64] has to applied to assign 
benignity and malignancy. The value of threshold could not be so big otherwise there 
will be FN classification; however it could not be too small which would lead to FP 
classification. A middle range of [16, 32] threshold is used to apply on the assignment.  
Due to the outputs for the malignancy testing images, any value below 16 has inferred a 
misdiagnosis for the MCGP network. One example has been shown in Figure 7-18. 
Figure 7-19 is the outputs of MCGP for a malignancy image as input (also as Figure 7-
15), it could be noticed that after a threshold valued at 32 is applied, there is no non zero 
outputs in MCGP output network. It shows the MCGP network give a FN when 
threshold = 32. When threshold = 16, almost all the output parts become 0 and the non-
zero output parts are actually a benign part of the corresponding input WPVs. The same 
as the MCGP outputs from benign image is applied by a threshold. It shows that after a 
threshold=16 has been applied, there is still a few non zero parts left on the MCGP 
outputs. Table 7-5 indicated that the MCGP network would give a wrong diagnosis in 
classifying benign microcalcifications.  
Table 7-5 Results for voting with threshold on the output of each chromosome network 
 Confusion Matrix (Average 
value) 
Statistics  
Experiments Bb Bm Mb Mm TP TN  FP FN MCC 
Threshold 16 0 18 13 0 0 0 1 1 -1 
Threshold 32 0 18 13 0 0 0 1 1 -1 
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Figure 7-17 The corresponding outputs of MCGP network to Figure 7-15 is applied by threshold=16 
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7.2.3 Further experimentation 
7.2.3.1 Training and Testing with a different threshold and bias strategy 
Considering the malignant microcalcifications are very small, most image parts will 
contain benign tissue surroundings for the classification when dividing the image into 
image parts. During training this leads to one chromosome CGP network that might not 
have had to deal with the classification of a malignant part at all. This means that some 
particular chromosome CGP networks will be specialised in classifying benign image 
properties while only few chromosome CGP networks are trained to recognise a 
malignant microcalcifications part. This is the problem that might arise from that and is 
the inability to classify malignancy during the test phase. In order to overcome this 
Figure 7-18 The corresponding outputs of MCGP network to Figure 7-15 is applied by threshold=32 
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problem, in the training stage a bias has been used to deal with the issue that there are 
more benign parts than malignant parts in the training images. Since the bias added on, 
the fitness function has altered to give the best training. The Threshold and bias 
algorithm is described below and applied in the training stage and the testing stage 
remained same. 
 
For the training stage, threshold is applied on each chromosome CGP network  in order 
to filter the small value before fitness calculated: 
 
if ( CGP output > threshold) 
         CGP output =  CGP output; 
Else  
         CGP output = 0; 
 
Then bias is applied on fitness function to reduce the weight of zero WPV parts when 
the network is trained.  
 
The fitness function : 
 
If  (CGP output > 0 && number_white_pixels >0) 
        Fitness of chromosome = 1; 
Else if (CGP output = 0 && number_white_pixels =0) 
        Fitness of chromosome = 1/bias; 
Else  
        Fitness = 0. 
 
There are several experiments which have been carried out to evaluate the combination 
value of bias and threshold. Both the threshold and the bias are given a range of [1, 64], 
'1' means that there is no bias and threshold applied in the system, '64' is a middle-value 
to test whether the improvement could lead to a better performance. After trials runs, the 
best average fitness occurs when bias= 30, threshold = 30, the MCGP network training 
fitness =0.502.  In the testing stage, the performance results as follows: 
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Table 7-6 Results for applying bias on training system 
 Confusion Matrix (Average value) Statistics  
Experiments Bb Bm Mb Mm TP TN  FP FN MCC 
Experiment1 1 17 13 0 0 0.17 0.83 1 -0.84 
Experiment2 0 18 13 0 0 0 1 1 -1 
Experiment3 1 17 13 0 0 0.17 0.83 1 -0.84 
Experiment14 0 18 13 0 0 0 1 1 -1 
From the numbers given in Figure 7-6 the algorithm with adding bias and changing 
fitness still cannot provide a positive performance of classifying microcalcifications. 
With the FN values equal to 1, it meant that the malignancy is always failed to detected, 
the new approach by adding bias and changing thresholds could not help to provide 
better performance.  
The example of 256 chromosomes outputs of testing image results are shown in Figure 
7-19.  
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Figure 7-19 shows a MCGP outputs when bias=30 is applied on the fitness function to 
reduce the weight of benign microcalcifications or non microcalcification parts and 
threshold applied to assign the malignancy and benignity. On the output results, it 
shows that the each chromosome over classified malignant microcalcifications in each 
part of ROI, it leaded that the MCGP network over classified malignant 
microcalcifications. It delivered relatively smaller values for the parts which truly 
contain malignant microcalcifications and relatively large values for the parts which 
contains breast tissues or benign microcalcifications. The results from this experiment 
delivered a message that adding bias and threshold could not solve the indicated 
problem. MCGP algorithm does not have a good performance in this experiment.  
Figure 7-19MCGP outputs with bias and thresholds 
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7.2.3.2 Single Chromosome CGP network  
The previous experiments showed that the performance of MCGP network on 
classification of microcalcifications is desirable. The MCGP network contains 256 
individual single chromosome CGP networks, each single chromosome network is 
working on one equal non-overlapped part of a ROI. Therefore, for one particular single 
chromosome CGP sub network, may only be trained on the benign part of the training 
images, but is used to classify the malignant part in testing images. This could cause a 
problem which is, this intelligent single chromosome CGP network never ever learnt 
enough information.  Although in the MCGP network training stage, the best genotype 
to represent the entire network has been recorded and used on the testing stage, this non 
or less training algorithm problem is still not solved. Therefore, to solve this problem, 
instead of putting all 256 Chromosomes CGP network for 256 parts in one image, only 
one chromosome CGP network is trained through all 256 parts of one image. The 
working procedure shows as follows: 
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Since the single chromosome CGP network is the subject of the MCG network, the 
parameters, which are used to construct single chromosomes, the CGP networks in both 
cases remain the same as table 6-6.  
The single chromosome CGP network is applied to train each individual parts of the 
image. For classification stages, there are a number of parts only containing benign 
microcalcification information, or surrounding the breast tissue and less parts containing 
malignant microcalcifications. Training results shown in Table 7-7 and Figure 7-20. The 
fitness function will be the same as Equation 6-1 and 6-2 for both linear and non-linear 
fitness functions: 
Table 7-7 average and best fitness for single chromosome CGP network training stage 
 Average Fitness Best Fitness Worst Fitness 
Experiment 1 0.97 0.99 0.51 
Experiment 2 0.96 0.99 0.55 
Experiment 3 0.97 0.99 0.34 
Experiment 4 0.97 0.99 0.55 
 
A ROI with equal nonoverlapped 
256 parts 
one CGP 
network  
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.   
Table 7-8 Confusion Matrix for the testing results of system 
Confusion Matrix (Average 
value) 
Statistics  
Bb Bm Mb Mm TP TN  FP FN MCC 
2 16 13 0 0 0.125 0.875 1 -0.88 
 
From the training results, the single chromosome CGP network has been created to 
classify microcalcifications into benign and malignant cases. Table 7-6 shows the 
fitness of the training stages.  These mean that the single chromosome CGP  network 
Figure 7-20 Training results of single chromosome CGP network 
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has been fully trained to achieve the best fitness score as 1.  From Table 7-8 , it could 
find that the single chromosome CGP network had same problem with the MCGP 
network which provide better fitness values on training stages and bad performance on 
testing stages. Figure 7-20, the malignant outputs started to contain larger numbers of 
outputs valued on the benign image output. However it also the output larger numbers 
for benign microcalcifications that shows that the single chromosome CGP network 
starts to learn from the malignant microcalcification information.  However it still 
cannot deliver a good performance.   
7.2.4 Discussion 
In this chapter, MCGP network has successfully detected the location and surround 
areas of microcalcifications by apply MCGP network in a mammogram dataset with 
microcalcification indicators. The detection of microcalcifications is not the entire 
automatic analysis of mammograms however it is one of the important part. The 
successful detection strongly showed the potentials of Multi chromosomes Cartesian 
Genetic Programming (MCGP) as a new, evolutionary algorithm on the area of 
automatic analysis mammograms. It also indicated that the advantages of evolutionary 
algorithm that they are based on learning how to do a task rather than just following the 
mathematics formula or sequential orders.   
The limitation of self learning algorithm is it requests a reliable dataset to train the 
algorithm.  To delivering a good performance on an algorithm, there are two important 
issues: 1) A suitable Algorithm which has the ability to solve the problem; 2) An 
reliable dataset to train the algorithm. The detection of microcalcifications by using 
MCGP have showed its good performance, however the performance of classification of 
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microcalcifications has failed by using same algorithms for detection stage and leave a 
problem that the algorithm has a better training results and a bad testing results, the 
better training results indicated that this new evolutionary algorithms are showing its the 
benefit on learning how to do a task and potential to automatic analysing mammograms. 
However the bad testing results are the evidence of a non reliable dataset cause 
problems on the performance of evolutionary algorithms; especially it is under the 
circumstances that there are different experiments have been carried out for optimizing 
the MCGP network in order to solve the problems. This leading the reason of non 
desired performance results of MCGP network on classification of microcalcifications  
is  due to a non-reliable dataset.  
Here are 4 examples of data training images, they are from this LLNL dataset and have 
been used to train the MCGP network for automated analysis of mammograms.  
    
 
These 4 different images, (a)-(c) contains malignant microcalcifications, with image (d) 
being a benign image. All the 4 images have different contrast and low quality (a) 
images. This information could easily confuse the CGP system when it is on the training 
stages. The contrast of the images are not united, the differences of features between 
malignant and benign  microcalcifications are not clear in these images, the features of 
(a) (b) (d) (c) 
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benign and malignant microcalcifications are leading confusing for MCGP network. All 
these issues could cause the MCGP network  learn how to classify benignancy  and 
malignancy microcalcifications not properly or miss- learning the typical features or 
over trained the system in training stage which leading a failure performance on testing 
stage.  As the survey reviews dataset has been mentioned in chapter 5, a reliable, trusted 
dataset which the data has been selected and supplied under same circumstances is one 
of the important key for the successful automatic analysis on mammograms by using 
evolutionary algorithm. A new dataset that is overcome the existing problems has been 
introduced in Chapter 8.  
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8 Conclusion 
8.1   Summary of work undertaken 
8.1.1 Motivation – Diagnosis cancer in mammograms for screening 
Breast cancer is the leading cause of death in women. The diagnosis of breast cancer at 
the earlier stage may be particularly important since it provides early treatment. The 
death rate of breast cancer has fallen since the breast screening program was introduced. 
The main method for screening patients is the mammogram - a high resolution x-ray of 
the breast. The hard work is the early detection of any tissues abnormality and 
confirmation of their cancerous natures. In addition, finding abnormalities on very early 
stages can also be affected by poor quality of image and other problems that might show 
on a mammogram. The process of identifying and evaluating signs of cancer from 
mammogram is a very difficult and time consuming task which requires fully trained 
radiologists. However, by natural and exposed to human error, there is a chance that 
cancer will be missed and patients being misdiagnosed. Computer aided diagnosis 
system has been introduced with the aim to achieve a more accurate and reliable 
diagnosis. 
The two powerful indicators to evaluate mammograms are masses and 
microcalcifications. In general, masses are more difficult to classify than 
microcalcifications. Microcalcifications are small calcium deposits which occur as 
secretion from the ductal structures which have been thickened and dried. They can 
have the most benign cases but could also indicate malignancy. They are common on 
mammograms and their appearance increases with age. Over a decade, there are many 
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researches on the application of CAD system, and many of them evolved image 
processing of digital mammogram. A typical approach is pattern recognition scheme 
with sensing, segmentation, feature extraction, selection and classification. Evolutionary 
algorithm particularly genetic algorithm has previews been used with success in CAD 
feature selection system. Evolutionary algorithm, particularly genetic algorithm has 
previously been used with success in CAD feature selection system, the limitation of 
using evolutionary algorithm is prompted to investigate the potential benefit in the 
classification of microcalcifications.  
8.1.2 Complexity and scale of problem Requires novel learning technology – 
evolutionary algorithm 
To automatically analysis images especially medical image as mammograms is a 
complex and difficult job requiring a reliable algorithm and a suitable dataset since a 
good performance of an algorithm is the data it is trained on. In the real world, this is a 
challenge.    
Since CAD system has a few problems on finding a system detection which does not 
necessarily have been detected by the radiologist, this might lead to the system not 
being trained correctly. Most CAD systems are based on classical imaging 
programming operations that are limited to the general understanding of how 
malignancy are found, as well as the limitations of CAD on practical implementation 
and classical image processing operations. To overcome this, evolutionary algorithms 
have the great advantage that they are based on learning how to do a task rather than 
just following a sequence of orders. EA has the great advantage that they are based on 
learning how to do a task rather than just following the mathematics formula or 
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sequential orders. EA contains programming technologies which simulate evolutionary 
behaviour of nature. The flexibility and learning ability of EA make it to be a good 
algorithm on automatic evaluating mammograms. In this work, it is decided to use 
Cartesian Genetic Programming for the representative EA to automatically analysis of 
mammograms. CGP is a special kind of Genetic Programming which is as a part of EA. 
Based on the aim of investigating the potential of EA on automatic analysis of 
Mammograms, the new representation CGP called Multi-chromosome CGP algorithm 
has been developed.  Its structure determined that MCGP algorithm is an entire network 
consists of a number of small single chromosome networks. Therefore an entire 
mammogram is divided into a number of sub-images in order to divide one big problem 
into many small sub problems. 
8.1.3 Suitable medical dataset required to train and evaluate algorithms 
8.1.3.1 Medical datasets have common problems 
Despite that EA have benefited from the traditional CAD system, there is also limitation 
from it. The performance of this algorithm require a good training database, more 
specifically, the classes represented in the training set must consist of true examples or 
reliable classes.  However, the good mammograms dataset is a major challenge. For 
traditional methods, the dataset is critical and yet obtaining one is not straightforward. 
An obvious approach would be to obtain access to a database that has already been 
prepared. A common problem is the clinical protocol under which the data obtained is 
not similar to the requirement for the target.  
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With world spread adoption of computer based health system, the digitized 
mammogram image has increased significantly. As mammographic screening has been 
used on the early detection of breast cancer, a large number of public databases are or 
have been available in the past.  However the quality, size and reliability of the data 
available are not under the same requirements. Also most of these databases have 
drawback which make them inappropriate for study.  
In Mammogram dataset, most of them are digitized mammography; there are different 
digitizer equipments to get the measurements. However different scanner from different 
manufactures will digitize the analogue films in slightly different ways, therefore some 
X-ray film are classified by an algorithm based on which scanner was used in the 
digitization process. 
8.1.3.2  Research has concluded that no suitable dataset currently exists 
A special volume of data has been extracted from LLNL for the use in evaluating CGP 
that on classification of micro calcifications in Chapter 6.  Additionally, according to 
the performance of MCGP working on the LLNL dataset, there are limitations with this 
dataset to evaluate the algorithm. In fact, that the LLNL dataset which has been used is 
relatively outdated. Based on the Implementation of this work, the non reliable dataset 
is the cause that the system could not provide a good performance on automatic 
diagnosis cancerous on mammograms. Such as there is no standard resolution for the 
images, the contrast differences cause the algorithm‘s confusion. The limited number of 
training data could not provide enough information to let the algorithm learn properly. 
Different formats and sources could generate artifacts that may interfere with training of 
algorithms.  
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8.1.4 Implementation challenging and experimental results  
The multi-chromosome CGP network could not give a good performance on the 
provided dataset; it is not because Multi-chromosomes CGP is not working properly, 
the experimental results have shown that MCGP could detect microcalcifications on 
mammograms which leads to potentially providing a confident diagnosis. However, 
when the MCGP network is used on the classification stage, the extra information 
required to train the network from dataset could not be gained. The non-reliability of 
this dataset caused MCGP network confusion when it tries to learn classification.   
8.1.5 Creating a new dataset 
For mammography, it is difficult as the data cannot be simply being generated due to 
the medical situation of mammograms. However, as mentioned in section 5.2,  several 
publically available datasets have their disadvantages. Therefore, to construct a 
clinically validated database of mammograms   is an important stage for the whole work, 
that‘s because the entire project requires a dataset to be absolutely stable, reliable, 
accurate and suitable to train and test the effectiveness of the EAs developed in 
diagnostic support in breast mammography. Heading towards on this aim, the 
acknowledgement of an expected mammogram dataset is introduced, and  a new YDH 
dataset has been produced based on the needs, objectives and purpose of this project, 
information on the tools used [107] by the user interface is also available to this section.  
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8.1.5.1 Contents of the New Dataset 
In order to construct a new dataset, it requires clinical co-operation to provide sufficient 
conditions and information to build up a well-served complete mammogram image data 
for the diagnosis of microcalcifications in mammogram.   
8.1.5.2 YDH Mammography Images 
This dataset contains mammograms obtained from York District Hospital, therefore, 
YDH has been chosen as the name of the new dataset.  
The number of patients required is one of the statistical justifications to show whether 
the performance of the algorithm is affected by specific patients. Normally, this 
information comes from the clinical record. This also shows the availability of patients 
by showing different aspects of the records of one case from a single patient. [108] 
indicated that in order to obtain statistical justification for measurements of the 
performance of the algorithm, it should be tested on a large dataset.  
The dataset contains the patient age, screening exam date, and the date when the 
mammogram was digitized. The patient‘s name or symbol name could also be shown in 
the dataset; this may help the radiologist for following up diagnosis or for statistics.   
8.1.5.3 Type of mammogram  
 The dataset needs to indicate whether the data is film screen mammograms or 
full digitized mammograms. If it is a film screen mammogram, the sampling rate, 
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number of grey levels and equation to estimate optical density from grey value 
for the scanner used to digitize the mammograms needs to be recorded.  
 Based on chapter 2, the four standard views (medio-latra oblique and cranio 
caudal) from each side of the breast for one patient are indicated in the dataset.  
 
MLO 
Left 
Right 
                  CC 
Left 
Right 
 
 What circumstances under which the mammograms have been taken.  
Screening exam screening  
Routine 
Follow up 
diagnosis 
Guiding 
biopsy 
 
Therefore, the data could be assigned into different volumes according to 
the severity of the findings.  
Normal Benign without call 
back 
Benign Malignant 
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 In Mammogram dataset, most of them are digitized mammography which are 
digitized by different scanners, therefore a standard unit digitizer to digitize 
mammograms is necessary.  
 To avoid any confusion made by algorithm, the data shares same contrast, pixel 
per inches and sample rate.  
 Image format need to be united in order to present a reliable dataset for training 
the evolutionary algorithms especially it has been highly recommended by itself 
learning motivation. 
Similar to the existing LLNL dataset, however still different,  the image format has been 
suggested with the common format as  follows: 
 The file will be a text file, and it contains 2 parts:  
Header:  
FILENAME: original image file name  
XRES: image x resolution  
YRES: image x resolution  
IRES: image intensity resolution (e.g. 255 grey-levels)  
MAN: digitizer manufacturer and model  
Time: when to select the ROI  
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Marking Scheme: from 1 to 5 
Body:  
Pixel X coordinate and pixel Y coordinate (repeated for all pixels within area of 
selection  
TYPE: structure type (e.g. MICROCALC or MASS)  
RATING: cancer risk - HIGH, MEDIUM or LOW  
CONFIDENCE: confidence of rate - HIGH, MEDIUM or LOW  
RATER: rate's initials  
 Marking scheme 
There will be two marking schemes.  One will mark the boundary of ROI as a larger 
marking core.  Then the secondary smaller marking scheme will be used to mark the 
core of speculated mass or cluster of microcalcifications. 
These marking schemes, which would be used by two radiologists, could result in a 
more confident diagnosis 
There could be two fully trained radiologists to mark up the frame and ROI which 
contains the suspicious mass or microcalcifications.  Each marking contains a 
descriptive value.  This value is specified by mammography radiologists using the 
UK scoring system called RCRBG which will maintain confidence in classification. 
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 User Interface 
Once the mammogram data in DICOM files have been supplied by YDH experts, a 
full trained radiologist starts to segment the Region of Interests by using 
Mammogram Data Acquisition System which is a user interface created by 
Christopher Booth, supervised by Dr. Steve Smith. This software user interface 
especially designed for this new data images would allow the user to convert images 
without changing the image quality. There are 1,237 images which are allowed to 
batch in this software. It would help the radiologist to zoom in the image in order to 
get a closer look. Once the radiologist has selected the Region of Interests, the 
images will be saved in one of the  four conversion format-BMP, PNG, BMP+ 
additional information output as text file, PNG+ additional information output as 
text file.  
 Pre-processing for image data 
Once the ROI has been selected by a radiologist, the data image needs to be 
segmented into smaller sub-images. In order to let Multi-chromosome CGP network 
learn properly, the sub-image for the new dataset is no long non-overlapping. There 
is a sliding window operation which will be used. Figure 8-1 shows how sliding 
window works. The particular window used 8×8 pixel sized mask, every time this 
mask only slides 4 pixels length to the left or right or up or down and record the 
pixels into a new 8×8 sub-images. After the window slides through the whole image, 
there will be an 8×8 sub-images. Then each chromosome from a multi-chromosome 
CGP network randomly chooses one sub-image as its training inputs. This will 
ensure that each chromosome learns all the information from the training image to 
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avoid any miss training. In addition, all the sub-images contains information of 
microcalcification from different angles, making sure the edge of the 
microcalcifications will not be missed out.   
 
8.1.6 An example of new image data file  
The new data are generated by the contents of YDH dataset. Here is one of example 
about a new image dat file, dat. files are converted by the data images of dataset and 
they are commonly used on the input training and testing images for evolutionary 
algorithms , on the application of  auto detected microcalcifications . 
 
Windo
w 
Windo
w 
Windo
w 
Windo
w 
Window Window 
Figure 8-1Sliding window 
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8.2 Hypothesis revisited 
The work presented in this thesis addressed the following hypothesis: 
―Multi-chromosome Cartesian Genetic programming is an effective evolutionary 
algorithm to facilitate automatic analysis of mammograms.‖  
Based on the aim of excess investigation in the potential benefit of MCGP on a 
confident automatic analysis of microcalcifications on mammograms, a Multi-
chromosome CGP network is developed to classify microcalcifications by using the raw 
pixel values. This self-learning algorithm has great advantages that they are based on 
learning how to do a task rather than just follow a sequence of orders. To achieve this, it 
relies on its training data. Two experiments have been designed towards the main aim, 
one is applying MCGP network on detection of microcalcifications, this stage is to 
investigates the suitability of whether MCGP could successfully apply on such a 
complex application. Both of the experiments are using LLNL dataset. From the results, 
it clearly showed that MCGP algorithm could deliver a confident detection of 
microcalcifications on mammograms; this is demonstrated on the paper [109].  On the 
stage of classification microcalcifications, a range of experiments have to implemented 
to approve that:  MCGP could not perform a confident classification microcalcifications 
based on the non-suitable dataset This problem indicates that the appropriate datasets of 
equal importance to algorithms when looking for a solution to automated assessment of 
mammograms. 
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The new dataset has been provided with several standards to meet the requirement of 
the studies; multiple chromosomes CGP is still a promising approach since it has 
already showed the potential on detecting microcalcifications.  
8.3   Further work 
During limited time, there is still some work which could help to evaluate this automatic 
Automated Analysis Evolutionary Algorithms.  
8.3.1 Create new datasets to known specification and hence characteristics 
A standard new dataset which have been introduced particularly for this algorithm, with 
the aim to avoid any problems caused by the current dataset. In this dataset, data has 
been formatted into a new standard format. The new dat. has been generated to fit into 
the MCGP network for the investigation.  
8.3.2 Test EAs developed 
Once the new dataset has been used to train the system, the stage of test of developed by 
MCGP for classification of microcalcifications could be brought to the table again.   
There is a new approach called sliding window mask which could be used to train the 
MCGP.   
The fitness function has been changed since the reference number used to compare with 
the CGP output is a range from 0-5 to indicate the diagnosis confidence. Therefore the 
new fitness function is: 
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CGP output is in a range of 0-255, which should add 45 then divided by 6: 
If the rescaled CGP output is in range of 0-50 then it rescaled into 0;  
Else if the rescaled CGP output is in range of 51-100 then it rescaled into 1;  
If the rescaled CGP output is in range of 101-150 then it rescaled into 2;  
. 
Then the number of parts which have the number 0 needs to be calculated, stored as 
NUM_0; 
Then the number of parts which have the number 1 need to be calculated, stored as 
NUM_1; 
Then the number of parts which have the number 2 needs to be calculated, stored as 
NUM_2; 
Then the number of parts which have the number 3 needs to be calculated, stored as 
NUM_3; 
Then the number of parts which have the number 4 needs to be calculated, stored as 
NUM_4; 
Then the number of parts which have the number 5 needs to be calculated, stored as 
NUM_5; 
Then the total fitness will be the largest number of NUM_0 to NUM_5.  
The network has been constructed by the author, with the new dataset and new 
structured network which could be used to determine the potential benefit of MCGP on 
automatic analysis of microcalcifications on mammograms.  The programming code is 
enclosed in the Appendix. 
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Appendix 
MCGP code for Classfication of mammograms 
 
#include <stdio.h> 
#include <stdlib.h> 
#include <string.h> 
#include <math.h> 
#include "cgp_breast2.h" 
 
 
/* validate cgp program command line and create file strings for .par 
and .data files */ 
void validate_command_line(int argc, char* argv[], char parfile[]) 
{ 
 puts(""); 
 puts("*********    WELCOME TO CARTESIAN GENETIC PROGRAMMING      
*********");  
 puts("********* Validating command line arguments to cgp program 
*********"); 
 
 if (argc!=2) 
 { 
  puts("INCORRECT NUMBER OF ARGUMENTS"); 
  puts("Type cgp <file.par> then return"); 
  exit(1); 
 } 
 if (strlen(argv[1])>(MAX_NUM_LETTERS-1)) 
 { 
     puts("filename for parameter file is too long"); 
  printf("It should be less than %d 
characters\n",MAX_NUM_LETTERS); 
  exit(2); 
 } 
 strcpy(parfile,argv[1]); 
 
} 
 
/* creates the list of training images and reads their names into an 
array 
   also calculates how many training images are provided */ 
void get_image_names(int train) 
{ 
 
 FILE *fp; 
 
 /* create list of files to be processed */ 
 if (train) 
 { 
  system("dir *_train.dat /B > list.txt"); 
  fp = fopen("list.txt","r"); 
  if (!fp) 
  { 
   puts("Error. Cannot find file list.txt"); 
   exit(0); 
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  } 
 } 
 else 
 { 
  system("dir *.tst /B > list-test.txt"); 
  fp = fopen("list-test.txt","r"); 
  if (!fp) 
  { 
   puts("Error. Cannot find file list-test.txt"); 
   exit(0); 
  } 
 } 
 
 
 num_images =0; 
 do 
 { 
 
  if (feof(fp)) 
   break; 
 
  fscanf(fp,"%s",image_names[num_images]); 
 
  num_images++; 
 
 } 
 while (!feof(fp)); 
 
 if (num_images == 0) 
 { 
  puts("Empty list of images"); 
  exit(0); 
 } 
 
 num_images--; 
 
} 
 
/* creates the list of test images and reads their names into an array 
   also calculates how many training images are provided  
   Added so that a test score can be provided during evolution */ 
void test_get_image_names(void) 
{ 
 
 FILE *fp; 
 
 /* create list of files to be processed */ 
 system("dir *.tst /B > list-test.txt"); 
 fp = fopen("list-test.txt","r"); 
 if (!fp) 
 { 
   puts("Error. Cannot find file list-test.txt"); 
   exit(0); 
 } 
 
 test_num_images =0; 
 do 
 { 
 
  if (feof(fp)) 
208 
 
   break; 
 
  fscanf(fp,"%s",test_image_names[test_num_images]); 
 
  test_num_images++; 
 
 } 
 while (!feof(fp)); 
 
 if (test_num_images == 0) 
 { 
  puts("Empty list of images"); 
  exit(0); 
 } 
 
 test_num_images--; 
 
} 
 
/* reads the image data as a .dat file (pgm image file with extra info) 
   also calculates some program globals 
*/ 
void read_data(char datafile[], int image) 
{ 
    int  i,j; 
    char dummy[MAX_NUM_LETTERS]; 
 char imagefilename[MAX_NUM_LETTERS]; 
    FILE* fp; 
 
    fp=fopen(datafile,"r"); 
    if (!fp) 
    { 
        puts("ERROR. Missing data file"); 
        exit(1); 
    } 
    else 
    { 
       fscanf(fp,"%s",imagefilename); 
    fscanf(fp,"%s %d",dummy,&malignancy_level); 
       fscanf(fp,"%s %d",dummy,&num_inputs); 
    if (num_inputs > MAX_NUM_INPUTS) 
    { 
     printf("\nERROR. num_inputs must be less 
than %d\n",MAX_NUM_INPUTS); 
     exit(0); 
    } 
       fscanf(fp,"%s %d",dummy,&num_xparts); 
       fscanf(fp,"%s %d",dummy,&num_yparts); 
       fscanf(fp,"%s %d",dummy,&num_parts_per_image[image]); 
    if (num_parts_per_image[image] > MAX_NUM_PRODUCTS) 
    { 
     printf("\nERROR. num_parts must be less 
than %d\n",MAX_NUM_PRODUCTS); 
     exit(0); 
    } 
  
       for (i=0;i<num_parts_per_image[image];i++) 
       { 
          for(j=0;j<num_inputs;j++) 
              fscanf(fp,"%u", &data_inputs[image][i][j]); 
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//    fscanf(fp,"%u", &number_white_pixels[image][i]); 
    } 
       fclose(fp); 
 
    } 
} 
 
 
/* reads the image data as a .dat file (pgm image file with extra info) 
   also calculates some program globals 
*/ 
void test_read_data(char datafile[], int image) 
{ 
    int  i,j; 
    char dummy[MAX_NUM_LETTERS]; 
 char imagefilename[MAX_NUM_LETTERS]; 
    FILE* fp; 
 
    fp=fopen(datafile,"r"); 
    if (!fp) 
    { 
        puts("ERROR. Missing data file"); 
        exit(1); 
    } 
    else 
    { 
       fscanf(fp,"%s",imagefilename); 
    fscanf(fp,"%s %d",dummy,&malignancy_level); 
       fscanf(fp,"%s %d",dummy,&num_inputs); 
    if (num_inputs > MAX_NUM_INPUTS) 
    { 
     printf("\nERROR. num_inputs must be less 
than %d\n",MAX_NUM_INPUTS); 
     exit(0); 
    } 
       fscanf(fp,"%s %d",dummy,&num_xparts); 
       fscanf(fp,"%s %d",dummy,&num_yparts); 
       fscanf(fp,"%s %d",dummy,&test_num_parts_per_image[image]); 
    if (test_num_parts_per_image[image] > MAX_NUM_PRODUCTS) 
    { 
     printf("\nERROR. num_parts must be less 
than %d\n",MAX_NUM_PRODUCTS); 
     exit(0); 
    } 
  
       for (i=0;i<test_num_parts_per_image[image];i++) 
       { 
          for(j=0;j<num_inputs;j++) 
              fscanf(fp,"%u", &test_data_inputs[image][i][j]); 
    fscanf(fp,"%u", &test_number_white_pixels[image][i]); 
    } 
       fclose(fp); 
 
    } 
} 
 
/* read from the parameter file all the global parameters */ 
void get_parameters(char parfile[]) 
{ 
 int  i; 
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 char dummy[50]; 
 FILE* fp;  
 
 printf("\n********* Reading parameters defined in %s 
*********\n",parfile); 
 fp=fopen(parfile,"r"); 
 if (!fp) 
 { 
  printf("Missing file: %s\n",parfile); 
  exit(1); 
 } 
 fscanf(fp,"%d %s",&population_size,dummy); 
 fscanf(fp,"%lf %s",&per_cent_mutate,dummy); 
 fscanf(fp,"%d %s",&num_generations,dummy); 
 fscanf(fp,"%d %s",&num_runs_total,dummy); 
 fscanf(fp,"%d %s",&num_rows,dummy); 
 fscanf(fp,"%d %s",&num_cols,dummy); 
 fscanf(fp,"%d %s",&levels_back,dummy); 
 fscanf(fp,"%d %s",&progress_report,dummy); 
 fscanf(fp,"%d %s",&report_interval,dummy); 
 fscanf(fp,"%u %s",&global_seed,dummy); 
 fscanf(fp,"%d %s",&save_best_chrom,dummy); 
 fscanf(fp,"%d %s",&run_from_chrom,dummy); 
 fscanf(fp,"%d %s",&malignancy_threshold,dummy); 
 fscanf(fp,"%d %s",&linear_fitness,dummy); 
 
 num_chromosomes = 1; 
 
 /* assigned global constants */ 
 num_functions=0; 
 num_genes_per_node=3; 
 
 num_outputs = 1; 
 
 for (i=0;i<MAX_NUM_FUNCTIONS;i++) 
 { 
  fscanf(fp,"%d %s",&number[i],&node_types[i]); 
  if (number[i]) 
  { 
   allowed_functions[num_functions]=i; 
   num_functions++; 
   if (i>15) 
    num_genes_per_node=4; 
  } 
 } 
 fclose(fp); 
 
 /* get training image names */ 
 get_image_names(1); 
 
 printf("\nReading image data\n"); 
 for (i = 0; i < num_images; i++) 
 { 
  read_data(image_names[i],i); 
 } 
 
 /* get testing image names and test data */ 
 test_get_image_names(); 
 
 printf("\nReading test image data\n"); 
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 for (i = 0; i < test_num_images; i++) 
 { 
  test_read_data(test_image_names[i],i); 
 } 
 
 //printf("\nnum_rows is %d\n", num_rows); 
 //printf("\nnum_cols is %d\n", num_cols); 
 //printf("\nnum_genes_per_node is %d\n", num_genes_per_node); 
 
 //exit(0); 
 
 /* assigned global constants */ 
 num_nodes=num_rows*num_cols; 
    num_genes=num_genes_per_node*num_nodes+num_outputs; 
 
 
 //printf("\nnum_images is %d\n", num_images); 
 
 //printf("\nnum_genes is %d\n", num_genes); 
 
 //exit(0); 
 
    end_count=num_inputs+num_nodes; 
 
 perfect_fitness = 1.0; 
 
 
 /* initialise output (used in cgp decoding) */ 
    for (i=0;i<end_count+num_outputs;i++) 
       output[i]=0; 
 
 if (population_size > MAX_POPULATION_SIZE) 
 { 
  printf("Too large a population size 
(<= %d)\n",MAX_POPULATION_SIZE); 
  exit(0); 
 } 
 
 if (num_chromosomes > MAX_NUM_CHROMOSOMES) 
 { 
  printf("Too many chromosomes requested 
(<= %d)\n",MAX_NUM_CHROMOSOMES); 
  exit(0); 
 } 
 
 if (num_genes > MAX_NUM_GENES) 
 { 
  printf("Too many genes selected (<= %d)\n",MAX_NUM_GENES); 
  exit(0); 
 } 
 
 if (num_runs_total < 1) 
 { 
  puts("Number of runs of EA must be at least 1"); 
  exit(0); 
 } 
 else if (num_runs_total > MAX_NUM_RUNS) 
 { 
  printf("Number of runs of EA must be less than %d\n", 
MAX_NUM_RUNS); 
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  exit(0); 
 } 
 
 if (num_genes < 10) 
 { 
  puts("Number of genes/bits must be at least 10"); 
  exit(0); 
 } 
 
 if ((progress_report < 0) || (progress_report > 3)) 
 { 
  puts("Progress report parameter must be less than 4"); 
  exit(0); 
 } 
 
 if (levels_back > num_cols) 
 { 
  puts("levels_back parameter must be less than or equal to 
number of columns"); 
  exit(0); 
 
 } 
 
 srand(global_seed); 
 
 puts("********* Beginning execution *********"); 
} 
 
/* write out parameter values in results file */ 
void write_cgp_info(char command[], char filename[MAX_NUM_LETTERS]) 
{ 
 int  i; 
 FILE* fp; 
 
 fp=fopen(filename,"w"); 
 fprintf(fp,"The program is        %s\n",command); 
 fprintf(fp, "The training image files are. Need to add these\n"); 
 fprintf(fp,"population_size is    %d\n",population_size); 
 fprintf(fp,"mutation rate is      %6.2lf\n",per_cent_mutate); 
 fprintf(fp,"num_generations is    %d\n",num_generations); 
 fprintf(fp,"num_runs is           %d\n",num_runs_total); 
 fprintf(fp,"num_rows is           %d\n",num_rows); 
 fprintf(fp,"num_cols is           %d\n",num_cols); 
 fprintf(fp,"levels_back is        %d\n",levels_back); 
 fprintf(fp,"progress report is    %d\n",progress_report); 
 fprintf(fp,"report interval is    %d\n",report_interval); 
 fprintf(fp,"global_seed is        %u\n",global_seed); 
 fprintf(fp,"save_best_chrom is    %d\n",save_best_chrom); 
 fprintf(fp,"run_from_chrom is     %d\n",run_from_chrom); 
 fprintf(fp,"malignancy_threshold is  %d\n",malignancy_threshold); 
 fprintf(fp,"linear_fitness is  %d\n",linear_fitness); 
 
 for (i=0;i<MAX_NUM_FUNCTIONS;i++) 
 { 
  fprintf(fp,"%d %s\n",number[i],node_types[i]); 
 } 
 fprintf(fp,"\nHere are the Results\n"); 
 fclose(fp); 
} 
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/*  returns a random integer between 0 and range-1 */ 
int newrand(int range) 
{ 
    int temp; 
 
    temp=rand() % range; 
    return(temp); 
} 
 
 
/* prints out all the chromosome in a geneotype both with and without 
active genes */ 
void fprint_a_user_readable_genotype(int** genotype, char name[], int 
append) 
{ 
 int k; 
 
 for (k = 0; k < num_chromosomes; k++) 
 { 
 
  fprint_a_user_readable_chromosome(genotype[k], name, 
append); 
 
  fprint_active_genes(genotype[k],name); 
 } 
} 
 
/* prints a chromosome to a file 
   when append is 1, the function appends the information to the file 
   when append is 0, the function creates a new file 
*/ 
void fprint_a_user_readable_chromosome(int* chromosome, char name[], 
int append) 
{ 
   int  i, node_label; 
   int      write_bracket=1; 
   FILE* fp; 
 
   if (append) 
    fp=fopen(name,"a"); 
   else 
    fp=fopen(name,"w"); 
 
 
   node_label = num_inputs-1; 
   for (i=0;i<num_nodes*num_genes_per_node;i++) 
   { 
      if ((i+1)%num_genes_per_node == 0) 
   { 
   node_label++; 
   fprintf(fp,"[%d]:%d)\t",chromosome[i],node_label); 
   write_bracket = 1; 
   } 
      else 
   { 
   if (write_bracket) 
   fprintf(fp,"("); 
 
         fprintf(fp,"%d,",chromosome[i]); 
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   write_bracket = 0; 
   } 
   } 
   fprintf(fp,"\t\t"); 
   for (i=0;i<num_outputs;i++) 
      fprintf(fp," %d",chromosome[num_nodes*num_genes_per_node+i]); 
   fprintf(fp,"\n\n"); 
   fclose(fp); 
} 
 
void fprint_a_genotype(int** genotype,char name[], int append) 
{ 
 int i; 
 
 for (i = 0; i < num_chromosomes; i++) 
  fprint_a_chromosome(genotype[i],name,append); 
} 
 
/* prints a chromosome to a file 
   This is in usual cgp format - not very readable 
   when append is 1, the function appends the information to the file 
   when append is 0, the function creates a new file 
*/ 
void fprint_a_chromosome(int* chromosome, char name[], int append) 
{ 
   int  i; 
   FILE* fp; 
 
   if (append) 
    fp=fopen(name,"a"); 
   else 
    fp=fopen(name,"w"); 
 
   for (i=0;i<num_genes;i++) 
   { 
      if ((i+1)%num_genes_per_node == 0) 
   fprintf(fp,"%d\t",chromosome[i]); 
      else 
         fprintf(fp,"%d ",chromosome[i]); 
   } 
   fprintf(fp,"\t\t"); 
   for (i=0;i<num_outputs;i++) 
      fprintf(fp," %d",chromosome[num_nodes*num_genes_per_node+i]); 
   fprintf(fp,"\n\n"); 
   fclose(fp); 
} 
 
/* prints a chromosome to the screen */ 
void print_a_chromosome(int* chromosome) 
{ 
   int i; 
 
   for (i=0;i<num_nodes*num_genes_per_node;i++) 
   { 
      if ((i+1)%num_genes_per_node == 0) 
  printf(" %d\t",chromosome[i]); 
      else 
         printf(" %d",chromosome[i]); 
   } 
   printf("\t\t"); 
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   for (i=0;i<num_outputs;i++) 
      printf(" %d",chromosome[num_nodes*num_genes_per_node+i]); 
   printf("\n"); 
} 
 
/* creates the active chromosome. This is the same as 
   the chromosome, except all junk entries are -1 
*/ 
void get_nodes_used(int* chromosome, int node_used[]) 
{ 
 int  i,j,index;  
 int  address[MAX_NUM_GENES_PER_NODE]; 
 int* active_chromosome = NULL; 
 
 active_chromosome = create_chromosome_space(); 
 
 for (i=0;i<num_genes;i++) 
  active_chromosome[i]=-1; 
 for (i=num_genes-num_outputs;i<num_genes;i++) 
  active_chromosome[i]=chromosome[i]; 
 
 /* first look at chromosome and identify gates not used */ 
 /* these are all the outputs of gates which do not appear in the 
chromosome */ 
 for (i=0;i<num_nodes+num_inputs;i++) 
  node_used[i]=0; 
 /* all the nodes whose output is given by the output genes are 
active */ 
 for (i=num_genes-num_outputs;i<num_genes;i++) 
  node_used[chromosome[i]]=1; 
 
 for (i=num_nodes+num_inputs-1;i>=num_inputs;i--) 
 { 
  if (node_used[i]) 
  { 
   /* get input addresses and type of this gate */ 
   index=num_genes_per_node*(i-num_inputs); 
   for (j=0;j<num_genes_per_node;j++) 
   { 
    address[j]=chromosome[index+j]; 
    active_chromosome[index+j]=address[j]; 
   } 
   if ((address[num_genes_per_node-1]==2) || 
(address[num_genes_per_node-1]==4)) 
   { 
    node_used[address[0]]=1; 
   } 
   else if ((address[num_genes_per_node-1]==3) || 
(address[num_genes_per_node-1]==5)) 
   { 
    node_used[address[1]]=1; 
   } 
   else if ((address[num_genes_per_node-1]>=6) && 
(address[num_genes_per_node-1]<=15)) 
   { 
    node_used[address[0]]=1; 
    node_used[address[1]]=1; 
   } 
   else if (address[num_genes_per_node-1]>15) 
   { 
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    node_used[address[0]]=1; 
    node_used[address[1]]=1; 
    node_used[address[2]]=1; 
   } 
  } 
 }   
 
   free(active_chromosome); 
} 
 
 
/* prints out a chromosome showing inactive genes as -1 */ 
void fprint_active_genes(int* chromosome,char name[30]) 
{ 
 int  i,j,index,node_label,write_bracket = 1; 
 int  num_unused_nodes=0; 
 int  num_nodes_active; 
 int  node_used[MAX_OUTPUT_SIZE]; 
 int* active_chromosome = NULL; 
 int  address[MAX_NUM_GENES_PER_NODE]; 
 FILE* fp; 
 
 
 active_chromosome = create_chromosome_space(); 
 
 fp=fopen(name,"a"); 
 
 fprintf(fp,"Inactive genes in this chromosome are marked with 
*\n"); 
 
 
 for (i=0;i<num_genes;i++) 
  active_chromosome[i]=-1; 
 for (i=num_genes-num_outputs;i<num_genes;i++) 
  active_chromosome[i]=chromosome[i]; 
 
 /* first look at chromosome and identify gates not used */ 
 /* these are all the outputs of gates which do not appear in the 
chromosome */ 
 for (i=0;i<num_nodes+num_inputs;i++) 
  node_used[i]=0; 
 /* all the nodes whose output is given by the output genes are 
active */ 
 for (i=num_genes-num_outputs;i<num_genes;i++) 
  node_used[chromosome[i]]=1; 
 
 for (i=num_nodes+num_inputs-1;i>=num_inputs;i--) 
 { 
  if (node_used[i]) 
  { 
   /* get input addresses and type of this gate */ 
   index=num_genes_per_node*(i-num_inputs); 
   for (j=0;j<num_genes_per_node;j++) 
   { 
    address[j]=chromosome[index+j]; 
    active_chromosome[index+j]=address[j]; 
   } 
   if ((address[num_genes_per_node-1]==2) || 
(address[num_genes_per_node-1]==4)) 
   { 
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    node_used[address[0]]=1; 
   } 
   else if ((address[num_genes_per_node-1]==3) || 
(address[num_genes_per_node-1]==5)) 
   { 
    node_used[address[1]]=1; 
   } 
   else if ((address[num_genes_per_node-1]>=6) && 
(address[num_genes_per_node-1]<=15)) 
   { 
    node_used[address[0]]=1; 
    node_used[address[1]]=1; 
   } 
   else if (address[num_genes_per_node-1]>15) 
   { 
    node_used[address[0]]=1; 
    node_used[address[1]]=1; 
    node_used[address[2]]=1; 
   } 
  } 
 } 
 
   node_label = num_inputs-1; 
   for (i=0;i<num_nodes*num_genes_per_node;i++) 
   { 
    if ((i+1)%num_genes_per_node == 0) 
    { 
     node_label++; 
     if (active_chromosome[i]<0) 
      fprintf(fp,"[*]:%d)\t",node_label); 
     else 
      
fprintf(fp,"[%d]:%d)\t",active_chromosome[i],node_label); 
           write_bracket = 1; 
    } 
    else 
    { 
   if (write_bracket == 1) 
    fprintf(fp,"("); 
 
      if (active_chromosome[i]<0) 
   fprintf(fp,"*,"); 
   else 
   fprintf(fp,"%d,",active_chromosome[i]); 
 
   write_bracket = 0; 
    } 
   } 
   fprintf(fp,"\t\t"); 
   for (i=0;i<num_outputs;i++) 
      
fprintf(fp," %d",active_chromosome[num_nodes*num_genes_per_node+i]); 
    
   for (i=num_inputs;i<num_inputs+num_nodes;i++) 
    if (!node_used[i]) 
     num_unused_nodes++; 
   num_nodes_active=num_nodes-num_unused_nodes; 
 
   fprintf(fp,"\nnumber of active gates is %d\n\n",num_nodes_active); 
   fclose(fp); 
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   free(active_chromosome); 
} 
 
/* this routine works out how many nodes are active */ 
int get_num_nodes_active(int* chromosome) 
{ 
 int   i,j,index; 
    int   address[MAX_NUM_GENES_PER_NODE]; 
 int   num_unused_nodes=0,num_nodes_active; 
 int   node_used[MAX_OUTPUT_SIZE]; 
 
 /* first look at chromosome and identify gates not used 
    these are all the outputs of gates which  
    do not appear in the chromosome */ 
 
 for (i=0;i<num_nodes+num_inputs;i++) 
  node_used[i]=0; 
 /* all the nodes whose output is given by the output genes are 
active */ 
 for (i=num_genes-num_outputs;i<num_genes;i++) 
  node_used[chromosome[i]]=1; 
 
 for (i=num_nodes+num_inputs-1;i>=num_inputs;i--) 
 { 
 
  if (node_used[i]) 
  { 
   /* get input addresses and type of this gate */ 
   index=num_genes_per_node*(i-num_inputs); 
   for (j=0;j<num_genes_per_node;j++) 
    address[j]=chromosome[index+j]; 
 
   if ((address[num_genes_per_node-1]==2) || 
(address[num_genes_per_node-1]==4)) 
   { 
    node_used[address[0]]=1; 
   } 
   else if ((address[num_genes_per_node-1]==3) || 
(address[num_genes_per_node-1]==5)) 
   { 
    node_used[address[1]]=1; 
   } 
   else if ((address[num_genes_per_node-1]>=6) && 
(address[num_genes_per_node-1]<=15)) 
   { 
    node_used[address[0]]=1; 
    node_used[address[1]]=1; 
   } 
   else if (address[num_genes_per_node-1]>15) 
   { 
    node_used[address[0]]=1; 
    node_used[address[1]]=1; 
    node_used[address[2]]=1; 
   } 
  } 
 } 
  
 for (i=num_inputs;i<num_inputs+num_nodes;i++) 
      if (!node_used[i]) 
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         num_unused_nodes++; 
 
 num_nodes_active=num_nodes-num_unused_nodes; 
 
 return num_nodes_active; 
 
} 
 
/* generate a starting population 
   from a chromosome read from a file (cgp.chr) 
*/ 
void read_from_chrom(int*** genotypes) 
{ 
 int   i,j,k; 
 FILE* fp; 
 
    fp=fopen("cgp.gen","r"); 
    if (!fp) 
    { 
  puts("Missing file cgp.gen (contains a genotype"); 
        exit(1); 
    } 
    else 
 { 
        /* make starting population copies of loaded chromosome */ 
  for (j=0;j<population_size;j++) 
        { 
   if (j==0) 
            { 
    k=0; 
    do 
    { 
     for (i=0;i<num_genes;i++) 
     
 fscanf(fp,"%d",&genotypes[j][k][i]); 
     k++; 
    } 
    while (!feof(fp)); 
 
    if ((k-1)!=num_chromosomes) 
    { 
     puts("ERROR. Number of chromosomes in 
cgp.gen does not match the expected number"); 
     puts("Check the number of chromosomes in 
the .par file"); 
     exit(0); 
    } 
            } 
            else 
            { 
    for (k=0;k<num_chromosomes;k++) 
     for (i=0;i<num_genes;i++) 
     
 genotypes[j][k][i]=genotypes[0][k][i]; 
            } 
        } 
  fclose(fp); 
 } 
} 
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/* This calculates the limits that are used in the calculation 
   of allowed gene values (alleles) */ 
void get_gene_limits(int column, int* limit_min, int* limit) 
{ 
 int limit_max; 
 
 limit_max=num_inputs+column*num_rows; 
 if (column<levels_back) 
  *limit_min=0; 
 else 
  *limit_min=num_inputs+(column-levels_back)*num_rows; 
 
 *limit=limit_max-(*limit_min); 
} 
 
/* returns a random valid connection gene that 
   obeys the constraints imposed by levels_back.  
   Also allows program inputs to disobey levels_back */ 
int get_connection_gene(int limit_min, int limit) 
{ 
 int limit_datas, rand_num; 
 int gene; 
 
 if (limit_min==0) 
  gene = newrand(limit); 
 else /* allows inputs to disobey levels_back */ 
 { 
  limit_datas = limit+num_inputs; 
  rand_num = newrand(limit_datas); 
  if (rand_num<limit) 
   gene = rand_num+limit_min; 
  else 
   gene = rand_num-limit; 
 } 
 
 return gene; 
} 
 
/* returns a random valid function gene */ 
int get_function_gene(void) 
{ 
 return allowed_functions[newrand(num_functions)]; 
} 
 
/* returns a random valid output gene */ 
int get_output_gene(void) 
{ 
 int limit_min,limit; 
 int output_gene; 
  
 limit_min=num_inputs+(num_cols-levels_back)*num_rows; 
 limit=levels_back*num_rows; 
 
    output_gene = newrand(limit)+limit_min; 
  
 return output_gene; 
} 
 
/* Calculates output of node in 8-bit format */ 
unsigned  char node_type(unsigned char in[MAX_NUM_GENES_PER_NODE], 
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                     unsigned code) 
{ 
   unsigned char result; 
 
   if (code==0)      /* constants */ 
      result=0; 
   else if (code==1) 
      result=MAXNUM; 
   else if (code==2) /* wire and inverter */ 
      result=in[0]; 
   else if (code==3) 
      result=in[1]; 
   else if (code==4) 
      result=~in[0]; 
   else if (code==5) 
      result=~in[1]; 
   else if (code==6) /* two input gate functions */ 
      result=(in[0] & in[1]); 
   else if (code==7) 
      result=(in[0] & ~in[1]); 
   else if (code==8) 
      result=(~in[0] & in[1]); 
   else if (code==9) 
      result=(~in[0] & ~in[1]); 
   else if (code==10) 
      result=(in[0]^in[1]); 
   else if (code==11) 
      result=(~in[0]^in[1]); 
   else if (code==12) 
      result=(in[0] | in[1]); 
   else if (code==13) 
      result=(in[0] | ~in[1]); 
   else if (code==14) 
      result=(~in[0] | in[1]); 
   else if (code==15) 
      result=(~in[0] | ~in[1]); 
   else if (code==16)  /* mux functions */ 
      result=((in[0] & ~in[2]) | (in[1] & in[2])); 
   else if (code==17) 
      result=((in[0] & ~in[2]) | (~in[1] & in[2])); 
   else if (code==18) 
      result=((~in[0] & ~in[2]) | (in[1] & in[2])); 
   else if (code==19) 
      result=((~in[0] & ~in[2]) | (~in[1] & in[2])); 
 
   return result; 
} 
 
/* Decodes a single cgp chromosome and executes it on a part. 
*/ 
unsigned char output_of_chromosome_on_one_part_on_one_image(int* 
chromosome, int part, int image) 
{ 
   register int i,k; 
   unsigned int index,function_type; 
   int count; 
   /* unsigned char output_of_cgp_program; */ 
   unsigned char in[MAX_NUM_GENES_PER_NODE]; 
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   /* load data_inputs into output */ 
 
   for (i=0;i<num_inputs;i++) 
    output[i]=data_inputs[image][part][i]; 
 
   count=num_inputs; 
   index=0; 
    
 /* process nodes */ 
   for (k=0;k<num_nodes;k++) 
   { 
  for (i=0;i<num_genes_per_node-1;i++) /* get input data to 
node */ 
   in[i]=output[chromosome[index+i]]; 
 
        function_type=chromosome[index+num_genes_per_node-1]; 
          
        output[count]=node_type(in,function_type); 
 
        count++; 
 
        index=index+num_genes_per_node; 
   } 
 /* process outputs */ 
   for (i=0;i<num_outputs;i++) 
   { 
       output[count]=output[chromosome[index]]; 
       index++; 
       count++; 
   } 
    
   /* check whether the cgp produce a number above or below a 
threshold 
   indicating the presence or absence of malignancy  
 
   fit =0; 
   for (i=0;i<num_outputs;i++) 
   { 
  output_of_cgp_program = output[end_count+i]; 
 
  if (malignant == 1) 
  { 
 
   if (output_of_cgp_program >= malignancy_threshold) 
    fit++; 
  } 
  else 
  { 
   if (output_of_cgp_program < malignancy_threshold) 
    fit++; 
 
  }  
   } 
*/ 
    
   /* divide the output of cgp (which is in range 0 to 255) by 4 
      to obtain valid white pixel counts per part */ 
   return (output[count-1]+3); 
} 
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/* get the output of cgp fro one part of one image and calculate 
   a fitness according to how close the output is to the  
   white pixel count in the image part */ 
unsigned char fitness_of_chromosome_on_one_part_on_one_image(int* 
chromosome, int part, int image) 
{ 
 unsigned char outvalue; 
 unsigned char fit; 
 
    outvalue = 
output_of_chromosome_on_one_part_on_one_image(chromosome, part, image); 
 
 /* 
    if (linear_fitness) 
  fit = 1.0 - (double)abs(number_white_pixels[image][part]-
outvalue)/64.0; 
 else 
  fit = 1.0/(1.0 + 
(double)abs(number_white_pixels[image][part]-outvalue)); 
    */ 
 /* NEW FITNESS METHOD */ 
    if ((outvalue >= 0) && (outvalue <= 43)) 
    { 
  fit = 0; 
 
    } 
 else if ((outvalue > 43) && (outvalue <= 2*43)) 
    { 
  fit = 1; 
 
    } 
 else if ((outvalue > 2*43) && (outvalue <= 3*43)) 
     { 
   fit = 2; 
 
     } 
 else if ((outvalue > 3*43) && (outvalue <= 4*43)) 
     { 
   fit = 3; 
 
     } 
 else if ((outvalue > 4*43) && (outvalue <= 5*43)) 
     { 
   fit = 4; 
 
     } 
 else if ((outvalue >5*43) && (outvalue <= 6*43)) 
     { 
   fit = 5; 
 
     } 
 
 /* 
 printf("\nnumber_white_pixels[%d] 
is %u\n",part,number_white_pixels[part]); 
 printf("\noutvalue is %u\n",outvalue); 
 
 getchar(); 
 */ 
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 return fit; 
} 
 
 
 
/* exceutes the genotype of an image to determine fitness 
  Note in training an image is a small collection of parts 
  of an image 
*/ 
unsigned char fitness_of_genotype_on_one_image(int** genotype, int 
image) 
{ 
 
 int part,i; 
 int fit = 0, final_fit=0; 
 int number[5]; 
 int *pmax; 
 
 
 /* 
 printf("\nIn fitness_of_genotype_on_one_image:\n"); 
    printf("\nnum_parts_per_image[%d] is %d\n",image, 
num_parts_per_image[image]);  
 getchar(); 
    */ 
 
 for (part = 0;part < num_parts_per_image[image]; part++) 
 { 
  fit = 
fitness_of_chromosome_on_one_part_on_one_image(genotype[0],part, 
image); 
  printf("\n fit for part %d is %d\n",part, fit); 
  if (fit = 0) 
  { 
   number[0]++; 
  } 
  else if (fit = 1) 
  { 
   number[1]++; 
  } 
  else if (fit = 2) 
  { 
   number[2]++; 
  } 
  else if (fit = 3) 
  { 
   number[3]++; 
  } 
  else if (fit = 4) 
  { 
   number[4]++; 
  } 
  else if (fit = 5) 
  { 
   number[5]++; 
  } 
  /* 
        printf("\npart is %d, fitness is %8.6lf\n",part,fit); 
  getchar(); 
  */ 
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 } 
 *pmax = number[0]; 
 for (i=0; i<6;i++) 
 { 
  if (*pmax < number[i]); 
  { 
     *pmax = number[i]; 
  } 
  final_fit = i; 
 } 
 
 
 
 
 
// return fit/(double)num_parts_per_image[image]; 
 return final_fit; 
} 
 
 
/* This runs all the chromosomes on all parts  
   of a sequence of images (in .dat format) 
*/ 
int fitness_get_best_genotype(int** genotype,int** best_genotype) 
{ 
 int i; 
 int total_fitness = 0.0; 
 
 
 /* 
 printf("\nIn fitness: num_images is %d\n", num_images); 
 getchar(); 
 */ 
 
 for (i = 0 ; i < num_images; i++) 
 { 
  /* fitness on image is scaled between 0 and 1.0 */ 
//  total_fitness = total_fitness + 
fitness_of_genotype_on_one_image(genotype,i); 
  total_fitness = total_fitness + get_best_genotype(genotype, 
best_genotype); 
 } 
 
 /* final fitness is scaled by number of images 
    this means that a perfect fitness is 1.0 */ 
 return (int)(total_fitness/num_images); 
 
} 
 
/******** TESt versions of the above fitness functions */ 
 
/* Decodes a single cgp chromosome and executes it on a part. 
*/ 
unsigned char test_output_of_chromosome_on_one_part_on_one_image(int* 
chromosome, int part, int image) 
{ 
   register int i,k; 
   unsigned int index,function_type; 
   int count; 
   /* unsigned char output_of_cgp_program; */ 
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   unsigned char in[MAX_NUM_GENES_PER_NODE]; 
 
 
   /* load data_inputs into output */ 
 
   for (i=0;i<num_inputs;i++) 
    output[i]=test_data_inputs[image][part][i]; 
 
   count=num_inputs; 
   index=0; 
    
 /* process nodes */ 
   for (k=0;k<num_nodes;k++) 
   { 
  for (i=0;i<num_genes_per_node-1;i++) /* get input data to 
node */ 
   in[i]=output[chromosome[index+i]]; 
 
        function_type=chromosome[index+num_genes_per_node-1]; 
          
        output[count]=node_type(in,function_type); 
 
        count++; 
 
        index=index+num_genes_per_node; 
   } 
 /* process outputs */ 
   for (i=0;i<num_outputs;i++) 
   { 
       output[count]=output[chromosome[index]]; 
       index++; 
       count++; 
   } 
    
   /* check whether the cgp produce a number above or below a 
threshold 
   indicating the presence or absence of malignancy  
 
   fit =0; 
   for (i=0;i<num_outputs;i++) 
   { 
  output_of_cgp_program = output[end_count+i]; 
 
  if (malignant == 1) 
  { 
 
   if (output_of_cgp_program >= malignancy_threshold) 
    fit++; 
  } 
  else 
  { 
   if (output_of_cgp_program < malignancy_threshold) 
    fit++; 
 
  }  
   } 
*/ 
    
   /* divide the output of cgp (which is in range 0 to 255) by 4 
      to obtain valid white pixel counts per part */ 
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   return (output[count-1]+1)/4; 
} 
 
/* get the output of cgp fro one part of one image and calculate 
   a fitness according to how close the output is to the  
   white pixel count in the image part */ 
double test_fitness_of_chromosome_on_one_part_on_one_image(int* 
chromosome, int part, int image) 
{ 
 unsigned char outvalue; 
 double fit = 0.0; 
 
    outvalue = 
test_output_of_chromosome_on_one_part_on_one_image(chromosome, part, 
image); 
 
    if ((outvalue == 0) && (test_number_white_pixels[image][part]==0)) 
  fit = 1.0; 
 else if ((outvalue != 0) && 
(test_number_white_pixels[image][part]!=0)) 
  fit = 1.0; 
 else if ((outvalue == 0) && 
(test_number_white_pixels[image][part]!=0)) 
        fit = -1.0; 
 else if ((outvalue != 0) && 
(test_number_white_pixels[image][part] ==0)) 
  fit = -1.0; 
 
 //printf("\ntest_number_white_pixels[%d] 
is %u\n",part,test_number_white_pixels[part]); 
 //printf("\noutvalue is %u\n",outvalue); 
 
 //getchar(); 
 
 return fit; 
} 
 
 
 
/* exceutes the genotype of an image to determine fitness 
  Note in training an image is a small collection of parts 
  of an image 
*/ 
double test_fitness_of_genotype_on_one_image(int** genotype, int image) 
{ 
 
 int part; 
 double fit = 0; 
 
 /* 
 printf("\nIn fitness_of_genotype_on_one_image:\n"); 
    printf("\nnum_parts_per_image[%d] is %d\n",image, 
num_parts_per_image[image]);  
 getchar(); 
    */ 
 
 for (part = 0;part < test_num_parts_per_image[image]; part++) 
 { 
228 
 
  fit = fit + 
test_fitness_of_chromosome_on_one_part_on_one_image(genotype[0],part, 
image); 
 
  /* 
        printf("\npart is %d, fitness is %8.6lf\n",part,fit); 
  getchar(); 
  */ 
 } 
 
 
 return fit/(double)test_num_parts_per_image[image]; 
} 
 
/* This runs all the chromosomes on all parts  
   of a sequence of images (in .dat format) 
*/ 
double test_fitness(int** genotype) 
{ 
 int i; 
 double total_fitness = 0.0; 
 
 /* 
 printf("\nIn fitness: num_images is %d\n", num_images); 
 getchar(); 
 */ 
 
 for (i = 0 ; i < test_num_images; i++) 
 { 
  /* fitness on image is scaled between 0 and 1.0 */ 
  total_fitness = total_fitness + 
test_fitness_of_genotype_on_one_image(genotype,i); 
 } 
 
 /* final fitness is scaled by number of images 
    this means that a perfect fitness is 1.0 */ 
 return total_fitness/test_num_images; 
} 
 
 
/* prints out a matrix showing the output of the CGP programs for each 
part. 
   It shows original white pixels, cgp output and the difference  
   It does this for each image. 
*/ 
void fprint_best_genotype_output(int**  best_genotype, char name[], 
char imagename[], int image) 
{ 
 int part; 
 unsigned char outvalue; 
 int fitness,fit; 
 int count[5]={0,0,0,0,0}; 
 
 FILE* fp; 
 
 fp = fopen(name,"w"); 
 
 
 fprintf(fp,"White pixel values for image %s\n",imagename); 
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 fprintf(fp,"malignancy level for image %s is %d\n", imagename, 
malignancy_level); 
 
// for (part = 0; part < num_parts_per_image[image];part++) 
// { 
//  fprintf(fp, "%4u",number_white_pixels[image][part]); 
// } 
// fprintf(fp,"\n"); 
 
 fprintf(fp,"\n\nCGP output values for best genotype on 
image %s\n",imagename); 
 
 for (part = 0; part < num_parts_per_image[image];part++) 
 { 
  outvalue = 
output_of_chromosome_on_one_part_on_one_image(best_genotype[0],part, 
image); 
  fitness = 
fitness_of_chromosome_on_one_part_on_one_image(best_genotype[0],part, 
image,&count[5]); 
 
  fprintf(fp, "%4u",fitness); 
 } 
 fit = fitness_of_genotype_on_one_image(best_genotype[0], image); 
 fprintf(fp,"\n\nmalignancy_level for best genotype on image %s 
is %d\n",imagename, fit); 
 fprintf(fp,"\n"); 
    fprintf(fp,""); 
 fclose(fp); 
 
} 
 
/* prints out a matrix showing the output of the CGP programs for each 
part. 
   It shows original white pixels, cgp output. 
   It does this for each test image. 
*/ 
void fprint_best_genotype_output_on_test_image(int**  best_genotype, 
char name[], char imagename[], int image) 
{ 
 int x, y; 
 int part; 
 unsigned char outvalue; 
 
 FILE* fp; 
 
 fp = fopen(name,"w"); 
 
 
 fprintf(fp,"White pixel values for image %s\n",imagename); 
 
 part = 0; 
 for (y = 0; y < num_yparts; y++) 
 { 
  for (x = 0; x < num_xparts; x++) 
  { 
   fprintf(fp, 
"%4u",test_number_white_pixels[image][part]); 
   part++; 
  } 
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  fprintf(fp,"\n"); 
 } 
 
 fprintf(fp,"\n\nCGP output values for best genotype on 
image %s\n",imagename); 
 
 part = 0; 
 for (y = 0; y < num_yparts; y++) 
 { 
  for (x = 0; x < num_xparts; x++) 
  { 
   outvalue = 
test_output_of_chromosome_on_one_part_on_one_image(best_genotype[0],pa
rt, image); 
   part++; 
 
   fprintf(fp, "%4u",outvalue); 
  } 
  fprintf(fp,"\n"); 
 } 
 
 fclose(fp); 
 
} 
 
 
 
/* creates initial population of chromosomes 
   either having been generated from a single 
   chromosome from a file or by generating 
   an entire random population  
*/ 
void initialise(int*** genotypes) 
{ 
    int  j,k, pop_member,row,col; 
 int  count; 
    int  limit=0,limit_min=0; 
 
    if (run_from_chrom) 
    { 
  read_from_chrom(genotypes); 
    } 
    else  /* generate random population */ 
    { 
  for (pop_member = 0; pop_member < population_size; 
pop_member++) 
  { 
   for (k = 0; k < num_chromosomes; k++) 
   { 
    count = 0; 
    for (col=0;col<num_cols;col++) 
    { 
     get_gene_limits(col,&limit_min,&limit); 
 
     for (row=0;row<num_rows;row++) 
     { 
      /* connection genes */ 
      for (j=0;j<num_genes_per_node-
1;j++) 
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 genotypes[pop_member][k][count+j]=get_connection_gene(limit_min,
limit); 
 
      /* function gene */ 
     
 genotypes[pop_member][k][count+num_genes_per_node-
1]=get_function_gene(); 
      count=count+num_genes_per_node; 
     } 
    }  
    for (j=0;j<num_outputs;j++) 
    
 genotypes[pop_member][k][count+j]=get_output_gene(); 
   } /* k loop */ 
 
 
  } /* pop_member loop */ 
    } /* generate random population */ 
} /* end of function */ 
 
 
 
/* calculate best population fitness and the best genotype */ 
double  get_best_genotype(int*** genotypes, 
                          int**  best_genotype) 
 
{ 
 int i, k,j; 
    double fitness_min; 
    int output; 
    int best_member; 
 double fit; 
 
 fitness_min=5.0; 
    best_member=0; 
 
    for (i = 0; i < population_size; i++) 
    { 
  /* printf("\npop member is %d\n",i); */ 
  fit =fabs((double)malignancy_level- 
fitness_of_genotype_on_one_image(genotypes[i],i)); 
 
 
  if (fit < fitness_min) 
  { 
   fitness_min = fit; 
   best_member = i; 
  } 
 
  if (fit == perfect_fitness) /* we solved the problem, so 
stop */ 
   break; 
 } 
 
 /* here is the best chromosome */ 
 for (k = 0;k < num_chromosomes; k++) 
 { 
  for (i = 0; i < num_genes; i++) 
   best_genotype[k][i]=genotypes[best_member][k][i]; 
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 } 
 return fitness_min; 
} 
 
 
 
 
/* checks to see if the gene is not an output gene */ 
int is_not_output_gene(int gene) 
{ 
 return (gene < num_genes_per_node*num_nodes); 
} 
 
/* checks to see if the gene is a function gene */ 
int is_function_gene(int gene, int locus) 
{ 
 return (is_not_output_gene(gene) && (locus==(num_genes_per_node-
1))); 
 
} 
 
/* calculates how many mutations to do per chromosome */ 
int get_num_mutant(int num_genes, double per_cent_mutate) 
{ 
 return (int)(num_genes*per_cent_mutate/100.0); 
} 
 
/* carry out one mutation on one chromosome */ 
void mutate(int*  chromosome) 
{ 
 int which_gene,which_locus; 
 int limit,limit_min; 
 int col; 
 
 which_gene=newrand(num_genes); 
 which_locus=which_gene % num_genes_per_node; 
 
 if (is_not_output_gene(which_gene)) 
 { 
  if (is_function_gene(which_gene,which_locus)) 
  { 
   if (num_functions == 1) /* redirect the mutation to 
a connection */ 
   { 
    which_locus=newrand(num_genes_per_node-1); 
    which_gene=which_gene-num_genes_per_node-
1+which_locus; 
   } 
   chromosome[which_gene]=get_function_gene(); 
  } 
  else /* it is a connection gene */ 
  { 
   col = which_gene/(num_genes_per_node*num_rows); 
    
   get_gene_limits(col,&limit_min,&limit); 
        
  
 chromosome[which_gene]=get_connection_gene(limit_min,limit); 
  } 
 } 
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 else /* it is an output gene */ 
 { 
  chromosome[which_gene]=get_output_gene(); 
 } 
} 
 
/* find out how many mutations to do and mutate the chromosome */ 
void mutate_chromosome(int*  chromosome) 
{ 
 int i; 
 int num_mutations; 
 
 num_mutations = get_num_mutant(num_genes,per_cent_mutate); 
 
 for ( i = 0; i < num_mutations; i++) 
 { 
  mutate(chromosome); 
 } 
 
} 
 
 
void mutate_genotype(int** genotype) 
{ 
 int k; 
 
 for (k = 0; k < num_chromosomes; k++) 
  mutate_chromosome(genotype[k]); 
} 
 
 
/* (1+lambda evolutionary strategy where lamda = population size -1 
   This defines the EA algorithm note that using mu=1 and  
   lambda = population_size -1 
   should give the same. 
*/ 
void generate_new_pop_es(int*** genotypes, 
       int**  best_genotype) 
{ 
 int i,j,k; 
 
     /* copy best_chromosome into last member of chromosome array */ 
 for (k = 0; k < num_chromosomes; k++) 
 { 
  for (j = 0; j < num_genes; j++) 
   genotypes[population_size-
1][k][j]=best_genotype[k][j]; 
 } 
    /* generate new population by mutating all but last */ 
    for (i=0;i<population_size-1;i++) 
    { 
  for (k = 0; k < num_chromosomes; k++) /* copy all 
chromosomes in genotype */ 
  { 
   for (j = 0; j < num_genes; j++) /* copy  best 
genotype */ 
    genotypes[i][k][j]=best_genotype[k][j]; 
  } 
  /* mutate the genotype */ 
  mutate_genotype(genotypes[i]); 
234 
 
    } 
} 
 
 
 
/* allocate space for a single chromosome */ 
int* create_chromosome_space(void) 
{ 
 int* chromosome = NULL; 
  
 chromosome=(int*)calloc(num_genes,sizeof(int)); 
    if (chromosome==NULL) 
    { 
  printf("ERROR.Not enough memory for a chromosome of this 
length\n"); 
        exit(0); 
    } 
 return chromosome; 
} 
 
/* allocate space for a collection of chromosomes */ 
int** create_genotype_space(void) 
{ 
 int k; 
 int **genotype = NULL; 
 
 genotype =(int** )calloc(num_chromosomes,sizeof(int*)); /* 
create space for pointers to int pointers */ 
 if (genotype==NULL) 
 { 
       printf("ERROR.Can not allocate space for this many genotype 
pointers\n"); 
       exit(0); 
 } 
  
 for (k = 0;k < num_chromosomes; k++) /* create array of pointers 
to ints (genes) */ 
 { 
   genotype[k] = create_chromosome_space(); 
      if (genotype[k]==NULL) 
      { 
         printf("ERROR.Not enough memory for genotypes of this 
length\n"); 
         exit(0); 
      } 
   } 
 
 return genotype; 
} 
 
/* allocate space for population of genotypes */ 
int*** create_genotypes_space(void) 
{ 
 int i; 
 int ***genotypes = NULL; 
 
 genotypes = (int*** )calloc(population_size,sizeof(int**)); /* 
create space for pointers to int pointers */ 
 if (genotypes == NULL) 
 { 
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       printf("ERROR.Can not allocate space for this many chromosome 
pointers to pointers\n"); 
       exit(0); 
 } 
  
 for (i=0;i<population_size;i++) /* create array of pointers to 
ints (genes) */ 
 { 
  genotypes[i] = create_genotype_space(); 
  if (genotypes[i]== NULL) 
  { 
    printf("ERROR.Not enough memory for a 
genotype %d of this length\n",i); 
    exit(0); 
  } 
 } 
 
 return genotypes; 
} 
 
 
/* release memory */ 
void free_genotypes(int*** genotypes) 
{ 
 int i; 
 
 for (i = 0; i < population_size; i++) 
 { 
  free_genotype(genotypes[i]); 
 } 
 free(genotypes); 
} 
 
/* release memory */ 
void free_genotype(int** genotype) 
{ 
 int k; 
 
 for (k = 0; k < num_chromosomes; k++) 
  free_chromosome(genotype[k]); 
 
 free(genotype); 
} 
 
/* release memory */ 
void free_chromosome(int* chromosome) 
{ 
 free(chromosome); 
} 
 
/* Do a run of the EA */ 
double  EA(int* best_gen, int run,  
  char prog[MAX_NUM_LETTERS], char stat[MAX_NUM_LETTERS]) 
{ 
 int  i,gen_index; 
 double best_fit=-1e10, previous_best_fit=-1e10; 
 double  test_fit = 0.0; 
 char filename[MAX_NUM_LETTERS]; 
 int*** genotypes; 
 int** best_genotype; 
236 
 
 FILE* fp; 
 
 genotypes = create_genotypes_space(); 
 best_genotype = create_genotype_space(); 
 
 initialise(genotypes); 
 
 for (gen_index=1;gen_index<=num_generations;gen_index++) 
 { 
  if (gen_index % report_interval==0) 
   printf("\nGENERATION is %d",gen_index); 
 
  /* find new best chromosome and its fitness */ 
  /* printf("\nJust before get_best_genotype\n"); */ 
 
  best_fit = get_best_genotype(genotypes,best_genotype); 
  test_fit = test_fitness(best_genotype); 
 
 
     /* printf("\nJust after get_best_genotype\n"); */ 
 
  if (best_fit > previous_best_fit) /* we have an 
improvement */ 
  { 
        if ((progress_report > 0) && (progress_report < 3)) 
   { 
           fp=fopen(prog,"a"); 
           printf("\nGENERATION is %u Best fitness is 
now %10.8lf",gen_index,best_fit); 
           printf("\nGENERATION is %u Best test_fitness is 
now %10.8lf",gen_index,test_fit); 
 
           fprintf(fp,"\nGENERATION is %u     Best fitness is 
now %10.8lf",gen_index,best_fit); 
           fprintf(fp,"\nGENERATION is %u     Test fitness is 
now %10.8lf",gen_index,test_fit); 
 
    fprintf(fp,"\nThe chromosome is\n"); 
           fclose(fp); 
 
    if (progress_report == 1) 
           
 fprint_a_user_readable_genotype(best_genotype,prog,1); 
 
   } 
 
   if (progress_report == 3) 
   { 
    fp=fopen(stat,"a"); 
   
 fprintf(fp,"%d\t%8.6lf\t%8.6lf\n",gen_index,best_fit,test_fit); 
    fclose(fp); 
   } 
 
   *best_gen = gen_index; 
   previous_best_fit = best_fit; 
  } 
  /* jump out of run if maximum fitness acheived */ 
  if (best_fit == perfect_fitness)  
  { 
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   break; 
   gen_index++; 
  } 
  else 
  { 
   generate_new_pop_es(genotypes,best_genotype); 
  } 
 } 
 
 
 fp=fopen("cgp.txt","a"); 
 fprintf(fp,"Run %d and gen %d acheived 
fitness %10.8lf\n",run,*best_gen,best_fit); 
 fprintf(fp,"Here is the chromosome\n"); 
 fclose(fp); 
 
 fprint_a_user_readable_genotype(best_genotype,"cgp.txt",1); 
 
 /* 
 
 fprint_best_genotype_classification(best_genotype,"cgpbest-
classification.txt"); 
 */ 
 
 /* write output of cgp for all images to files */ 
 for (i = 0; i < num_images; i++) 
 { 
  sprintf(filename,"cgpbest-output-run%d-image%d.txt",run, 
i); 
  fprint_best_genotype_output(best_genotype, filename, 
image_names[i], i); 
 } 
 
 /* get testing image names. These are complete dat files */ 
 get_image_names(0); 
 
 /* read in image data for all testing images */ 
 printf("\nReading testing image data\n"); 
 for (i = 0; i < num_images; i++) 
 { 
  read_data(image_names[i],i);  
 } 
 
 
 /* write output of cgp for all images to files */ 
 for (i = 0; i < num_images; i++) 
 { 
  sprintf(filename,"cgpbest-output-run%d-
testimage%d.txt",run, i); 
  fprint_best_genotype_output_on_test_image(best_genotype, 
filename, image_names[i], i);  
 } 
 
 
 fprint_a_genotype(best_genotype,"cgp.gen",0); 
 
 free_genotypes(genotypes); 
 
 free_genotype(best_genotype); 
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 return best_fit; 
} 
 
 
/* do mutiple runs of EA and write out results */ 
void run_EA(int num_runs_total) 
{ 
 int  j; 
 int  best_gen,run; 
 double worst_of_best_fit=1.0e10,best_of_best_fit=-1e10; 
 double fitness_final=0.0; 
 char prog[20],stat[20],runstring[10]; 
 double fitnesses[1000], temp; 
 double av_fitness=0.0,av_best_gen=0.0,st_dev=0.0; 
 FILE* best; 
 FILE* fp; 
 
 for (run=0;run<num_runs_total;run++) 
 { 
 
  sprintf(runstring,"%d",run); /* store run as characters */ 
  printf("\n\nRUN %d\n",run); 
 
  if (progress_report>0) 
  { 
   strcpy(prog,"cgp"); 
   strcat(prog,runstring); 
 
   strcpy(stat,prog); 
   strcat(prog,".prg"); /* create .prg file name */ 
   strcat(stat,".txt"); /* create .txt file name */ 
 
   fp=fopen(prog,"w");  /* create empty .prg file */ 
   fclose(fp); 
 
   fp=fopen(stat,"w"); 
   fprintf(fp,"\nRUN %d\n\n",run); 
   fprintf(fp,"Gen\tfit\ttest fitness\n",run); 
   fclose(fp); 
  } 
 
  fitness_final =  EA(&best_gen,run,prog,stat); 
 
        if (fitness_final < worst_of_best_fit) 
   worst_of_best_fit=fitness_final; 
 
  if (fitness_final > best_of_best_fit) 
  { 
   best_of_best_fit=fitness_final; 
    
  } 
 
   
  fitnesses[run]=(double)fitness_final; 
  av_fitness=av_fitness+(double)fitness_final; 
  if (fitness_final == num_chromosomes) 
   av_best_gen=av_best_gen+(double)best_gen; 
   } 
 
   av_fitness=av_fitness/((double)num_runs_total); 
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   av_best_gen=av_best_gen/((double)num_runs_total); 
 
   st_dev=0.0; 
   for (j=0;j<num_runs_total;j++) 
   { 
  temp=(fitnesses[j]-av_fitness); 
  temp=temp*temp; 
  st_dev=st_dev+temp; 
   } 
 
   st_dev=st_dev/(double)num_runs_total; 
   st_dev=sqrt(st_dev); 
 
   best=fopen("cgp.txt","a"); 
   fprintf(best,"\naverage fitness  %6.4lf\n",av_fitness); 
   fprintf(best,"\nstd dev          %6.4lf\n\n",st_dev); 
   fprintf(best,"\nThe best solution of all runs  
is  %6.2lf\n",best_of_best_fit); 
   fprintf(best,"\nThe worst solution of all runs 
is  %6.2lf\n",worst_of_best_fit); 
   fprintf(best,"\nOf perfect solutions, the average number of 
generations is  %6.4lf\n",av_best_gen); 
   fclose(best); 
 
} 
 
 
 
 
 
 
 
 
 
 
 
 
240 
 
List of Abbreviations 
CGP            Cartesian Genetic Programming 
MCGP        Multi-chromosomes Cartesian Genetic Programming 
CAD           Computer Aided Detection 
CT               Computer Tomography 
CC               CranioCaudal 
DDSM         Digital Database for Screening Mammography 
DCIS           Dutual Carcinoma In Situ 
ES                Evolutionary Strategies 
EA                Evolutionary Algorithm 
EC                Evolutionary Computation 
EP                 Evolutionary Programming 
FN                False Negative 
FP                 False Positive 
GA                Genetic Algorithm 
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GP                Genetic Programming 
ISO               InferoSuperior Oblique 
LLNL           Lawerance Livermore National Laboraty 
LCIS             Lobular Carcinoma In Situ 
MRI              Magnetic Resonance Imaging 
MIAS            Mammography Imaging Analysis Society 
MLO             MedioLateral Oblique 
ML                MedioLateral 
NHS              National  Health Service 
NPV              Negative Predictive Value 
PPV               Positive Predictive Value 
|ROI               Region of Interests 
TN                 True Negative 
TNR              True Negative Rate 
TP                    True Positive 
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TPR                  True Positive Rate 
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